The feasibility of monitoring exercise intensity in mechanically ventilated patients recovering from critical illness in Intensive Care by Black, CJ
The feasibility of monitoring exercise
intensity in mechanically ventilated
patients recovering from critical illness
in Intensive Care
Claire Black
University College London
Thesis submitted for the award of the degree of
Doctor of Philosophy
2
Declaration
I, Claire Black confirm that the work presented in this thesis is my own. Where information
has been derived from other sources, I confirm that this has been indicated in the thesis.
Signed...............................
November 2015
3
4
Acknowledgements
I have learnt and achieved far more in the last six years than could ever be documented in these
pages. For this I am indebted to many people and many organisations. My supervisors; Prof.
Mervyn Singer, not only for his boundless enthusiasm and belief that I could embark on and
complete this PhD, but his inclusion of everyone who steps foot into his lab, and Prof. Mike
Grocott for his guidance and whose timely reality checks were well-founded. To the NIHR, for
funding my clinical doctoral research fellowship and giving me the opportunity to investigate
an area of my clinical life I am so passionate about. To Victor Ford and Dr. George Latter at
UCH, both now retired, for their technical advice in the early stages. Dr. Stewart Laing from
the British Olympic Medical Institute for sharing his expertise on the Douglas Bag technique.
Dr. Parvis Habibi, for the loan of the Deltatrac, a device I begrudgingly came to admire. To
Alison Gordon, Nikki Webster and the ICU team at UCH for making the data collection pos-
sible. To all the patients and their families who participated with such enthusiasm and interest.
To the friends I made in the Singer Lab over the years; Saima Saeed, Bernardo Bollen-
Pinto, Alex Dyson, Neil Hill, Nas Ekbal, Nish Arul, Steve Harris, Vic Khaliq, Anna Lac and
Anna Kleyman, I owe you my sanity.
To Zac for his humorous acceptance of my “doing work”. And finally to Bruce; sounding-
board, proof reader and without whose unwavering support none of the following would have
been possible. Thanks for putting up with me.
5
6
Data analysis acknowledgements
All data was analysed using R [1]. The graphs were plotted using ggplot2 [2], scatterplot3d [3],
RColorBrewer [4], gridextra [5] and lattice [6]. The tables were generated using plyr [7], xtable
[8], texreg [9] and tidyr [10]. Statistical analysis was carried out using lme4 [11], influence.ME
[12], PredictABEL [13], pROC [14], caret [15], e1071 [16] and merTools [17].
7
8
Abstract
Critical illness survivorship is frequently characterised by profound long-term physical and
psychological disabilities. These arise as a result of the complex interaction between the
patho-physiological effects of critical illness, clinical interventions and the impact of prolonged
bed rest on physical and psychological health. Early rehabilitation in the ICU is an important
intervention that can overcome some of the devastating impacts of critical illness on patients
and their carers.
However, with little or no scientific basis for its prescription and no validated means of
assessing individual patient workload during rehabilitation, a “one-size-fits-all” approach is
generally adopted. In contrast, the field of sports science has an extensive literature base
describing the optimisation of individual training programs. This thesis explores the potential
translation of key precepts of exercise physiology into the ICU setting in order to quantify
the workload during rehabilitation in mechanically ventilated (MV) patients recovering from
critical illness. Breath-by-breath-gas-exchange-analysis (BBGEA) is the gold standard for
measuring exercise capacity and intensity in non-ventilated individuals. However, validated
devices in MV patients are lacking.
In this thesis the MedGraphics Ultima, a BBGEA device, was validated in the critical care
setting, within the limits of two reference techniques; Douglas bag collection and Deltatrac II.
The feasibility of using BBGEA in patients rehabilitating in the ICU and the oxygen cost of
this rehabilitation were then investigated. I established that, while this device is an invaluable
research tool, it is impractical for day-to-day clinical practice. I further identified that the
oxygen cost of rehabilitation activities in the ICU is not directly activity-dependent. I then
developed two models to generate proxy values of oxygen consumption, during rehabilitation
interventions, evaluating their performance with a small validation sample.
The huge variations in the exercise load of rehabilitation interventions between and within
patients highlights the need to establish personalised exercise regimens.
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Chapter 1
Introduction
Since Margaret Herridge’s landmark paper [18] on the poor physical outcomes of 109 ARDS
survivors, numerous papers have described the experience of surviving critical illness [19–
23]. These reports highlight survivorship as a significant challenge facing the critical care
community [24]. Characteristically, the complex interaction of physical, cognitive and men-
tal health sequelae render patients immobile, reliant on carer support for activities of daily
living, unable to process simple information and frequently suffering post-traumatic stress
syndromes. The development of rehabilitation strategies to overcome the devastating legacy
of critical illness on its survivors and their carers has become a priority within the critical care
community. Particular attention is being paid to promoting early activity within the ICU.
The expectation is to minimise the patho-physiological effects of critical illness, its subsequent
therapies and the impact of prolonged bed rest on short and long-term functional outcomes.
The absence of a theoretical framework for the mechanisms of injury and recovery contin-
ues to hinder the development of preventative strategies and the design of appropriate later
interventions. So with little or no scientific basis for its prescription, clinicians are compelled
to take a pragmatic approach to the rehabilitation of patients recovering from critical illness.
We can not accurately identify those patients who have the multi-system capacity to respond
to rehabilitation interventions. Nor can we identify the intensity or duration of the interven-
tion that will have the most value for an individual patient. Moreover, having provided the
intervention, we have yet to identify a consistent way to measure outcome [25].
This thesis aims to address just one of these issues; how to quantify the intervention of
rehabilitation. Given that many rehabilitation interventions are probably dose-responsive,
regardless of the underpinning mechanism, it is a reasonable assumption that most patients
enrolled in interventional studies and, indeed, receiving rehabilitation in the acute setting, are
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either being under or over-trained. This raises very real questions for clinicians; How do we get
the training load right for each of our mechanically ventilated patients? How do we ensure we
do not over-train some patients, potentially slowing their weaning, physical and psychological
recovery, while not under-training others, holding them back and not allowing them to reach
their full potential?
My overall aim is to establish a method of quantifying rehabilitation interventions in mech-
anically ventilated patients with, and recovering from, critical illness in the ICU.
My objectives are.
Objective 1: To validate a medical device to measure oxygen consumption in mechanically
ventilated patients.
Objective 2: To develop a standardised reproducible exercise stimulus.
Objective 3: To identify a method of quantifying rehabilitation interventions.
Objective 4: To validate the exercise quantification tool.
In this thesis I shall first provide an overview of survivorship following critical illness and
the role that deteriorating physical function takes in the subsequent disability experienced
by the patient. To better inform the theoretical framework for prevention of deterioration
or recovery of physical function, I shall then take a closer look at impairments that lead to
these physical function deficits, highlighting the need to quantify rehabilitation interventions.
Following on from this I will review the rapidly growing literature on rehabilitation in the
acute care setting in the context of global variations in both clinical practice and cultural
ICU differences, and then this literatures translation into practice. Having recognised the
need for a validated tool to quantify rehabilitation interventions, I shall then review possible
techniques of doing this in mechanically ventilated patients, identifying one method; breath-
by-breath-gas-exchange-analysis (BBGEA), as worthy of further investigation. The fourth
chapter covers validation of the BBGEA equipment in the critical care setting, with a section
on the challenges using this technique in mechanically ventilated patients. The fifth chapter
investigates the feasibility of using this technique in patients rehabilitating in ICU and the
oxygen cost of this rehabilitation. The sixth chapter deals with a potential way to quantify
rehabilitation interventions using BBGEA, its translation into clinical practice and a small
validation sample of the models created. The final chapter draws all this together and looks
to future work.
Chapter 2
Physical function following
critical illness
2.1 Survivorship following critical illness
In 2003 Margaret Herridge published her landmark paper on the physical outcomes of 109
acute respiratory distress syndrome (ARDS) survivors [18]. Numerous papers describing the
experience of surviving critical illness have since been published [19–23]. These reports high-
light survivorship as a significant challenge facing the critical care community [24]. Charac-
teristically, the complex interaction of physical, cognitive and mental health sequelae render
patients immobile, reliant on carer support for activities of daily living, unable to process
simple information, and frequently suffering from post-traumatic stress syndromes.
2.1.1 Sub-cohorts
The all-encompassing term of ICU survivorship accommodates several sub-cohorts of patients
with different long-term survival rates, rehabilitation trajectories, caregiver burdens and on-
going health care costs [26]. A crude but none-the-less pragmatic way to stratify patients has
been put forward by Kress and Herridge [27]. They suggest a continuum of worsening phys-
ical disability from young ARDS through “chronic critical illness” to “debilitated elderly”.
Essentially, poorer outcomes are seen with increasing physiological age.
2.1.2 Survival
Hospital and one year survival following mechanical ventilation for critical illness depends on
various factors such as the patient’s age, comorbidities, underlying condition and the duration
of mechanical ventilation. Only 33% of elderly patients ≥65 years survive to hospital discharge
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[28], compared to 60% of ARDS patients with a mean age of 47 years [18] and 71% of pro-
longed mechanical ventilation (PMV) patients with a mean age of 55 years [29]. At one year,
survival is 22%, 50% and 55% respectively for each cohort. Chronological age is a controversial
predictor of survival from critical illness [30, 31]. However, physiological age, accounting for
the co-morbidity burden, physiological reserve and the trajectory of health prior to the critical
illness, may be much more important [26].
2.1.3 Health-Related Quality of Life
A systematic review of health related quality of life (HRQOL) during post-discharge follow-up,
published in 2005, found ICU survivors had significantly lower HRQOL scores than the general
population in all SF-361 domains. After 12 months, 2 of the 4 studies reviewed, found clinically
meaningful improvement in each SF-36 domain except mental and general health perceptions.
The majority of studies found that age and severity of illness predicted adverse physical
function outcomes [32]. A more recent review [33] found that survivors of critically illness had
a lower HRQOL than an age and gender-matched population. Interestingly, HRQOL differed
according to the patients diagnostic category. The most significant reductions in quality of
life were seen in patients with severe ARDS, PMV, severe trauma and severe sepsis.
2.1.4 Physical function
A consistent feature of survivorship from critical illness is the profound deterioration in long-
term physical function. The extent and trajectory of recovery is modulated by numerous
factors [26, 33, 34]. Herridge’s original report described a group of ARDS survivors with me-
dian six-minute walk distances (6MWD)2 that were 49%, 64% and 66% of predicted at 3,6
and 12 months post-discharge, respectively. Later follow-up revealed ongoing physical function
problems at 5 years, with median 6MWD still only 76% of predicted [35]. Subsequent studies
of similar cohorts have also demonstrated similar outcomes, with a relative plateau in recov-
ery of the physical outcome measures at 12 months post-acute lung injury (ALI) [35–39]. In
contrast, in a cohort of 126 patients who received ventilation for >4 days with a tracheostomy,
or >21 days without, of those alive at one year, only 9% had no functional dependency, 26%
had moderate dependency, while 21% had complete functional dependency [29].
The impact of pre-illness functional status on long-term outcomes has been borne out in a
number of papers. In a prospective Spanish study of 230 previously healthy, elderly patients
1The Short Form-36, is a 36-item, patient-reported survey of patient health. There are eight sections;
vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role
functioning, social role functioning and mental health.
26MWD, the distance that a patient can walk on a flat, hard surface in a period of 6 minutes.
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(≥65 years), with a Barthel Index (BI)3 score ≥75, and without cognitive impairment, only
112 (48.9%) were alive after 12 months. The survivors demonstrated a significant decrease
in functional autonomy and quality of life measured by EQ-5D4 compared to their baseline
(pre-illness) status (p <0.001). Multivariate analysis shows a higher BI (≥60) and EQ-5D at
hospital discharge is associated with full functional recovery (p <0.01) at 12 months [40]. A
prospective Israeli study of patients with greater functional dependency on admission, with
20% having a functional independence measure (FIM)5 <60, had a 1 year survival of 22%. At
this time point, only 11% of the original cohort had a FIM score ≥90, equating to living at
home independently [28].
The patient’s physical functional trajectory prior to admission impacts on both survival
and the trajectory of physical recovery on discharge. Patients generally experience a stepwise
deterioration in physical function on admission to ICU. This stepwise deterioration is greater
than a matched hospital cohort. Ferrante et al modelled three physical function trajectories
(minimal, mild-to-moderate and severe disability), before and after ICU admission in 281 in-
dividuals aged ≥70 years. They found the severity of disability increased over the year prior
to admission in the mild-to-moderate and severe groups, but not in the minimal disability
group. A quarter of those with minimal disability either died or became severely disabled.
Forty percent with mild-to-moderate pre-ICU disability transitioned to severe disability and
25% died. Of those with severe pre-ICU disability, 33% experienced early death, while the
survivors remained severely disabled [41].
To unpick the complex interaction of pre-admission functional levels with a number of other
factors, Barnato et al [20] followed 26,072 Medicare beneficiaries; i.e. an aged population >70
years. Those who received mechanical ventilation were more likely to have worse baseline
mobility, activity of daily living (ADL) disability scores and cognitive function. However,
their prior functional status alone could not explain the increase in disability beyond that
seen in survivors of hospitalisation alone.
3The Barthel Index (BI) is composed of 10 weighted items. The original score was marked out of 20; higher
scores represent a greater degree of independence. Subsequent studies have sought to improve the sensitivity
of the scale by extending it to 100 points.
4The EuroQol 5 dimensions (EQ-5D), comprises of five dimensions of health: mobility, ability to self-care,
ability to undertake usual activities, pain and discomfort, and anxiety and depression. There are five levels
under each domain.
5The Functional Independence measure (FIM) includes 18 items, 5 measure cognition and 13 are physical
domains based on the Barthel Index. Each item is scored from 1 to 7 and is based on the level of independence,
(1 represents total dependence and 7 complete independence). Possible scores range from 18 to 126.
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2.1.5 Psychological function
The psychological sequelae of an ICU admission can be broadly categorised as depression,
anxiety, post-traumatic stress and cognitive dysfunction. All of these are strongly associated
with negative perceptions of HRQOL [42–45]. Reports of the prevalence of these disorders
in the literature are inconsistent; while these conditions do not occur in isolation there is a
tendency to report them as isolated occurrences.
In a systematic review involving 1213 ARDS survivors enrolled in 10 studies [46], the me-
dian point prevalence of clinically significant depressive symptoms was 28% (range 8-57%)
[42, 43, 47, 48]. The widely varying population characteristics and inconsistencies in the tools
used to identify depression may account for some of this variation. The rate of post traumatic
stress disorder (PTSD) was reported to be 21-44% [44, 45, 49, 50], with patients exhibiting
avoidant behaviours and many reporting intrusive thoughts or hyper-arousal. While these
symptoms can be a normal reaction to what is perceived as a life-threatening event, symp-
toms often persisted, interfering with normal life. In this particular group of patients, a 24%
prevalence of psychiatrist-diagnosed symptoms was still present at 8 years.
The risk factors for psychological symptoms following critical illness are gradually becom-
ing apparent. When risk factors are assessed in post-ALI/ARDS for PTSD and depressive
symptoms, significant predictors include sedation, a longer duration of mechanical ventilation
and a longer intensive care unit stay. To what extent psychiatric disorders are newly acquired
or pre-exist is difficult to establish. Most studies tend to exclude patients with prior histories
of psychiatric disorders, although this has not been done consistently. Unsurprisingly, a prior
history of depression is a significant predictor of post-ICU depression [43].
2.1.6 Cognitive function
Current research suggests that neurocognitive impairments following critical illness are com-
mon, long-lasting and are associated with decreased daily function, quality of life and an
inability to return to work. Girard et al found severe impairments in memory, attention and
executive function in 62% of medical ICU patients at their discharge from hospital. This
cognitive dysfunction persisted up to 12 months in over half of those affected. The duration
of delirium was independently associated with poor cognitive outcomes [51]. In a sicker group
of patients with ARDS, 74% had cognitive impairment at hospital discharge, reducing to 46%
at 2 years following discharge [47]. At 2 years, memory was affected in 13%, verbal fluency in
16% and executive function in 49% [52].
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In a group of 448 ICU survivors, 40% had global cognition scores at 3 months that were
worse than those typically seen in patients with moderate traumatic brain injury. Twenty-six
percent had scores 2 standard deviations (SD) below the population mean, equivalent to a
diagnosis of mild Alzheimer’s disease. The median score measured by the RBANS6 global
cognition score was approximately 1.5 SD below the age-adjusted population mean, similar
to scores for patients with mild cognitive decline. When 382 of these patients were re-tested
at 12 months, the median score was similar, with 34% equating to moderate traumatic brain
injury and 24% having scores similar to individuals with mild Alzheimer’s disease. The au-
thors found that a longer duration of delirium was independently associated with worse global
cognition and executive function at 3 and 12 months [53].
These poor neurocognitive outcomes can remain apparent years after the critical illness. A
German retrospective cohort study of 46 ARDS survivors found that 25% had poor cognitive
function in various tasks assessing attention skills at 6 years following ICU treatment. Physical
disability was found in 41.3% of patients. All ARDS survivors with cognitive deficits were
disabled, with only 22.9% of the non-cognitively impaired subset having a physical function
problem [54].
2.1.7 Impact on caregivers
Many papers have been published regarding the devastating impact of survivorship experienced
by patients. However, the impact on families and carers can also be life-changing. Cox et
al provided a distressing narrative of the strain experienced by the caregivers of 23 ARDS
survivors at 3-9 months following hospital discharge.
“Once we were out of the hospital, we were on our own. Nobody realises that
leaving the hospital is not the end for some people. The next place is just as hard,
sometimes worse.” [55]
Symptoms of depression have been increasingly reported by many caregivers. The caregivers
of 290 patients ventilated for >3 days were followed up by Douglas et al [56] 2 months after
hospital discharge. Twenty-five percent of the caregivers were classified as depressed 16.7%
of whom were deemed moderately or severely depressed. Informal caregivers of patients with
depressive symptoms, and those caring for patients who experience the most lifestyle changes
(for example, patients who did not return home) were affected the most [57–60]. The highest
risk of depression was seen in carers of patients who were institutionalised following discharge
6RBANS, the Repeatable Battery for the Assessment of Neuropsychological Status, is a neuropsychological
test. It consists of two tests for each of the five domains tested; immediate memory, visuospatial/constructional,
language, attention and delayed memory.
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[56]. The negative impact on caregivers’ health outcomes can still be present at 2 years
following discharge [60].
2.1.8 Impact on society
Following hospital discharge, patients recovering from critical illness continue to consume
health care resources, primarily through rehabilitation services and accessing general practice.
The use of such resources is dependent on the demographic of the population studied.
A majority of ICU survivors either do not return to their own homes or do so with increased
support. Of a cohort of 92 Canadian ARDS survivors, 50% used home-care services in the
first 2 years following discharge [61]. In 103 North American survivors of PMV, only 5% re-
turned home without paid home healthcare. The remaining 95% were discharged either home
with paid home healthcare (11%), to a long-term acute care facility (29%) or a skilled nursing
facility (13%), or to a rehabilitation facility (18%) [29]. In a multi-centre, questionnaire-based
study of survivors of critical illness in the UK, 25% reported that they required care assistance
at 6 months and 22% at 12 months. The majority of this care was provided by family members
(80% at 6 months and 78% at 12 months post-discharge) [58].
Subsequent readmission to hospital is also common for ICU survivors. Forty percent of
Cheung’s ARDS cohort were readmitted to hospital, half of whom were readmitted multiple
times [61]. In another study there were 150 readmissions for 68 (67%) of the 103 PMV hospital
survivors [29].
The largest portion of the total health care bill assigned to ARDS survivors is the initial hos-
pital admission, with ICU costs accounting for 76% of the hospital tariff. Following discharge,
subsequent hospitalisation and inpatient rehabilitation are the predominant costs followed by
home-care, outpatient pharmacy and physician costs, with nursing being the largest part of
the home-care costs [61].
Physical and to a greater extent, cognitive disabilities frequently prevent ICU survivors
returning to work. A German 6 year follow-up study in 2001 reported on 46 ARDS survivors.
Forty-five percent returned to work, however none of the 23% with cognitive impairments were
able to return to work [54]. Fewer than 10% of patients who had received PMV and who had
been previously employed returned to work by 2 years [29]. Similar statistics are reported
by other authors [18, 47, 62]. Additionally, a 15% reduction in employment among informal
caregivers of critical illness survivors has been described [63].
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2.1.9 Relationship between physical and psychological function
”Orandum est, ut sit mens sana in corpore sano”.
A sound mind in a sound body is to be prayed for. (Juvenal, 1st Century)
There has long been an implicit link between mental and physical health. The inter-dependency
between physical and psychological function during and following critical illness is complex
and poorly understood. Poor physical function in ICU survivors is a significant predictor
of depressive symptoms in the first year post-ICU [43, 64]. Poor physical function on ad-
mission to ICU is also a risk factor for developing depressive symptoms [23]. Additionally,
prior depressive symptoms are a strong independent risk factor for developing new physical
impairments following ICU admission [23].
2.2 Theoretical frameworks for deterioration in physical
function following critical illness
There is no clear framework to describe the mechanisms of injury that result in the poor
physical function outcomes described in the previous section. Only recently has an attempt
been made to determine a theoretical framework for functional dependence following critical
illness [26]. This group has taken a translational approach, pairing clinical phenotypes with
molecular mechanisms of injury in an attempt to derive a strategy to drive forward current
research that has become bogged down in study population heterogeneity.
Greater interest is now being paid to the International Classification of Functioning, Dis-
ability and Health (ICF) [65]. This framework was developed and endorsed in 2001 by the
54th World Health Assembly as a means of classifying health-related states at both an indi-
vidual and population level. It is the frame of reference underpinning rehabilitation medicine,
categorising acute illness and the subsequent sequelae, into:
• damage to body structures or “impairments” e.g. muscle weakness, fatigue, poor con-
centration,
• limitations to activities e.g inability to stand, poor exercise tolerance, inability to se-
quence getting dressed, and
• restrictions in participation in social roles, e.g. inability to return to work, to shop, to
manage in own home.
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This is a particularly useful framework for both developing interventions and for measuring
outcomes from rehabilitation interventions in complex patient groups. It focuses clinicians’
attention on impairments that require addressing to gain the desired functional outcome. For
example, muscle weakness is the usual suspect in poor physical function outcomes; most inter-
ventions are therefore based around prevention of muscle loss or restoration of muscle function.
However, it is not the only impairment that contributes to the disability arising from a de-
terioration in physical function. The received wisdom is that any observed recovery is simply
the reversal of the injury sustained. However, the recovery of function and improvements in
the disability experienced by patients may be a functional adaptation to a constellation of
impairments.
The following section explores impairments that may be, or are accepted as being, ulti-
mately responsible for functional disability. I then consider potential modifiers of the impair-
ments themselves and of the related physical disability.
2.2.1 ICU-acquired weakness
ICU-acquired weakness (ICUAW), i.e. dysfunction of the motor unit, which consists of peri-
pheral nerve, neuro-muscular junction and skeletal muscle fibre, is often cited as the corner-
stone of functional problems following an ICU admission [32]. This label is habitually given to
clinically weak ICU patients in whom there is no satisfactory explanation for their weakness
other than critical illness. Depending on the diagnostic criteria and the duration of mechanical
ventilation, the prevalence of ICUAW is reported as 25-100% [66–69]. At a cellular level three
commonly described characteristics in patients with ICUAW have been found: selective thick
filament loss, type II muscle fibre atrophy and muscle membrane inexcitability.
The association between muscular weakness and function has long been assumed. However,
only recently has a clear association been demonstrated between muscle weakness and a reduc-
tion in physical function. Fan et al [69] assessed muscle and physical function and HRQOL in
222 survivors of acute lung injury. One third were discharged from the hospital with objective
evidence of ICUAW which persisted at 12 months. This muscle weakness was associated with
substantial impairments in physical function and HRQOL that were still evident at 24 months.
Critical illness myopathy (CIM) and polyneuropathy are widely recognised as the under-
lying culprits of ICUAW. The diagnostic criteria of both are well described in the literature
[39] but a unifying molecular or cellular mechanism to explain their development, progression
and/or recovery is still lacking. Both processes are often present in an individual patient.
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However, there is no consensus as to the relative contribution of either to the global picture
of ICUAW.
2.2.1.1 Critical illness myopathy
Critical illness myopathy is a primary myopathy, i.e. it is not secondary to muscle denerva-
tion. Recently, Poulson et al [70] found no differences in maximum electromyography (EMG)
amplitude, EMG onset, reaction time or co-activation of either endurance or fast contractions,
between ICU survivors and controls. This indicates an intact central motor drive, processing
of visual information, signalling pathways from motor cortex to muscle and muscle activa-
tion strategy. They concluded that in light of the reduced rate of force development and
a trend towards electromechanical delay, the deficits responsible for physical impairment in
ICU survivors are most likely to be within the muscle tissue. Similarly, Angel et al [71], in a
small cohort of patients, reported structural abnormalities in muscle biopsies in the absence
of electrophysiological abnormalities. In contrast, Semmler et al [72] found no critical illness
myopathy in any of the 51 post-ICU patients they investigated with EMG and nerve conduc-
tion studies at 6-24 months’ post-discharge from ICU.
Histology findings are also extremely variable. In one study [73] of 98 muscle biopsies
taken from 57 ICU patients, with the initial biopsy taken at 1-25 days after ICU admission,
38% were histologically normal, 31% demonstrated atrophy of both type 1 and 2 fibres and
31% showed necrosis. Fifteen patients had sequential biopsies, of which 69% demonstrated
relative atrophy of the muscle fibres in the second sample while electron microscopy showed
loss of myosin filaments.
Puthucheary and colleagues [74] have begun to explore the question of the relative con-
tributions of decreased synthesis and increased degradation to the loss of muscle mass. They
evaluated rectus femoris cross sectional area (CSA) on days 1,7 and 10 of ICU admission and
took sequential muscle biopsies on day 1 and 7. A subgroup were also given before-and-after
primed infusions of 1,2-13C2 leucine. In 28 patients assessed by all three measurement meth-
ods, on days 1 and 7, the rectus femoris CSA decreased by 10.3% (95% CI, 6.1-14.5%), fibre
CSA decreased by 17.5% (95% CI, 5.8-29.3%) and the ratio of protein to DNA by 29.5%
(95% CI, 13.4-45.6%). In those patients who had sequential muscle biopsies, myofibre necrosis
occurred in 20 of 37 patients (54.1%). The pattern of intracellular signalling supported both
increased breakdown (n = 9, r = -0.83, p = 0.005) and decreased synthesis (n = 9, r = -0.69,
p = 0.04).
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While ICUAW is typically associated with muscle wasting, muscle wasting does not al-
ways result in neuro-muscular dysfunction. Muscle strength, defined as the force per CSA, is
dependent on the force generating capacity of a given amount of muscle and the total muscle
mass available. Fundamentally, force per CSA and regulation of total muscle mass are modu-
lated by different mechanisms and can both independently alter muscle strength. For example,
in a model of prolonged nutritional deprivation, diaphragm mass was reduced by 50%, but
diaphragm-specific force generation was normal [75]. Additionally, after 48 hours of mechan-
ical ventilation, Le Bourdelles et al [76] showed limb muscle mass was reduced significantly
without an associated reduction in muscle-specific force generation.
Conversely, it does not hold that enhancing or preserving muscle mass improves muscle-
specific force generation. This was demonstrated in a study assessing muscle contractile per-
formance in myostatin-knockout mice [77]. Myostatin is a negative regulator of muscle mass.
While the force generating capacity of the knockout mice was greater, the specific force-
generating capacity was much reduced. Furthermore, passive mechanical loading, applied for
2.5 hours, four times per day for 9± 1 days in immobilised, sedated and mechanically ventil-
ated ICU patients prevented a 35% reduction in ex vivo muscle fibre function, despite similar
reductions in muscle mass [78].
2.2.1.2 Critical illness polyneuropathy
Critical illness polyneuropathy (CIP) is a distal axonal sensory and/or motor polyneuropathy
affecting both limb and respiratory muscles [79]. Proximal muscle groups are more affected
than distal groups and facial motor control is spared [45]. A contemporary theory is that CIP
is integral to the underlying process leading to multi organ-dysfunction.
Despite electrophysiological evidence of reduced amplitude of compound muscle action po-
tentials and sensory nerve action potentials, with normal or mildly reduced nerve conduction
velocities on around day 15 of ICU admission, there is little evidence to support structural
changes to nerves in the early stages of CIP [79, 80]. However, electrophysiological changes
can be evident within hours of the onset of critical illness [81]. In an animal model these
changes recover relatively quickly [82].
One postulated mechanism for CIP is an impairment of the blood-nerve barrier (BNB) [83]
due to accumulation of metabolites which is a result of hypoperfusion secondary to microvas-
cular alterations in nerve capillaries. This results in axonal depolarisation. This process may
be the result of mediators such as TNFα, serotonin and histamine released during a systemic
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inflammatory response (SIRS) [79], although CIP occurs in the absence of an identifiable
circulating mediator or neurotoxin [84]. An alternate hypothesis is that neurotoxic factors
may disrupt the BNB [85]. The pathophysiology underlying the CIP that persists beyond 12
months remains elusive. Risk factors for the development of long-term critical illness neuro-
pathy include the duration of ICU treatment, duration of ventilator support and a high Acute
Physiology and Chronic Health Evaluation II (APACHE II) score but, interestingly, not a
diagnosis of sepsis [72].
ICUAW clearly plays a major role in physical function deficits following critical illness.
However, as demonstrated in the next section, muscle wasting occurs for many reasons other
than sepsis. Prolonged bed rest, fasting, cardiac failure, adrenal dysfunction and malignancy
are all states that frequently accompany sepsis.
2.2.2 Deconditioning as a result of bed rest
The negative impact of bed rest has been known as far back as Hippocrates [86]. Notwith-
standing the impact of sepsis on skeletal and cardiac myocytes, bed rest itself has a profound
effect on cardiac and skeletal muscle performance.
2.2.2.1 Skeletal muscle unloading
Duration of bed rest is the risk factor most consistently associated with muscle weakness
throughout ICU follow-up. Muscle strength is 3-11% lower for every additional day of ICU bed
rest after adjusting for all other risk factors [69]. Actual or simulated anti-gravity situations
that mechanically unload muscle reduced muscle CSA by 6-24% in 8-197 days; the longer the
duration the greater the loss of CSA [87]. Morphologically, there was a decrease in CSA of
muscle fibres and a reduction in whole muscle volume and mass, but no change in the number
of fibres [88]. There are considerable regional differences in the loss of CSA following bed
rest [89]. There is also a shift in the contractile nature of the fibres toward fast glycolytic
phenotypes [90]. For example, soleus, a postural muscle, is predominantly slow twitch and as
such, is highly susceptible to disuse and fibre-type switching [91].
2.2.2.2 Cardiovascular deconditioning
The duration of inactivity and an individual’s baseline cardiovascular fitness are the main
determinants of the reduction in maximal aerobic capacity caused by bed rest [92]. In healthy
individuals bed rest reduces peak V˙O2
7 by approximately 0.9% per day over 30 days, in-
7V˙O2 peak, the peak oxygen uptake or the peak volume of oxygen that can be utilised in one minute,
during maximal or exhaustive exercise. It is measured as millilitres of oxygen used in one minute per kilogram
of body weight.
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dependent of age and gender, with a greater proportional loss of performance observed in
fitter individuals. For example, five US college students were shown to decrease their peak
V˙O2 by 27% following 18 days of bed rest [93]. After 10 days of bed rest 12 sedentary men
showed 15% decreases in peak V˙O2. Shibata’s ultra fit group, despite a protocol to normalise
cardiac filling volumes, lost 20% of their peak V˙O2 in 18 days. This reduction in V˙O2 peak
was concurrent with a 25% reduction in maximal cardiac output over the same time period [93].
Both resting and maximal heart rates are elevated following bed rest. While a reduction in
vagal tone is the most likely explanation for the increase in resting heart rate, the mechanism
for the elevated exercise heart rate remains unclear. However, it is likely to be a result of
increased sympathetic tone.
Simulation of microgravity situations by head-down tilt have suggested that the reduction
in stroke volume, approximately 12% over 2 weeks [94], is partly responsible for the reduced
cardiac output. However, the relative contributions of a reduction in plasma volume (15%
over 2 weeks) [94] and ventricular remodelling on ejection fraction and left ventricular end-
diastolic volume (-20% over 2 weeks) [94] is unclear. In healthy individuals, it is possible to
attenuate these effects by regular supine exercise, but only in the presence of volume loading.
This suggests that both volume depletion and cardiac atrophy are independently responsible
for the reduction seen in stroke volume [95].
While muscle weakness is the oft-cited and investigated impairment, critically ill patients
are also subject to severe cardiovascular deconditioning [96, 97]. Therefore, due consideration
needs to be given to the cardiovascular stress that rehabilitation interventions are imposing on
patients. If patients have been in ICU for protracted periods of time with little or no physical
activity, commencing rehabilitation will potentially bring some very close to their maximum
exercise capacity. Extrapolating from studies in healthy individuals, a patient receiving PMV
in the ICU, whose peak exercise capacity was reached by walking at 3 mph pre-illness (3.3
METs8, roughly 11.5 mL.Kg.-1min-1), who is on bed rest for 30 days, even without sepsis, will
see a reduction in their peak exercise capacity to only being able to walk at 2 mph (2.5 METs,
8.75 mL.Kg.-1min-1). This does not allow a great deal of scope for rehabilitation. Indeed,
this evidence is inline with recent data from the Manchester Royal Infirmary where patients
ventilated for ≥14 days had significantly lower peak V˙O2 than those ventilated for 5-14 (12.9
± 3.7 vs. 15.3 ± 4.2 mL.Kg.-1min-1, p = 0.023) [97].
81 MET or metabolic equivalent = 3.5 mL.Kg.-1min-1
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2.2.2.3 Disuse skeletal muscle atrophy
Disuse is a major determinant of the skeletal muscle phenotype. The evidence regarding the
relative contribution of muscle protein synthesis and muscle protein breakdown in human
skeletal muscle, as a result of disuse, is currently favouring a reduction in muscle protein
synthesis [98]. However, there are also profound alterations in muscle metabolic performance as
a result of disuse. Not only is there a marked change from oxidative to glycolytic metabolism,
but there is also a significant down-regulation of the transcriptional co-activator, PGC1-α [99].
2.2.3 Sepsis-induced myocardial dysfunction
In addition to the effect of bed rest on myocardial function, sepsis also alters cardiac per-
formance. A reduced ejection fraction is seen in 50-64% of patients with sepsis [100, 101]
and in non-septic ICU patients up to 4 weeks following ICU admission [102]. Although not
a major suspect in long-term functional disability, myocardial dysfunction during the early
stages of rehabilitation is an important consideration when prescribing an exercise intensity
for a rehabilitation program.
2.2.4 Bio-energetic failure
Mitochondria are the main producers of the cellular energy substrate ATP required for cardiac
and skeletal muscle function. Mitochondrial dysfunction occurs in critically ill patients and is
associated with non-survival from ICU [103]. Fredriksson et al demonstrated a 2-fold decrease
in the mitochondrial content in both vastus lateralis and intercostal muscle of a small group of
ICU patients with multi-organ dysfunction, 2-22 days after admission, compared to healthy,
age and sex-matched, patients undergoing surgery [104]. They also found that the activity
of mitochondrial complex IV, the last part of the electron transport chain, was 30% lower in
vastus lateralis than in the intercostals and this was accompanied by a 40% increase in serum
lactate. This finding led the group to postulate that mechanical stretching of the respiratory
muscle during mechanical ventilation may play a role in the preservation of mitochondrial
function. More recently, Mofarrahi et al demonstrated that the locomotor muscles of septic
mice were more susceptible to sepsis-induced mitochondrial injury and autophagy than respir-
atory muscles [105]. Furthermore, stimulation of mitochondrial biogenesis, the production of
new mitochondrial proteins and apparatus, at day 1-2, is associated with ICU survival [106].
2.2.5 Neurocognitive deterioration
Outside critical care there is a fast-growing body of literature suggesting that exercise may
attenuate cognitive impairment and reduce dementia risk [107]. Mechanisms by which this
occurs are unclear, but most probably occurring through;
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i) neurogenesis in the hippocampus, resulting in improved memory and learning [108],
ii) neurotrophic factors such as BDNF, IGF-I, synapsin-I and ghrelin which increase during
(or as a result of) exercise, and may be responsible for maintaining not only the health of
existing pathways but stimulating the growth and differentiation of new neurones [109],
or
iii) increased angiogenesis [110].
However, based on a rat model, exercise within 2 weeks of brain injury may decrease BDNF and
impair learning, therefore the timing of exercise may be crucial [111, 112]. Neuroendocrine or
inflammatory mechanisms triggered by depression may affect physical function [113]. However,
behavioural factors may also be responsible. For example, patients with depression are difficult
to engage in rehabilitation. It is also likely that depressive symptoms influence a patient’s
perception of what they are able to do when they are followed up.
2.2.6 Modifiers of impairments and limitations to activities
While increasing age, a greater burden of co-morbid illness and prolonged ICU stay as a direct
consequence of the admission illness are difficult factors to change [114], impairments such
as ICUAW, cardiovascular deconditioning and cognitive and psychological function are all,
individually, potentially modifiable through various rehabilitation interventions. However, the
underlying therapeutic mechanisms for the benefits of exercise/rehabilitation in these patients
requires further delineation.
Exercise improves skeletal muscle performance in both health and disease [115] and is
typically divided into endurance and heavy resistance, creating markedly different phenotypes.
It is accepted that endurance training stimulates:
• mitochondrial biogenesis,
• fast-to-slow twitch fibre type transition,
• change in substrate utilisation, favouring fatty acid over glucose metabolism,
• angiogenesis.
Heavy resistance training stimulates the synthesis of the contractile proteins responsible for
muscle hypertrophy and an increase in maximum force output. Endurance training in ath-
letes [116] and heart failure patients [117] is associated with up-regulation of mitochondrial
biogenesis, as measured by markers of biogenesis, such as the transcriptional activation factor
PGC1-α in skeletal muscle tissue. PGC1-α also has other important roles in the regulation of
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fibre-type transition during bed rest and exercise which may be of importance during critical
illness. For example, there tends to be greater loss of type I fibres than type II9 following bed
rest and sepsis. Interestingly, this type I to type II fibre-type transition is often considered
partly responsible for the reduced excise capacity seen in patients with chronic obstructive
pulmonary disease (COPD) and chronic heart failure [118]. Conversely, exercise stimulates
a transition from type II to type I and is associated with an increase in PGC1-α. Similar
up-regulation in patients recovering from critical illness may translate to improved exercise
capacity and hence, improved functional outcomes.
Age-related muscle atrophy may play a significant role in elderly patients’ ability to re-
cover from ICUAW. Younger patients, who have been exposed to less sarcopenia before the
onset of critical illness, may have more capacity to compensate for ICUAW. This may also
be important with comorbidities such as COPD, chronic heart disease (CHD) and chronic
kidney disease (CKD) all of which have significant effects on muscle function even before ICU
admission.
Rehabilitation is a modifier of physical function, enabling patients to develop coping
strategies to manage their impairment level problems. Given that muscle strength recov-
ers before physical function and HRQOL [69], persistence of physical function limitations are
likely to be due to a combination of factors. These factors include, but are not limited to,
cognitive and mental health morbidity [23], home environment and caregiver support [56, 60].
How ICUAW is modulated by such factors is as yet unclear [26]. However, a patient’s mental
health, along with the extent to which their caregivers are supported, as well as other envir-
onmental factors will greatly influence how a patient’s physical dependency affects their role
in society.
While many interventional studies have demonstrated that rehabilitation is possible for a
significant proportion of patients [119–121], “rehabilitation” remains a complex entity. One
which is dependent on a number of interacting factors including, but not limited to, health care
culture, staffing, patient delirium and severity of illness. Ultimately, a complex intervention
that encompasses both the physical and psychological aspects of recovery is most likely to be
effective. However, as I will demonstrate in the next section, very little is known about the
individual aspects of providing a rehabilitation intervention.
9Type I or “slow twitch” fibres, (referring to the Myosin Heavy chain ATPase activity) are predomin-
antly aerobic muscle; they are less fatiguable than Type II or “fast twitch” fibres (IIa and IIx) which are
predominantly glycolytic.
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2.3 Interpretation of current published work
There has been an exponential increase in the number of publications regarding rehabilitation
or “early exercise” in critical care (Figure 2.1 ). However, there are very few interventional
studies and interpretation of those that have been published is complicated by the lack of
an explicit theoretical framework. The type and dose of any intervention and the stage and
severity of the patient’s illness may be crucial factors in the impact of a rehabilitation program.
With this in mind, I shall review the current literature base with respect to those studies
providing sufficient information with regarding the timing of the intervention, the intervention
itself, and the severity of illness of the enrolled patients (Tables 2.1 and 2.2).
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Figure 2.1: ICU-related rehabilitation papers on PubMed 1968 to 2015.
(Data downloaded March 2015)
2.3.1 Timing
A fundamental issue that continues to be avoided in study design is whether the intervention
is:
i) targeted at an impairment level i.e. limiting, or even preventing, the detrimental effects
of bed rest and/or sepsis-induced nerve, muscle and cardiac injury,
ii) an impairment-level intervention promoting recovery, or
iii) an impairment and limitation-level rehabilitation program, focusing on patient-specific
impairments (e.g. muscle weakness or cardiovascular deconditioning) in order to facilit-
ate maximum independence.
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Muscle injury occurs early in the ICU admission [122]. Thus, the correct timing of the cor-
rect intervention may be crucial. One could argue that the earlier the intervention, the more
impact it will have on prevention of the detrimental effects of bed rest and sepsis. In later
interventions, the mechanism is most probably promotion of recovery. The current European
guidelines, based on expert opinion rather than evidence, recommend starting when the pa-
tient is “medically stable” [123]. Indeed, this has been common practice in most London
teaching hospitals since the early 2000’s (personal communications).
There are currently seven studies, four of which are randomised controlled trials (RCT), of
interventions that intended to commence before day 5 of an ICU admission [119, 120, 124–128].
Eight studies commenced after day 5, four of which are RCTs [121, 129–135]. However, while
the studies enrol patients at this time-point, few are explicit about when different aspects
of the intervention actually start. As such, some patients may have only received passive
mobilisation on day 1 and not have experienced active rehabilitation e.g. sat over the edge of
the bed (SOEB), until day 14.
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Figure 2.2: Interventional Rehabilitation Studies. Illness severity vs. mean duration of mech-
anical ventilation at study enrolment. APACHE II (Acute Physiology and Chronic Health
Evaluation II).
2.3.1.1 Interventions before day five
Three studies started within 72 hours of ICU admission [119, 124, 125]. The most prominent
of these studies, by Kress’ group in Chicago [119], assessed the effect of combining daily inter-
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ruption of sedation with physical and occupational therapy on functional outcomes in patients
receiving mechanical ventilation in intensive care. They randomised ICU patients mechanic-
ally ventilated for <72 hours who were functionally independent prior to admission, to either
mobilisation (physical and occupational therapy) during periods of daily interruption of sed-
ation (n = 49) or to daily interruption of sedation with therapy as ordered by the primary
team (n = 55). The time to first-out-of-bed in the intervention group was a median of 1.7
days (interquartile range (IQR) 1.1-3.0) vs. 6·6 (IQR 4·2–8·3) in the control group. Twenty-
nine (59%) patients in the intervention group returned to independent functional status at
hospital discharge, compared with 19 (35%) control patients. The difference between groups
did not appear until after ICU discharge, leading to a number of questions: does exercise in
ICU precondition patients to cope with further rehabilitation, or does it prevent a decline
in function, providing an improved baseline for further rehabilitation? However, while this
group mobilised early, they had a much lower APACHE II score (18) and average age (55
years) compared to patients in other early intervention studies.
Routsi et al [124] instigated daily electrical muscle stimulation (EMS) within two days
of ICU admission in 104 ICU patients. They finally evaluated 52 patients, following con-
siderable dropout. Using an MRC sum score10 cut-off of 48/60 to diagnose critical illness
polyneuro-myopathy (CIPNM), they reported a significantly lower incidence of CIPNM in
the intervention group, 3 compared to 11 patients in the control group, (hlOdds Ratio (OR)
= 0.22; CI: 0.05-0.92, p = 0.04). No functional data were available. However, there was
no intention to treat analysis and all patients receiving paralysing agents in the intervention
group were excluded from analysis. It is also unclear what baseline rehabilitation was received.
Davis et al [125] carried out a small (n = 15) prospective cohort study in a targeted,
aged population ≥65 years. They had received mechanical ventilation >72 hours, with a pre-
admission Barthel Index score ≥70. These patients were recruited early, were elderly (mean
age 76 years) and had a mean APACHE II of 23.5 (above the average of the 14 studies re-
viewed). However, only 41 (24%) of the mobilisation sessions involved intubated patients.
They did not give information regarding time to first SOEB.
Most recently, Brummel and colleagues investigated the feasibility of a combined cognit-
ive and physical therapy intervention [126]. They randomised 87 medical and surgical ICU
patients to usual care (UC), early once-daily physical therapy (PT), or an early once-daily
physical therapy plus twice-daily cognitive therapy (CT) protocol, within 72 hours of admis-
10MRC sum score measures 6 antigravity muscle groups, wrist, elbow, shoulder, hip, knee and ankle flexion
using the 1-5 MRC muscle grading scale, giving a total possible value of 60.
47
sion. The CT included orientation, memory, attention and problem-solving exercises. The PT
included progressive mobilisation. Both intervention groups performed SOEB on day 1 or 2
after enrolment. This study recruited a relatively sick group of patients (mean APACHE II
= 24 ), and mobilised them early (Figure 2.2). In the CT and PT groups, 95% received CT
every day, with 98% receiving PT on 75% of the days. Of the PT group, 95% received PT
on 67% of the days. In the UC group, 77% received PT on 17% of the days. Cognitive, func-
tional and health-related quality of life outcomes did not differ between groups at 3 month
follow-up. However, the study was not powered to find a statistically significant difference
between groups for either the cognitive test battery, functional outcomes of TUG11, Katz12,
or Functional Ambulatory Category (FAC)13. While feasibility was demonstrated, 17% of the
CT and PT groups dropped out. The severity of illness in the control group (mean APACHE
II = 27), was greater than either of the intervention groups (PT = 21, PT and CT = 25).
Morris et al [120] prospectively assessed the impact of a daily mobility protocol on pa-
tients in a medical ICU in North Carolina. All medical admissions were enrolled within 48
hours of intubation and 72 hours of admission. Over a two year period 330 (23%) of 1427
intubated admissions met the study criteria. Of these, a third were receiving vasopressors. In
the UC group 47.4% underwent at least one physical therapy session compared with 80% of
protocol patients (p <0.001). Of 64 UC patients who received PT, 12.5% had PT initiated
during ICU treatment compared with 91.4% of protocol patients (p <0.001). However, only
18 (10.9%) of these patients got as far as SOEB. After adjusting for BMI, APACHE II and
vasopressor usage, UC patients were first out of bed in 11.3 days compared to 5 days for pro-
tocol patients (p <0.001). This shows an unsurprising association between implementation of
a mobility protocol and time to first out of bed. In the USA, at the time of publication, this
was considered early rehabilitation in a relatively sick group of patients. However, it probably
reflected current practice in London teaching hospitals at the time (personal communications).
Needham et al [127] carried out a quality improvement project, comparing outcomes be-
fore and after employing full-time physical and occupational therapists, and a multidisciplinary
team commitment reducing sedation. The intervention group comprised 57 patients who had
received mechanical ventilation >4 days. The patients were relatively young compared to
the other studies, (mean age 50 years). Benzodiazepine use decreased markedly following the
intervention and patients had improved sedation and delirium status. There were more rehab-
11TUG; is the time taken for a patient to rise from a chair, walk 3 m at a comfortable and safe pace, turn
and walk back to the chair and sit down. Originally designed for elderly patients, to assess their risk of falls.
12Katz is a 6 item Activity of Daily Living scale. The items, Bathing Dressing, toileting, transferring,
continence and feeding are graded as to dependent = 0, independent = 1, scored out of 6.
13FAC categorises patients according to basic motor skills necessary for functional ambulation. There are 7
levels. 1 = Non functional, 7 = Independent on level and non-level surfaces [136]
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ilitation treatments per patient (median 1 vs. 7, p <0.001) and a higher proportion of those
treatments involved sitting (or greater mobility) (56% vs. 78%, p = 0.03). However, they did
not report the time to first SOEB.
Burtin et al [128] compared standard physiotherapy with standard physiotherapy plus cycle
ergometry in 90 patients with an expected length of stay >7 days. They recruited one of the
sickest groups of patients with a mean APACHE II score of 26.5, however the intervention
group did not start exercise until day 14 (Figure 2.2). The standard physiotherapy group
received active or passive motion of upper and lower limbs, with intensity increased accord-
ing to the individual patient’s capabilities. Ambulation was started when it was considered
appropriate by medical staff. The treatment group had active or passive training sessions
of 20 minutes using a bedside ergometer five times per week, with sedated patients cycling
passively. When patients were able to cycle actively, this was done in two bouts of 10 minutes,
with intensity increased as tolerated. 6MWD at hospital discharge, the primary outcome, was
greater in treatment compared with control patients (196 m (126-329 m) vs. 143 m (37-226
m)). However, actual vs. predicted 6MWD was severely reduced for both groups at 29%
(19-43%) and 25% (8-36%) for control and intervention groups, respectively. There was a
greater relative increase in quadriceps force between ICU discharge and hospital discharge in
the treatment group (1.83 ± 0.91 to 2.37 ± 0.62 N.Kg-1, p <0.01) than in controls (1.86 ± 0.78
N.Kg-1 to 2.03 ± 0.75 N.Kg-1, p = 0.11). Despite no significant difference in quadriceps force
between the two groups on ICU discharge. The physical functioning section of the SF-36 score
was higher in the treatment group (mean (CI), 21 points (18-23) vs. 15 (14-23), p <0.01). The
proportion of patients with a Berg Balance Scale14,“sit to stand” score of ≥ 2, (indicating the
ability to stand independently) did not differ between groups at ICU (34% vs. 23%, p = 0.40)
and hospital discharge (85% vs. 79%, p ≥ 0.74). The proportion of patients with a FAC score
≥415 was also similar at ICU (10% vs. 14%, p = 0.72) and hospital discharge (73% vs. 55%, p
= 0.18). Despite the similarity between groups on ICU discharge in both muscle strength and
ability to stand or mobilise independently, the intervention group demonstrated improvements
in HRQOL and 6MWD. The authors postulated that either passive movement [138] or better
coordination [139] were factors that led to later improved outcomes. During the 2 year study
period, only 90 patients were recruited, representing just 5.9% of ICU admissions.
14Berg balance scale, was designed to assess falls risk in elderly patients [137]. It has 14 items, scored from
0-4 each
15Indicating the ability to walk independently.
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2.3.1.2 Interventions after day 5
There is little evidence to demarcate the phases of damage and recovery to nerve and muscle
in the course of critical illness. Therefore, the cut-off of 5 days to divide these studies into
restorative rather than preventative is arbitrary and pragmatic. However, the seven studies
that recruited patients after day 5 represent more complex interventions performed in patients
with lower illness severity.
Bailey et al [121] studied the feasibility and safety of early activity in 103 respiratory failure
patients ventilated≥ 4 days, 92 of whom were mechanically ventilated. The enrolled patients
had been in another ICU for 10.5 ± 9.9 days. Once transferred to their respiratory ICU
(RICU), they received twice daily physical therapy (PT) with the goal of ambulating≥ 100
feet before ICU discharge. They performed 1,449 activity events in 103 patients. Activity
events included 233 (16%) sitting on the edge of the bed, 454 (31%) sitting in a chair and 762
(53%) ambulation. Forty one percent of the activity events were in patients with endotracheal
tubes, 249 (42%) of which were ambulation. Thirty-four patients went home, while 49 went to
either rehabilitation or an extended care facility. Of those who survived to hospital discharge
2.4% had no activity on RICU discharge, 4.7% could sit on the edge of the bed, 15.3% could
sit in a chair and 8.2% ambulated <100 feet and 70% of admissions could mobilise≥ 100 feet.
The median distance ambulated by hospital survivors was 200 feet (range 0-600).
Thomsen et al [129] investigated whether transfer of respiratory failure patients from a gen-
eral ICU to an RICU improved ambulation independent of their underlying pathophysiology.
They included 104 patients who had been in a previous ICU for >2 days and who had re-
ceived mechanical ventilation for >4 days in their RICU. The patients were mobilised 10.3 ±
7.5 days after their initial ICU admission. Using multivariate logistic regression adjusting for
co-variables, they found four significant predictors of increased ambulation: transfer to RICU
(p <0.0001), absence of sedatives (p = 0.009), female gender (p = 0.019) and lower APACHE
II scores (p = 0.017). This supports their hypothesis that the general ICU philosophy of care
and the environment was partly responsible for poor physical function outcomes. This high-
lights, health care culture as a significant factor in the decision to mobilise patients, rather
than the patient’s level of sickness.
Nava et al [130], who published the first prospective RCT in this area, studied the effect of
a pulmonary rehabilitation (PR) program on 80 Italian COPD patients recovering from acute
respiratory failure, 61 of whom were mechanically ventilated. They started their rehabilitation
5-19 days following their original ICU admission. The 60 PR group patients received passive
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mobilisation, early ambulation, respiratory and skeletal muscle training and, if able, lower
extremity treadmill training. The 20 control patients received standard therapy including an
ambulation program. Functional ambulation was regained at hospital discharge in 87% of
the PR group vs. 70% in the control group. At discharge, 6MWD results were significantly
better in the PR group (p <0.001) with a mean increase of 100 m vs. 50 m in the controls.
Interestingly, hospital length of stay was longer in the intervention group. Of note, the control
group received more rehabilitation than most patients currently receive in the UK.
Clini et al [132] prospectively evaluated, in 77 patients, the association between the degree
of change in functional status after a daily rehabilitation regimen and the clinical outcomes of
remaining ventilator-free and surviving. Rehabilitation began 24 ± 3 days following their ICU
admission. The rehabilitation regimen included supported and unsupported limb exercise with
an ergometer for a minimum of 15 sessions, plus functional rehabilitation. They measured the
change in Katz score, survival and weaning success rate as their clinical outcomes. Sixty-seven
(87%) of the 77 enrolled patients survived, 74% of whom were liberated from mechanical vent-
ilation. There was a mean ± SD increase in Katz score of 2.5 ± 2 points. Better functional
capacity was associated with the probability of remaining ventilator-free (p = 0.043) and of
hospital survival (p = 0.001).
Zanotti et al [133] recruited 24 Italian COPD patients who had received mechanical vent-
ilation >30 days. The control group received active limb mobilisation and the intervention
group EMS 30 minutes twice a day for 28 days. Patients demonstrated a decrease in the
number of days to transfer from bed to chair (10.75 ± 2.41 days vs. 14.33 ± 2.53 days, p
<0.001).
Martin et al [131] retrospectively evaluated the prevalence and magnitude of weakness in
49 patients who had received mechanical ventilation for 18 ± 7 days. Observations were made
of muscle strength and functional status after a non-randomised “whole-body” rehabilitation
program. On admission, all patients were bedridden and had severe weakness of upper and
lower extremities measured by a 5-point muscle strength score. Following rehabilitation, pa-
tients demonstrated an increase in upper and lower extremity muscle strength: upper limb
from 1.9 to 3.6, lower limb from 1.5 to 2.7 (p <0.001). All were able to stand and 81% could
ambulate by hospital discharge. This demonstrates the potential for significant changes in
muscle strength and functional capacity over time, but not an association with rehabilitation
interventions.
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Chiang et al [134] examined the impact of 6 weeks’ physical training on the functional
status of 20 patients who required PMV. The cohort reflected an aged population with an
average age similar to that of Davis et al [125]. However, the average duration of mechan-
ical ventilation at enrolment was 4 times the average of the 14 studies. Physical training,
performed 5 days per week included strengthening exercises for upper and lower limbs and
functional activity training. The control group received nothing beyond encouragement from
nursing and medical staff. Over the 6 week period, muscle strength increased significantly in
the intervention group and deteriorated in the controls. However, the increased strength in the
intervention group was insufficient to return them to their predicted pre-morbid levels. Phys-
ical function was assessed using FIM. The total FIM score decreased in controls but increased
significantly in the intervention group. However, muscle power deteriorated in controls yet
the motor component of their FIM score remained the same. Thus, FIM may be insufficiently
sensitive to detect change at this low level of functioning, or that further deterioration in
muscle power was insufficient to impact on the FIM score. Additionally, the small deterior-
ation in total FIM score of the control group was generally due to deterioration in executive
function, rather than any further decline in physical function. This perhaps highlights the role
of cognitive function in the development of physical function limitations.
The only interventional study with follow-up to 12 months after ICU discharge was carried
out in Melbourne, Australia [135]. This study recruited patients from days 5-11 of their ICU
admission. Patients had a mean and IQR age of 60 (15.8) and a mean ± SD APACHE II
of 20 ± 7.7. Only 55% of the patients were ventilated at the beginning of the study. They
used an exercise prescription approach to create rehabilitation programs for 74 patients. The
rehabilitation programs started in ICU and continued to the ward and then out into the
community. While the trajectory of improvement in 6MWD and TUG was greater in the
intervention group, there was no significant difference in any of their outcomes.
2.3.2 Safety
The primary concern for ICU clinicians, given the tenuous stability of some of their patients,
is safety during rehabilitation. Indeed, Thomsen et al [129] found that for every point decrease
in the APACHE II score, the likelihood of ambulation increased by 6%.
If the definition of safety is the absence of “critical events” e.g. cardiovascular comprom-
ise, falls or accidental extubation, the question of safety has been answered. Nydahl [140]
reviewed 16 publications reporting safety data, where the focus of the rehabilitation was to
mobilise patients onto the edge or out of bed. Using the inherent safety limits, the mean
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Figure 2.3: Rehabilitation studies by age, severity and days ventilated.
reported complication rate was 3 ± 9% (n = 144) in 453 patients and 3613 mobilisation epis-
odes. Serious complications that led to further consequences were observed in 10 (3%) of cases.
Similar results were seen in a single-centre prospective evaluation of 1110 intensive care
unit admissions with 5267 physical therapy sessions [141]. There were 34 (0.6%) adverse
events. The majority 18 (53%) of which occurred when sitting patients on the edge of the
bed. The authors did not provide information regarding the illness severity of the patients. A
group in Brazil [142] recruited 19 patients within the first 72 hours of mechanical ventilation
into an observational study involving 20 minutes of passive leg cycling using an electric cycle
ergometer. This cohort had an average SOFA score of 6 ± 3. They reported only 2 minor
adverse events, neither related to haemodynamic instability, although they do not report how
many cycling episodes were carried out in total.
Consensus recommendations on the limits to start and continue rehabilitation have since
been published [143]. Interestingly, the one area on which consensus was not gained was the
concurrent use of inotropic or vasopressor support. The issue of patient capacity to respond
safely to a physiological challenge beyond that they are already experiencing as a result of
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their illness has yet to be considered. This is in part because there is no definitive way to
evaluate subtle harm caused to sub-cohorts of patients. For example, the time to death of the
non-survivors of Schweickerts’ intervention group was significantly less than that of the control
group (2.5 days (95% CI: 2.4-5.5) vs. 9.5 days (95% CI:5.9-14.1) p <0.04) [119]. Potentially
coincidental, this is non-the-less, a warning that early exercise may not be beneficial in all
patients.
2.3.3 Variations in baseline or usual care
Several challenges are inherent in the interpretation of these rehabilitation studies, particu-
larly with respect to differences in the structure of care of mechanically ventilated patients
across North America, Europe and Australia. North American ICUs manage critically ill pa-
tients with multi-organ failure during the acute phase of their illness, whereas patients with
single organ failure requiring ongoing ventilatory support are managed in long-term Acute
Care Units. This is in direct contrast to the UK where ICUs generally provide long-term
ventilatory support for up to 6.3% of their mechanically ventilated admissions [144]. Of equal
importance, European [145] and Australian [146] physiotherapists provide both rehabilitation
and respiratory care to ICU patients, although the extent to which rehabilitation is delivered
varies considerably [146–152]. In contrast, respiratory therapists provide respiratory care in
North America, while physical therapists, the presence of whom is currently limited but not
absent in ICUs [153], provide rehabilitation. To a certain extent this difference provides an
opportunity to investigate the impact of early physical interventions against a control group
[119, 134], unlike studies that originate from Europe or Australia, where interventions would
be compared to a baseline of current clinical practice. Both of these situations impact on
the “start point” of the interventions along the continuum of a patient’s critical illness, the
prior exposure of the patient to variable periods of non-intervention and to the baseline in-
terventions that are common practice in some centres. Therefore, it is important to establish
whether a training load has been delivered to all patients in the intervention limb of a study,
and whether this is actually different to that delivered to the control group [154].
2.3.4 What is the intervention?
Rehabilitation in the context of critical care takes on many different forms. “Early mobilisa-
tion”, a term used in North American studies, includes the application of traditional modes
of physical therapy at an earlier stage than their conventional practice and is delivered more
frequently. These interventions are often protocolised [155]. In contrast, “Enabling and sup-
porting individuals to recover or adjust, to achieve their full potential and to live as full and
active lives as possible” [156], is more of a European descriptor of rehabilitation.
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Many of the programs that recruit patients early may only involve passive exercise in the
early stages. Given that continuous passive movement use for 10 hours per day is required
to prevent a reduction in ex vivo muscle fibre function [78, 138], it is not clear what role
this aspect of the rehabilitation program takes in the preservation of muscle function, beyond
maintaining joint range of movement. Traditionally, rehabilitation has been about enabling
patients to regain functional autonomy. More recently in the context of critical care, it has
become about breaking the cycle of bed rest. How this cycle is broken (e.g. tilt-tables, active
arm and leg cycle ergometery or even interactive video games, [157]), may not be important.
What may be important is the level of engagement of the patient in the activity. For example,
EMS is an impairment level intervention and as such, it is unlikely to have the same psycholo-
gical role as engaging a patient in a rehabilitation program. Also this will not provide patients
with strategies to minimise their functional disability. Conversely, early mobility programs,
whatever the intervention, may engage the patient and prevent some of the cardiovascular
consequences of bed rest. However, one needs to be mindful of the myocardial depression
endured by some patients during the early stages of their illness.
The common factor with all of these interventions is that we do not know how to meas-
ure the dose. The conceptual framework of both pulmonary and cardiac rehabilitation, and
one that might be applicable to the rehabilitation of patients in critical care, is grounded in
the concept that physical activity presents a serious challenge to homeostasis [158]. When
patients are repeatedly exposed to, and have the capacity to respond appropriately to such a
challenge, the inherent adaptations that follow are usually associated with improved physical
performance. This is borne out by the well-established link between functional capacity and
exercise capacity in the normal, cardiac and pulmonary rehabilitation populations. In other
words, functional capacity is influenced by the individual’s cardiovascular fitness i.e. their
ability to take up, transport and utilise oxygen. One would expect all rehabilitation interven-
tions, e.g. sitting upright in bed, sitting over the edge of the bed, transferring to a chair, or
cycle ergometry, to increase a patient’s energy consumption beyond their resting metabolic
rate. However, these activities are currently described in terms of absolute exercise intensity
and not one that is relative to the patient’s current state of fitness. Hence, a fixed increased
activity for one patient may be well within their current level of cardiovascular fitness, but for
another patient it may impose significant physiological stress.
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2.3.5 Measurement of outcome
Measurement of outcome from rehabilitation studies is inconsistent. In 14 studies 14 different
outcome measures were used. There has been a recent call for future published work to
provide a consistent minimal data set for post-ICU interventions and a consensus on outcome
measurement [159].
2.3.6 Financial implications
Few authors have investigated the cost effectiveness of early rehabilitation programs. The
Johns Hopkins Hospital Medical ICU [160] developed a cost model for North American ICUs
with 200, 600, 900 and 2,000 annual admissions. The model accounted for both conservative
and best-case reductions in ICU and hospital length of stay (LOS), based on their own data
from implementing, removing, and then re-implementing a rehabilitation program on their
ICU. Costs were based upon data published in 2008 [161]. Their example scenario of 900
annual admissions and length of stay reductions of 22% and 19% for the ICU and ward,
respectively, gave a net cost saving of $817,836. They modelled 24 scenarios using 10% and
25% reductions for both ward and ICU LOS, varying the ICU and ward costs from 80-120%
and with 200-2,000 annual admissions. The financial projections ranged from $87,611 (net
cost per scenario) to $3,763,149 (net savings per scenario). Net savings were demonstrated
with 20(83%) of the scenarios.
2.3.7 Summary
The underlying mechanisms which result in impairments leading to the physical function prob-
lems following ICU admission are still not fully elucidated. Several factors, caregiver support,
cognitive and psychological function modulate how these impairments manifest as poor phys-
ical function outcomes. Some factors, while not open to modulation, age, pre existing disease
and prior physical function deficits are major determinants of how an individual will respond
to a rehabilitation program.
The age, severity of illness and the time point that patients are recruited into the few
published interventional studies vary considerably, as does the type of intervention (Figure
2.3 ). This makes extrapolation into a clinical setting a serious challenge. Although there is
a general trend towards increasing severity with decreasing time to enrolment in the studies
(Figure 2.2 ), the 2 studies that commenced within the first 48 hours did not have the highest
severity of illness. This is important to take into consideration as they may not reflect the
severity of illness in UK ICU patients. Additionally, we do not know how to choose the correct
dose or, indeed, what the intervention should be.
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Over training, the symptoms of which include but are not limited to fatigue, insomnia and
worsening physical and psychological performance, may seem an unusual concept in an ICU
patient. Indeed these maybe potentially impossible to separate from the consequences of an
ICU admission. However, if patients are exposed to cardiovascular deconditioning as much as
the literature suggests, then there is the potential to overstretch if not “over train” patients.
The limited available evidence suggests that active rehabilitation interventions, e.g. sitting on
the edge of the bed, standing, transferring to a chair or cycle ergometry, increase a patient’s
energy expenditure beyond their resting metabolic rate, therefore presenting a homoeostatic
challenge. The pertinent question is to what extent these perturbations provide a positive
stress i.e. improvements in muscle strength, cardiac output, mitochondrial biogenesis etc. and
to what extent they are detrimental as a result of overload and or inadequate rest before the
next challenge.
For some of our longer-term ICU patients, a daily exercise program is a significant hard-
ship. For example, Denehy’s patients refused exercise sessions in 168 of 836 sessions (20%)
[135]. Although there are no published reports of patient experience of exercise or rehabilita-
tion in the ICU, the daily actuality of therapists within our centre is that of patients needing
significant motivation to engage in exercise programs. Therefore, there is considerable benefit
from knowing the minimum required to gain benefit. For example, in the free living population
there is increasing evidence that low volume sprint interval training may be as beneficial as
traditional endurance training. Clearly, this has a potential application in a group of patients
who are only able to tolerate exercise for very short periods of time, and who may already
be exercising at near-maximum relative exercise intensity [162, 163]. Despite this knowledge,
there are very few exercise parameter recommendations for such patients [143, 164, 165].
Given the multifaceted nature of the impairments responsible for the physical function
deficits, an intervention that engages a patient and includes a cardiovascular, musculoskeletal
and metabolic challenge is most likely to have an impact. However, the level at which an
intervention actually becomes a training load and when it becomes excessive, will be dictated
by the patient’s duration of exposure to both bed rest and sepsis, along with their incumbent
level of physiological fitness before they arrive in ICU.
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Study Location Age n Duration Illness Control Intervention Outcome
of MV severity (C) (I)
(Nava (1998)
[130]
Italy
RCU
66
(58-76)
80 5-19 P:F 34 FR
PR & progressive
mobility program
including treadmill
LOS 38± 14 days vs.
33.2 ± 11, I vs. C
6MWD significantly
improved (p <0.001)
in I group only
Zanotti (2003)
[133]
Italy
RCU
(COPD)
66
(60-70)
24
≥30
Not
available
Active
limb
mobilisation
EMS
30 minutes BD
for 28 days
Days to 1st BCT
I vs. C 10.75 ± 2.41
vs.14.33 ± 2.53
(p <0.001)
Chiang (2006)
[134]
Taiwan
76
(63-80)
20
52
(22-80)
Respiratory
Failure
resolved
Bed Rest
Functional
rehabilitation
Significant decrease in
FIM in Cs & increased
significantly in Is
Schweickert (2009)
[119]
USA
55
(36-69)
104 1-2
APACHE II
20
(16-24)
Nothing OT & PT
Increase no. of ventilator
free days at D28. Median
walking distance at
hospital dc 0 m vs. 30 m
Continued on the next page...
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Study Location Age n Duration Illness Control Intervention Outcome
of MV severity (C) (I)
Burtin (2009)
[128]
Belgium
59
(42-81)
90 4-14
APACHE II
26
(20-42)
FR
Cycle
ergometry
PF section of SF36 &
6MWD improved at
hospital dc compared
to standard PT group
Routsi (2010)
[124]
Greece
GICU
60
(40-90)
105 >1
APACHE II
18 ± 5
Unclear EMS Decreased incidence of
CIPNM in EMS group
Brummel (2014)
[126]
USA 60 87 3 24
(17.5-31)
UC PT or
PT & CT
No difference
Davis (2013)
[125] USA
76 15 3 APACHE II
23.4
(3.7)
UC
Early Mobility
Program
Intervention
feasible
& safe
Denehy (2013)
[135]
Australia
GICU
150 60.1(15.8) 5-11 APACHE II
20.7
(7.7)
Mobility
exercise
7 days/week
Individualised
Exercise
prescription
No difference in
6MWD or TUG
between C & I
Table 2.1: Prospective randomised controlled trials. Rehabilitation Interventions. RCU = Respiratory Care Unit, C = Control, I = Intervention, PR = Pulmonary
Rehabilitation, FR = Functional Rehabilitation, MV = Mechanical Ventilation, EMS = Electrical Muscle Stimulation,GICU = General ICU, BCT = bed chair transfer
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Study Location Age n Duration Illness Design Intervention Outcome
of MV severity (I)
Morris (2008)
[120]
USA
MICU
54
SD(16)
66 2 23.5 ± 8.8 OBS Mobilisation
UC patients were first out of
bed in 11.3 days vs. 5 days
for protocol patients (p <0.001).
Thomsen (2008)
[129]
USA
RICU
57.9 ± 18.1 104 10.3 ± 7.5 18
OBS Mobilisation
protocol
Predictors of increased mobilisation
were transfer to their ICU,
lower APACHE II, absence of
sedatives & female gender
Bailey (2009)
[121]
USA
RICU
62.5 ± 15.5 103 ≥ 4 17 ± 4.8
OBS Active
mobilisation
2.4% no activity on RICU dc,
4.7% could SOEB, 15.3% could BCT
8.2% ambulated <100 feet &
70% mobilise ≥ 100 feet.
Needham (2010)
[127]
USA
MICU
50 (43-59) 57 10.5 ± 9.9 26 (21-29)
QIP
Various
Decreased benzodiazepine use.
Greater no. of mobilisation episodes.
Decrease in ICU length of stay
by 2.1 days (95% CI: 0.4-3.8)
Continued on next page...
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Study Location Age n Duration Illness Design Intervention Outcome
of MV severity (I)
Clini (2011)
[132]
Italy
RICU
75 ± 7 77 23 ± 3 11.5 ± 4.4
OBS
Supported &
unsupported limb exs
with ergometer
for 15 sessions
Better functional capacity
associated with probability of
remaining ventilator-free (p = 0.043) &
of hospital survival (p = 0.001).
Martin (2005)
[131]
USA
MICU
58 ± 7 49 18 ± 7 20 OBS
Functional
Rehabilitation
Increases in limb muscle strength,
81% could ambulate
by hospital dc
Table 2.2: Non-prospective randomised controlled trials. Rehabilitation Interventions. RCU = Respiratory Care Unit, C = Control, I = Intervention, PR = Pulmonary
Rehabilitation, FR = Functional Rehabilitation, MV = Mechanical Ventilation, EMS = Electrical Muscle Stimulation, MICU= Medical ICU, dc = discharge
Chapter 3
Quantifying the exercise load of
rehabilitation interventions
In the previous chapter I identified the need for a reliable means of quantifying interventions
for the purpose of developing a dose for testing the effectiveness of different rehabilitation
strategies. Much work has been done within the field of sports science to optimise training
programs of elite and non-elite athletes. There is much that the critical care community could
draw upon to optimise rehabilitation strategies to balance the stress of exercise with periods
of recovery, thus preventing under- or over-training of individual patients.
3.1 The known physiological response to exercise in
ICU patients
Before rehabilitation became the focus of physiotherapy interventions in ICU, two studies
looked at the effect of mobilising patients on respiratory parameters. Zafiropulous et al looked
at the impact of mobilising 17 post-operative surgical patients who remained ventilated on
their first post-operative day [166]. They found a 40% mean increase in minute ventilation
(V˙E) in the transition from supine to standing (13% tidal volume (VT ) and 14% respiratory
rate (RR)), (Table 3.1 ). There was no further increase when sitting out of bed or marching
on the spot.
Activity V˙E (L.min
-1) VT (mL) RR (bpm)
Supine 15.1 ± 3.1 712.7 ± 172.8 21.4± 5
Standing 21.3 ± 3.6 883.4 ± 196.3 24.9 ± 4.5
Table 3.1: Changes in V˙E with rehabilitation. Zafiropulous (2004).
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Similarly, Chang et al [167] assessed the respiratory impact of the tilt-table procedure
on 15 patients with chronic critical illness. Patients had received mechanical ventilation for
5-37 days, seven were self-ventilating and all had an FiO2 ≤0.4. They found a 27% increase
in V˙E , (19% increase in RR, 17% increase in VT ). No metabolic parameters were measured.
They comment that, as no increase in oxygen consumption (V˙O2) has been reported in healthy
individuals when tilt-tabled with the straps attached, they would not have expected an increase
in metabolic rate in ICU patients. This is, in part, supported by Collings et al [168] who
found non-significant changes in V˙O2 when passively sitting patients out in a chair, while
they observed significant increases in V˙O2 when patient’s actively performed SOEB (Table
3.2 ). However, the robustness of this study is difficult to establish as insufficient information
regarding respiratory exchange ratio (RER)1 is provided to establish reliability of the results.
A rough calculation would suggest that some of the RERs would have been considerably lower
than expected.
Activity Stage V˙O2 V˙CO2
Mean (95% CI) Mean (95% CI)
(mL.min-1) (mL.min-1)
PCT
Rest 270(224-315) 166(134-199)
Sitting 284(241-328) 174(126-222)
SOEB
Rest 262(201-322) 171(131-211)
Sitting 353(303-402) 206(151-611)
Table 3.2: V˙O2 and V˙CO2 values during passive and active rehabilitation. Collings et al
(2015).
A recent Brazilian study [169] has looked at the impact of the tilt-table procedure on the
cardiac parameters of 17 non-sedated patients with admission APACHE II scores (mean ±
SD) of 26 ± 5.37 who were weaning from mechanical ventilation. They report mean arter-
ial pressure (MAP), heart rate (HR) and RASS2 on Day 1 and 2 and then on the last day
of ICU admission. On the first day of tilt-table patients demonstrated a 6% reduction in
MAP at 60° tilt, with no increase in HR; on the 2nd day, a 13% drop in MAP and a 4% rise
in HR was seen at 90° tilt. These cardiovascular perturbations were not associated with a
deterioration in RASS. While these changes were reported as insignificant, they do not rep-
resent a normal response to exercise. By ICU discharge MAP was stable with a 4% rise in HR.
1RER = V˙CO2/V˙O2, in steady state RER = RQ, which is the ratio of CO2 output to O2 uptake per unit
time.
2RASS, the Richmond agitation score[170] categorises patients from -5 (unarousable, no response to voice
or physical stimulation) to +4 (combative, overtly combative or violent, immediate danger to staff).
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Another Brazilian group [142] have just reported on the metabolic, respiratory and cardiac
changes seen in 19 sedated patients undergoing 20 minutes of passive cycling starting on day
1 of ICU admission. Patients were aged 55 ± 17 years with SOFA 6 ± 3, PaO2/FiO2 = 29
± 7.5 and 13 (68%) required norepinephrine. While they conclude there were no overall car-
diovascular or metabolic consequences of passive leg-cycling, their results show considerable
individual patient variation in the reported values. For example, while the mean change in
cardiac output from rest to exercise was 1%, the range was -16 to +15%; while there was no
mean change during recovery the range was -9 to +27%. The mean change in MAP from rest
to exercise was 0.8%, but ranged from -16 to +8% and 0.6% during recovery range (-13 to
+13%). The V˙O2 at rest was 185.7 mL.min
-1, with no mean change during exercise but a
range of -9 to +21%, and 2% during recovery with a range -25 to +31%. These values suggest
that there is considerable individual variation in the cardiovascular response to passive cycling.
Hickman et al [171] looked at the metabolic cost of leg cycling at 0, 3 and 6 watts in pa-
tients recovering from critical illness compared to healthy individuals. Only 2/17 of the 6 watt
group were mechanically ventilated, none of the 3 watt group and 13/15 of the 0 watt group.
Patients who were unable to cycle actively were allocated to the 0 watt group; this sub-group
had a higher APACHE II score. They found no statistical difference in V˙O2 between controls
and patients during passive cycling or cycling at 6 watts. However, they did find a difference
between patients and controls at 3 watts, the increment in V˙O2 was 38.5 ± 14.2% vs. 28.6 ±
6.9%, (p = 0.04). They did not give details regarding the accuracy of their ergometer at such
low power outputs, nor did they give details of the speed (revolutions per minute) achieved
by individual patients.
The little that is known about the exercise response of patients with, or recovering from,
critical illness suggests that there is considerable inter-patient variation in the response to very
low exercise loads.
3.2 Current methods of exercise prescription in the
critically ill
In the absence of an an agreed method of exercise prescription, therapists continue to take
a Gestalt approach to terminating rehabilitation interventions. In a postal survey of 111
Physiotherapists working in Australian ICUs, the five most frequently used parameters to
decide when to begin, progress and cease exercise were blood pressure, heart rate, oxygen
saturation, respiratory rate, and arterial blood gases (ABGs). However, there was no recom-
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mended way to utilise these [146].
Two recent papers have made recommendations based on expert consensus for the safe
limits of exercise for mechanically ventilated patients. While providing frameworks for rehab-
ilitation none of the parameters suggested have been validated in the mechanically ventilated
population nor do they give an indication of either relative or absolute exercise intensity
[143, 164].
The Physical Function ICU Test (PFIT) was developed as a sub-maximal test that could
be used both as an outcome measure and as a way to prescribe exercise [172, 173]. Originally
it had four components, representing the four domains thought to be amenable to exercise
training;
• Level of assistance required to sit to stand (0-3 people).
• Steps, duration and cadence of marching on the spot (MOS) at a rate of perceived
exertion (RPE) of 3-5 of the modified Borg scale [174].
• Shoulder flexion duration that maintained >90°flexion and >2 seconds between repeti-
tions.
• Muscle strength, (using the 0-5 Oxford scale [175]) for knee extension and shoulder
flexion.
The shoulder flexion section has since been removed and PFIT is now scored on sit-to-stand
(STS), cadence of marching and muscle strength. The authors advocate its use as a way to
set exercise intensity, by utilising 70% of the duration of the MOS time. If unable to MOS
then the patient performs STS until unable to continue without assistance. While the authors
have demonstrated its responsiveness in a small cohort of the ICU population, it clearly has
a floor effect by virtue of the need to stand even before the patient can be assessed. Indeed,
in their population it had a 20% floor and ceiling effect.
A real time quantification of how hard a patient is working, or a measurement of their
“exercise intensity,” would allow clinicians to make a informed judgement as to whether to
continue with an intervention or to allow the patient to rest.
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3.3 Current methods of exercise prescription in healthy
individuals
Outside critical care the three most common ways to prescribe exercise and its intensity are
through heart rate derived measures, metabolic equivalents and rate of perceived exertion, all
of which are estimates of oxygen consumption (V˙O2).
3.3.1 V˙O2 measurement
Muscular work requires an integrated physiological response of the ventilatory and cardiovas-
cular systems to the increased metabolic demand in order to maintain homeostasis. V˙O2 can
be measured via double labelled water, Douglas bag collection, mixing chamber or breath-
by-breath-gas exchange-analysis (BBGEA). The latter is the gold standard exercise capacity
measurement as it provides a direct measurement of oxygen consumption during exercise (see
chapter 4 for a description of the techniques). To standardise the measurement of exercise
capacity and the prescription of exercise intensity, either a treadmill or arm/leg ergometers are
usually employed to generate a quantifiable stimulus. Such stimuli are usually either constant
load or incremental tests, from which a variety of different surrogates of exercise capacity and
intensity can be obtained. Incremental tests have an increasing load throughout. For example,
unloaded cycling for 1 minute, then 5 watts for 1 minute and increasing by 5 watts.min-1 until
the end of the test. An estimate is made of the individual’s peak V˙O2 and the protocol is
adjusted to keep the test duration between 8-10 minutes. Constant load protocols maintain
the same work level throughout the test and, depending on the method of interpretation may
involve a series of increasing constant loads to establish peak V˙O2 or maximum work in watts.
3.3.1.1 Peak V˙O2
The peak value of V˙O2 reached during an incremental or ramp test provides information re-
garding an individual’s exercise capacity that is comparable both between and within patients.
An increase in peak V˙O2 indicates an improvement in exercise capacity, although this may
also indicate an increase in patient motivation. V˙O2 peak can be used to derive parameters
to prescribe exercise, i.e. a target heart rate or work rate can be determined at which the
subject is known to be working at proportion of their V˙O2 peak.
3.3.1.2 V˙O2max
V˙O2max is more difficult to obtain than peak V˙O2 during an incremental test due to uncer-
tainty regarding the reason for cessation of exercise. It can be most reliably be obtained from
discontinuous constant workload tests where failure to increase V˙O2 despite an increase in
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work rate indicates the actual V˙O2max. V˙O2max is unlikely to be reliably or safely achieved
in ICU patients.
3.3.1.3 Anaerobic threshold
Anaerobic threshold (AT) is the V˙O2 at which an individual moves from aerobic to anaerobic
metabolism during exercise. It is usually identified from a ramp or incremental test, but it can
also be estimated from a series of constant-load tests. In healthy individuals, if steady-state
(identified by a plateau in V˙O2) has not been achieved within three minutes of exercise, it
is assumed that they are working above their AT. If AT can be identified it can be used to
prescribe exercise intensity i.e. if the HR or work-rate at which the patient reaches AT can be
identified, this can be used to steer a training stimulus. Additionally, it can be used to monitor
exercise capacity. An increase in AT would indicate an improvement in exercise capacity.
3.3.1.4 Oxygen uptake efficiency slope
Oxygen uptake efficiency may be a useful sub-maximal indication of cardiorespiratory reserve.
The oxygen uptake efficiency slope (OUES) is defined by the logarithmic regression line de-
scribing the relationship between V˙O2 and minute ventilation (V˙E) representing the ∆V˙O2,
in response to a given change in V˙E . It therefore represents the absolute increase in V˙O2
associated with a 10-fold rise in ventilation.
V˙ O2 = a ∗ logV˙E + b
 where the units of V O2 are mL.kg.
-1min-1
and V˙E is L.kg.
-1min-1
(3.1)
Thus, OUES is a variable that indicates how effectively oxygen is extracted by the lungs and
taken into the body. Importantly, OUES is an index of physical fitness that is independent of
the motivation of the patient to perform maximal exercise [176]. A change in the slope of the
OUES may indicate a change in the patient’s physical fitness. If a clear relationship between
V˙O2 and V˙E can be established it may also be possible to use V˙E as a surrogate of V˙O2.
3.3.1.5 Oxygen uptake kinetics
Uptake of oxygen during exercise is classically divided into three stages. During exercise
below the AT, phase I of exercise is characterised by an immediate increase in V˙O2. This is
thought to be in response to the abrupt increase in pulmonary blood flow and an increase in
HR and stroke volume (SV). Phase II lasts from about 15 seconds to 3 minutes and phase
III represents a steady state where V˙O2 increases linearly with work rate during incremental
tests or plateaus during constant load tests. The mean V˙O2 response time (MRT); the time
constant of the exponential rise in V˙O2 (63% of the asymptotic response), can be used to
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quantify the V˙O2 kinetics of the response to exercise. The MRT decreases as physical fitness
increases, but it would only be useful for monitoring change in exercise capacity rather than
accurately setting an exercise intensity. However it would provide an indicator of the level of
a patient’s physical deconditioning.
3.3.1.6 Excess post-exercise oxygen consumption
During the recovery period after exercise V˙O2 remains elevated and is termed excess post-
exercise oxygen consumption (EPOC). It reflects the level of anaerobic metabolism in the
previous exercise bout and the circulatory, hormonal and thermal adjustments that are inher-
ently necessary in the restoration of homeostasis. EPOC consists of fast and slow components.
The metabolic consequences of exercise are dependent on both the intensity and duration of
the exercise which in turn, are related to the duration and magnitude of EPOC. The relation-
ship between the magnitude of EPOC and intensity is curvilinear, with a linear relationship
between duration of exercise and magnitude of EPOC at high intensities. Therefore, a single
constant-load test repeated at set intervals would provide the data to track an individual’s car-
diorespiratory fitness over time. Additionally, once an acceptable recovery period was defined,
sequential tests of increasing workload would identify a level at which to set the intensity of
an exercise session.
3.3.2 Lactate
An increase in blood lactate is a key feature of high intensity exercise [177]. The magnitude of
the increase is dependent on the level of fitness of the individual [178] plus factors that affect
the uptake, transport or extraction of oxygen e.g. mitochondrial, lung or cardiac disease and
the rate of metabolism of lactate [179–181]. It is also important to consider potential accli-
matisation of patients to their hypoxic state and the impact this may have on accumulation
of lactate [182]. Lactate starts to accumulate in muscle and blood only when a critical ca-
pillary oxygen partial pressure is reached. The net increase in anaerobic glycolysis required
for the re-oxidation of nicotinamide adenine dinucleotide (NADH) to NAD+ lowers the mito-
chondrial cytosolic redox state, resulting in an accumulation of lactate in muscle and blood.
While exercise remains aerobic the rate of removal of lactate by other tissues matches its rate
of production [183]. For healthy untrained persons, lactate accumulation and its subsequent
exponential rise occurs at about 55% of the individual’s capacity for aerobic metabolism. Ad-
aptation within muscle from aerobic training enables high rates of lactate turnover. Thus,
lactate only begins to accumulate at higher intensity levels than in the previously untrained
state. Serial measurements of lactate can be obtained during a ramp protocol to establish the
onset of blood lactate accumulation (OBLA), defined as a systematic increase of blood lactate
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equal to 4.0 mM [184]. OBLA allows an estimation of the HR below which the individual
can be assumed to be exercising aerobically which, in a normal individual, would indicate a
V˙O2 of 60-80% of their maximum. Hence, it should be possible to prescribe absolute work
intensities for individual patients based on the work intensity at which OBLA occurs. Exercise
capacity could be monitored by repeating the same test, and monitoring the change in work
rate before OBLA.
As BBGEA and lactate measurement are not readily available outside of the laboratory,
the three most common ways to prescribe exercise and its intensity are through HR derived
measures, metabolic equivalents and rate of perceived exertion, which have all been developed
as proxies for oxygen consumption.
3.3.3 Heart rate derived measures
3.3.3.1 Heart rate maximum
There is a clear linear relationship between HR and V˙O2 in the normal population [185],
with an error in estimating %V˙O2max from %HRmax of ± 8% [186]. However, this relation-
ship becomes uncoupled with comorbidities such as heart disease where the HR increase is
relatively steep for the increase in V˙O2 due to the relatively low stroke volume in affected
patients. In patients with coronary artery disease the ∆V˙O2 increase slows as the patient
becomes ischaemic [187]. In this instance the ∆HR relative to V˙O2 will also become steeper.
Additionally, patients with airflow obstruction have a moderately elevated HR for a given V˙O2
due to restrictions in venous filling [188].
Obtaining an accurate value of HRmax from an exercise stimulus is not practical or safe
in the ICU setting. Although it is possible to estimate HRmax from various variable-derived
equations, consideration must be given to the accuracy of using such final indices. Additionally
the prescription of Digoxin and beta-adrenoceptor blockade precludes use of HR in isolation.
For example, the SD of the estimated HRmax calculated by 220-Age is 11 beats.min
-1 [189].
Recently, the validity of the “percentage of maximum” concept for calculating training intens-
ity has been questioned [190]. While this threshold may be appropriate for young individuals
of average fitness, subsequent investigators have suggested that the threshold for men in their
sixties and seventies should be 40% of heart rate reserve [191].
Karvonen’s landmark study in the 1950s identified a minimal level of exercise intensity,
above which a beneficial training effect was demonstrable [192]. This set a training threshold
at a HR equal to 60% of the difference between resting and maximum, or heart rate re-
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serve (HRres). The accuracy of both %HRmax and %HRres assumes a functional relationship
between cardiorespiratory and metabolic markers, and may not be applicable under certain
circumstances e.g. beta-adrenoceptor blockade [193]. Unfortunately, there is no evidence on
which to model uncoupling of HR from V˙O2 in patients recovering from critical illness. Given
the common incidence of COPD, heart failure and ischaemic heart disease in the failure-to-
wean from mechanical ventilation population and the length of time taken for cardiac ejection
fraction to return to normal, these factors most probably exclude heart rate changes as a reli-
able indicator of exercise capacity or intensity. Therefore, unless a nomogram can be created
for patients in critical care, the use of HR to prescribe exercise from estimated maximums has
little value.
3.3.3.2 Heart rate recovery
Heart rate recovery (HRrec) typically follows a decreasing mono-exponential pattern [194]
quantified by the absolute difference between the HR at exercise completion and after 60 or
120 seconds of recovery (T60, T120), or the time constant (HRRpi) of the HR decay obtained
by fitting the post-exercise HRrec into a first-order exponential decay curve. The rate of
HRrec is the consequence of parasympathetic reactivation and sympathetic withdrawal follow-
ing exercise [195]. Large cohort studies have shown that HRrec is independent of age, gender,
and maximum heart rate, and is positively modulated by exercise training in patients with
heart disease. Both endurance and strength-trained athletes have a faster HRrec following
exercise at similar absolute intensities than untrained subjects [196, 197]. Conversely, slowing
of HRrec is associated with acute increases in training load [198] and worsening performance
[199]. Data suggest that the kinetics of HRrec differ between maximal and sub-maximal ex-
ercise. The initial rapid decline in HR as described by short-term indexes such as T30 and
T60 are considered markers of increased cardiac parasympathetic outflow, which occurs early
post-exercise at all intensities [200]. The second, slower HR decay, as depicted by HRRpi, is
believed to be workload-dependent [194] and related to the clearance of stress-system meta-
bolites e.g. H+ and lactate. Following higher levels of exercise, this second decay phase is
modulated by sympathetic drive, which continues well into the recovery period, contributing
to maintenance of high HR despite parasympathetic activation. The modulation of this second
decay phase by high intensity exercise means that HRRpi does not provide an adequate model
of HRrec following maximal exercise [201].
The within-subject day-to-day variation in HR for a given exercise intensity decreases with
increasing exercise intensity [202]. Imai et al [203] investigated the workload dependence of T30
and T120 on three levels of exercise intensity (50% of anaerobic threshold, anaerobic threshold
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and at maximal exercise). V˙O2, systolic BP and heart rate at the end of exercise were all
increased with increasing workload. This trend was also noted at T120, indicating that this
index is largely dependent on the exercise workload. In contrast, T30 was nearly independent
of exercise intensity, though the value of T30 at maximal exercise was significantly greater
than that at anaerobic threshold. Gore et al [204] found that T30 was also intensity and not
duration dependent.
The use of HRrec as a tool to evaluate both exercise capacity and session load requires the
development of a population-specific, standardised, sub-maximal test that could be performed
on a weekly basis. Such a test would track the impact of exercise strategies on HRrec over time,
allowing tailoring of the intensity of exercise for individual patients, and also allow tracking of
changes in exercise capacity. Thus, increased HRrec for the same given absolute work intensity
exercise would indicate improvement in exercise capacity, allowing comparison both between
and within patients.
3.3.3.3 Heart rate variability
The autonomic nervous system is central to an individual’s ability to respond to the dynamic
challenge of exercise. Heart rate variability (HRV) is a relatively new concept in monitoring
both exercise session load and exercise capacity. HRV increases following exercise training,
but decreases with over-training. It is measured by the variation in the R-R interval of the
ECG. The R-R interval of consecutive beats is calculated and plotted on a tachogram. Signals
are then transformed by Fast Fourier Transformation (FFT) waveform analysis into frequency
domains.
HRV modulation is considered to be exercise intensity rather than duration dependent
[205, 206]. Tulppo et al [207] demonstrated that HRV decreased during exercise almost to the
extent that it disappears during high intensity exercise, i.e. the greater the relative exercise
intensity, the less variability is seen in the R-R interval. Seiler et al [208] found that doubling
exercise duration from 60 to 120 minutes while maintaining exercise intensity in both trained
and highly trained individuals had little impact on HRV recovery. Kaikkonen et al [209] also
found that doubling the running distance from 3,500 to 7,000 m had no impact on the ex-
tent of HRV nor its rate of recovery. However, increasing the training intensity caused slower
HRV recovery and lower High Frequency Power (HFP) and Total Power (TP) during the first
five minutes of recovery. Conversely, Kaikkonen et al [210] found that a fourfold increase in
running distance at 60% V˙O2 max, and an increase in exercise intensity from 60% to 85%
decreased HFP, LFP and TP during the first two minutes of recovery. They also found that
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decreased post-exercise HRV was closely related to an increase in blood lactate and the RPE.
Recovery of HRV is faster in trained than untrained individuals [208, 209]. In order to use
HRV to monitor training load, either HRV could be monitored at rest, over time, or following
a set stimulus such as unloaded cycling. Alternatively, HRV could be recorded before, during
and after a rehabilitation intervention. Depending on the rate of HRV recovery following the
session, the training load (duration or intensity) could be adjusted.
3.3.4 Rate of perceived exertion
There is an extensive literature describing the relationship between RPE and physiological
variables during exercise. Although RPE was developed to describe the intensity of exercise,
its subjective nature also takes the duration of exercise into account. The most frequently
used RPE scale is Borg’s 6-20 category scale [211]. Although recommended for use by the
Delphi consensus group published by Hanekom et al [164], the use of the Borg scale has not
been validated in the ICU population.
3.3.5 Metabolic equivalents
One metabolic equivalent (MET) is defined as the amount of oxygen consumed while sitting
at rest and equates to 3.5 mL.kg.-1min-1 of O2. The MET concept expresses the energy
cost of physical activities as a multiple of the resting metabolic rate. Therefore, the relative
energy cost of an activity can be determined by dividing the oxygen cost of the activity in
mL.kg.-1min-1 by 3.5. Thus, 1 MET (sitting at rest) equates to about 245 mL.min-1 for a 70
kg person. Exercise performed at 2 METs requires twice the energy required at rest. Compen-
diums of activity with their associated METs are available to estimate a persons’ maximum
functional oxygen consumption by the most strenuous activity they can complete, giving an
indication of their peak V˙O2 [212]. However, given that similar workloads in patients recover-
ing from critical illness have been shown to require a higher MET than in healthy individuals
[171], metabolic estimations in a healthy population may not be accurate in patients recover-
ing from critical illness. Additionally, the majority of activities reported in the compendiums
take place while individuals are already standing.
3.4 Potential measures of exercise capacity and intensity
in patients recovering from critical illness in ICU
Surrogate measures of exercise intensity and capacity are dependent on the development of a
reproducible and quantifiable exercise stimulus.
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3.4.1 The modality of exercise used to generate the
exercise stimulus.
Treadmill, arm and leg ergometry are the modalities generally used during exercise testing.
The use of treadmills is clearly not feasible in a patient cohort unable to stand. Prior clinical
experience on the ICU at UCH indicated that greater numbers of patients were able to use
an arm ergometer than a leg ergometer. However, there are significant differences between
the physiological response to arm and leg ergometry. At a given sub-maximal workload, arm
exercise is performed at a greater physiological cost than leg exercise, reflected in the greater
HR and V˙O2 response in arm vs. leg exercise at identical workloads. It is postulated that
this discrepancy is due to reduced mechanical efficiency during arm exercise vs. leg exercise
[213, 214]. Anaerobic threshold and peak V˙O2 achieved during arm ergometry tests are re-
ported to be 64%-80% of that achieved during leg ergometry [215, 216]. This is likely to be
due to the involvement of smaller muscle groups and the static effort required with arm work,
which increases V˙O2 but does not affect the external work output.
Despite these differences, I felt that arm ergometry was sufficiently accepted as a repro-
ducible exercise stimulus in the wider population and that more patients would be recruited
using arm than leg ergometry.
3.4.2 Potential exercise tests
There are four possibilities.
i) An incremental ergometry test specifically for mechanically ventilated ICU patients,
thus giving the potential to measure V˙O2 peak, OUES and AT. If sufficient patients
who are representative of the wider ICU rehabilitation population were able to complete
an incremental test, then it may be possible to derive a population-specific equation for
HR vs. V˙O2. This would circumvent the need for an initial exercise test to prescribe
exercise intensity.
ii) A sub-maximal incremental ergometry test specifically for mechanically ventilated ICU
patients. If factors causing patients to stop exercise were unclear it may be possible to
use a sub-maximal incremental ergometry test to measure OUES.
iii) A series of constant load tests would allow measurement of oxygen uptake kinetics,
EPOC and HRV in addition to V˙O2 peak, OUES and AT.
iv) A single constant load ergometry test would allow measurement of oxygen uptake kin-
etics, EPOC and HRV.
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v) If a clear relationship between V˙O2 and V˙E can be established, it may also be possible
to use V˙E as a surrogate of V˙O2, with either a constant load or series of constant load
tests.
There is a wealth of knowledge and experience within sports and exercise science that the
critical care community can draw upon to build a scientific basis for the prescription of exercise
interventions in patients recovering from critical illness. Such knowledge will allow us to move
away from the “one-size-fits-all” approach we currently employ and to tailor exercise programs
to individual patients. We may then begin to understand who has the capacity to respond to
a physical rehabilitation intervention and who does not.
3.5 Measuring oxygen consumption in mechanically
ventilated patients
There are several ways to measure oxygen consumption in mechanically ventilated patients.
The following are the most commonly used and published methods:
3.5.1 Inverse Fick principle
The inverse or reverse Fick technique is perhaps the most commonly used method to measure
oxygen consumption in mechanically ventilated patients in ICU. Originally, the Fick principle
[217] was used to calculate cardiac output from V˙O2 and the arterio-venous oxygen difference,
where V˙O2 was an assumed value based on the patient’s gender and body weight (Equation
3.2). However, the introduction of the pulmonary artery catheter as a bedside tool for meas-
uring cardiac output through thermodilution allowed the calculation of oxygen consumption
from cardiac output and the arterio-venous oxygen difference (Equation 3.3 ).
Cardiac output =
V˙ O2
arterio-venous O2 difference
{
Fick equation (3.2)
V˙ O2 = Cardiac output*arterio-venous O2 difference
{
Inverse Fick equation. (3.3)
The development of oesophageal Doppler (and other techniques) now negates the need for a
pulmonary artery catheter to measure cardiac output, but it is still necessary for accurate
measurement of mixed venous oxygenation [218]. Very few patients recovering from critical
illness will have a pulmonary artery catheter in situ, thus it is unsuitable for monitoring during
exercise.
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3.5.2 Double-labelled water
Double-labelled water uses water labelled with deuterium (2H) and oxygen-18 (18O), or deu-
terium oxide (D2
18O). Metabolic rate can be estimated by measuring the elimination rates of
deuterium and 18O by the regular sampling of heavy isotope concentrations in saliva, urine,
or blood. When O2 in water is labelled with
18O, the CO2 produced by respiration contains
labelled O2. Additionally, the
18O equilibrates in bicarbonate and the dissolved carbon diox-
ide pool (through the action of the enzyme carbonic anhydrase). 18O is lost from the body in
CO2 and through urine and insensible losses. However, deuterium is lost only through urine
and insensible losses. Thus the loss of deuterium can be used to mathematically compensate
for the loss of 18O by the water-loss route. The net loss of 18O in CO2, provides an estimate
of the CO2 production the between the samples. However, knowledge of the RQ is required
and measurements can only be made over long periods of time.
3.5.3 Open-circuit indirect calorimetry
Open-circuit indirect calorimetry is the measurement or derivation of oxygen consumption
and carbon dioxide production from values obtained from the analysis of inspired and expired
gas (Equation 3.4 and 3.5).
V˙ O2 = (V˙I · FiO2)− (V˙E · FeO2)
{
Oxygen consumption (3.4)
V˙ CO2 = (V˙E · FeCO2)− (V˙E · FiCO2)
{
Carbon dioxide production (3.5)
One of the biggest challenges when measuring pulmonary gas exchange is the precision
required of the values for inspired and expired V˙E . Both volumes must be measured, with
an inherent error associated with subtracting two potentially inaccurate values. Alternatively,
inspired or expired volume must be measured and the Haldane equation (Equation 3.6) used
to calculate the remaining value (Equation 3.7). This equation makes the assumption that
nitrogen is neither produced nor retained by the body and that no other gases are present
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other than oxygen, carbon dioxide and nitrogen.
V˙I · FiN2 = V˙E · FeN2
{
Haldane equation. (3.6)
V˙I = V˙E · FeN2
FiN2
 Calculation of inspired volumeusing the Haldane equation. (3.7)
V˙I = V˙E · (1− FeCO2 − FeO2)
1− FiO2
{
Substitution of known values. (3.8)
RQ =
(1− FiO2)
(FiO2−FeO2)
(FeCO2)
− (FiO2)
 Transformation ofthe Haldane equation (3.9)
V˙ O2 =
V˙ CO2
RQ
{
Calculation of V˙O2 (3.10)
Additionally, gas volumes vary with temperature, ambient pressure and humidity. These
factors must be accounted for to ensure accurate gas exchange measurements. Most systems
use algorithms to adjust for gas volumes. Additionally, the device must be correctly calibrated
and correct conditions entered into the analysis software to ensure accurate results. However,
there are other potential sources of error that require consideration when evaluating such
devices:
i) How the device handles flow-by or bias-flow, which is an integral system in most modern
ventilators, can lead to a significant bias in all obtained values. Bias-flow or flow-by is
the delivery of a continuous flow of gas, usually in the order of 2 L.min-1 of the pre-set
concentration of oxygen, through the patient’s ventilation circuit. Bias flow is considered
to reduce the sensation of air hunger experienced by the patient during the breath trigger
phase of the breathing cycle. Mishandling of this extra volume of oxygen added to the
expired volume can significantly impact upon the values obtained.
ii) Although the precision of the gas analysers of most modern systems is no longer con-
sidered a major confounding factor, the response time of the gas analysers is. Breath-
by-breath systems must cope with the rapid and irregular breathing patterns of the
tachypneoic ventilated patient. This necessitates a response time of 0.15-0.2 seconds to
accommodate respiratory rates of 40-50 bpm [219].
iii) The high pressures generated by mechanical ventilation in the inspiratory limb of the
ventilator circuit can significantly alter gas partial pressures. Therefore, a single gas
analyser must be able to measure gas presented under different conditions and apply a
correction factor dependent on the pressure measured in the sampling tube.
iv) The difference in inspired and expired concentrations of oxygen becomes proportionally
smaller as the concentration of the inspired gas increases. Thus, increasing inspired
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oxygen concentration may introduce further inaccuracy if the system is reliant on the
Haldane equation. Additionally, instability of the fraction of inspired oxygen (FiO2)
during inspiration is difficult to control in most modern ventilators, but does need to
be monitored and accounted for during analysis of collected values. As most systems
rely primarily on collection of expired gas volume, leaks from the ventilator circuit can
introduce significant error.
There are three methods of measuring pulmonary gas exchange in mechanically ventilated
patients: Douglas bag collections, the mixing chamber and breath-by-breath-gas exchange
analysis.
3.5.4 Douglas Bag Collection
This first method of calculating oxygen consumption was described in 1911 by Gordon Douglas,
an Oxford physiologist. All gas expired by a subject is collected into gas collection bags (now
made of PVC). Samples of this expired gas are extracted from the bag and the CO2 and O2
content analysed [220]. The volume of gas is then measured and the volume of O2 extracted
and CO2 produced calculated (Equations 3.4 and 3.5). This is feasible with mechanically
ventilated patients but does present several challenges especially with respect to the handling
of conditions presented to the gas, and the partial pressure of inspired oxygen [221]. While
cumbersome, and time consuming, Douglas bag collections (DBC) do provide a means of
validating other methods of measuring V˙O2.
3.5.5 Deltatrac II
An alternative method is to use an automated indirect calorimetry device such as the Deltatrac
II (Datex−Omeda, Finland). This measures the concentration of inspired and expired oxygen
and carbon dioxide, and measures or calculates the inspired and expired volumes of gas.
The Deltatrac II is possibly the most widely used indirect calorimeter in the critical care
setting. It circumvents potential error introduced by measuring or calculating expired minute
ventilation (V˙E) and calculating inspired minute ventilation (V˙I) by using a transformation
of the Haldane equation (Equation 3.9 ).
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Deltatrac V˙CO2 calculation.
V˙ CO2 = FdCO2 ∗ 40

Where FdCO2 is the fraction of
expired and diluted carbon dioxide
and 40 is the flow constant.
(3.11)
Therefore:
V˙ O2 =
V˙ CO2
RQ
(3.12)
The device is an open-circuit calorimeter with two chambers. The first collects and mixes the
gas expired by the patient. Gas is sampled from this chamber and the fraction of expired
O2 and CO2 analysed. The expired gas is then drawn through an air dilution chamber at a
constant flow rate. In most machines this is roughly 40 L.min-1 but there is variation between
and within machines over time, necessitating regular calibration. The gas is sampled from
the air dilution chamber and the fraction of CO2 analysed allowing calculation of the original
volume of CO2 expired by the patient.
The Deltatrac was first described by Merila¨inen [222] in 1987. Takala et al [223] published
the first clinical validation study comparing V˙O2 values obtained from indirect Fick meas-
urements and the Deltatrac II in 20 patients following cardiac surgery who were ventilated
in controlled mandatory ventilation (CMV) mode, and 10 tests in 5 patients ventilated with
synchronised intermittent mandatory ventilation (SIMV). The mean ± SD V˙O2 obtained by
indirect calorimetry was consistently higher than with inverse Fick (294 ± 59 vs. 247 ± 58), a
mean difference of 49± 25 mL or 16± 9% (p<0.01). This error was magnified to 25± 8% when
patients were ventilated in SIMV. Increasing FiO2 from 0.4 to 0.6 during stable ventilation did
not make a significant difference to either V˙CO2 or V˙O2 values. The authors concluded that
the error was acceptable for clinical practice given that a previous study using DBC [224] gave
a 15% greater value for V˙CO2 obtained from indirect calorimetry. Tissot et al [221] compared
the Deltatrac II with both DBC and mass spectroscopy (MS) in 35 mechanically ventilated pa-
tients. They found a much smaller -3.5 ± 2.5 mL (DBC) and -5.8 ± 1.6 mL (MS) V˙CO2 error.
For the last two decades the Deltatrac II has remained the “gold standard” against which
the majority of new devices have been compared. However, there has been little consistency
demonstrated in the margins of error between the Deltatrac II and other devices [225–227].
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3.5.5.1 Breath-by breath-gas exchange analysis
Until recently, BBGEA technology has struggled to manage the flow-by system of modern
ventilators. A number of new gas exchange analysis devices have become commercially avail-
able but they have yet to be validated in the ICU population. The MedGraphics Ultima
(MGU) is one such device that provides breath-by-breath analysis of gas exchange. It has
been validated and is widely used for exercise testing in spontaneously breathing patients,
but has yet to be validated in mechanically ventilated patients. It has however been shown
to be unaffected by “bias flow” in a lung simulator model [228]. The system measures both
inspiratory and expiratory flow, and thus does not require the Haldane equation. It achieves
this through a bi-directional, patented flow-sensor. The oxygen analyser is a fuel cell with a
response time <80 ms while the carbon dioxide analyser is a non-dispersive infra-red sensor
with a response time <150 ms. The system samples gas continuously and phase-aligns the
oxygen and carbon dioxide signals with the flow signal to calculate inspired and expired values
for CO2 and O2 (Figure 3.1). There are three potential sources of error for the measurements
Figure 3.1: Phase alignment of MGU flow, CO2 and O2 signals.
made with the MedGraphics Ultima (MGU). 1. Volume measurements. 2. Oxygen and car-
bon dioxide gas concentration analysis. 3. Handling of humidity and temperature of in vivo
measurements.
3.6 Summary
The ideal way to measure exercise capacity and intensity in mechanically ventilated patients
would appear to be through measurement of V˙O2. The only feasible techniques to do this
are DBC, or indirect calorimetry. The DTII has been widely used in mechanically ventilated
patients at rest, but not during exercise and only gives measurements on a minute-by-minute
basis. DBC are cumbersome and time-consuming and only measure over 5 minute periods.
Before BBGEA can be used in this population, it requires validation.
Chapter 4
Validation of the
MedGraphics Ultima
There is no precedent for the validation of BBGEA systems during exercise in mechanically
ventilated patients. While studies have measured V˙O2 and V˙CO2 during rehabilitation inter-
ventions, no details regarding the precision, bias or reproducibility of the measurements have
been provided [142, 168]. The gold standard for automated gas-analysis system validation
during exercise is the Douglas bag technique to analyse the gas generated from a reproducible
exercise stimulus. This is unfeasible, given the development of a reproducible exercise stim-
ulus was one of the objectives of my research. The MGU is validated for use in a dynamic
environment but not for use during mechanical ventilation. The gold standard for measuring
gas exchange in mechanically ventilated patients is the Deltatrac II which requires that the
patient be in steady state during the measurements. Therefore, until a reproducible stimulus
could be established, the only realistic validation technique was to compare Douglas bag col-
lections, Deltatrac II measurements and the MGU, with the patient in steady state. Table 4.1
lists the main issues using a system designed primarily for exercising athletes in mechanically
ventilated patients.
4.1 MedGraphics Ultima familiarisation
The paucity of data available to support the accuracy of the MGU device required a series
of tests be performed to investigate the precision of the device, before beginning a direct
comparison with Douglas bag collections and the Deltatrac II, to then establish accuracy.
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Precision and response time of the gas analysers
High pressures within the inspiratory limb of the ventilator
circuit
Leaks from the ventilator circuit
High inspired oxygen concentrations
Need for meticulous calibration and for correct ambient
conditions entered into the analysis software
Handling of bias flow (flow-by) from the ventilator
Instability of the fraction of inspired oxygen (FiO2) during
inspiration
Dead space created by the ventilator tubing and heat
moisture exchange systems
High signal-to-noise ratio due to relatively low levels of V˙O2
Table 4.1: Challenges associated with indirect calorimetry monitoring.
4.1.1 Gas exchange system validator
Gas exchange system validators (GESV) simulate respiratory gas exchange for verification of
cardiopulmonary gas exchange measurement systems [229]. These have been developed for
quality control of gas exchange measurements using automated systems. Gas exchange simu-
lators do not simulate the normal variation in breathing pattern waveforms nor do they sim-
ulate moist, room temperature exhalate. Thus, the effectiveness of drying exhaled air before
analysis, or application of temperature and humidity corrections, are not tested. Therefore,
these calibrators are perhaps most useful for the detection of variations in performance of the
system (precision) rather than accuracy.
Theoretically, if all the inspired O2 were extracted from room air during a metabolic
process, assuming a respiratory quotient (RQ)1 of 1, approximately 20.6% CO2 would be
produced. Hence, if a standard metabolic calibration medium of 20.6% CO2 and 79.4% N2 is
used, the potential error when calculating inspiratory from expiratory volumes is negated. One
litre of gas simulates metabolism of 210 mL.min-1 for both V˙O2 and V˙CO2. The MedGraphics
GESV draws in room air (21.6% O2 and 79.4% N2) through the flow sensor (Figure 4.1a).
Downstream of the flow sensor a precision gas (21.6% CO2:79.4% N2) is bled into the room air
within the reservoir. At the end of the inspiratory cycle the gas is then pushed back through
the flow sensor. The resulting expired gas mixture has a higher fraction of CO2 and a lower
1RQ=V˙CO2/V˙O2
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fraction of O2 than the inspired room air, mimicking the expected concentrations of expired
gas (Figure 4.1b).
(a) MedGraphics gas exchange
system validator.
Piston MGU 
Pneumotach 
855 ml room air 
(176ml O2 &  
679 ml  N2) 
Reservoir 
145 ml 20.6% CO2  
 
1000 ml combined gas  
(176 ml of  O2,  
794 ml N2 &  
30 ml of CO2 ) 
 
(b) Schematic.
Figure 4.1: MedGraphics gas exchange system validator.
Thus if an 855 mL inspiratory “breath” comprises:
• 176 mL O2 = 20.6%*855 mL and
• 679 mL N2 = 79.4%*855 mL.
The 1000 mL expiratory “breath”, will have:
• 30 mL CO2 = 20.6%*145 mL and
• 115 mL N2 = 79.4%*145 mL added.
Hence the expired gas will be:
• 17.6% O2, 3% CO2 and 79.4% N2.
Assuming 10 breaths.min-1:
• 2060 mL.min-1 O2 will be inspired and 1760 mL.min-1 O2 expired.
Resulting in:
• 300 mL.min-1 of V˙O2 and V˙CO2.
The system has two variables, each with three possible values each; VT (0.5 L, 1.0 L and 1.5
L) and respiratory rate (10 bpm, 20 bpm and 40 bpm). This provides a range of flows and
volumes seen in patients at rest and during exercise (Table 4.2).
4.1.1.1 Objective
To evaluate the precision of values obtained for V˙O2 and V˙CO2 with different flow rates
generated by a gas exchange system validator.
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Breaths per Duty cycle Expiratory time Tidal Volume
minute (Sec) (Sec) 0.5(L) 1.0(L) 1.5(L)
10 6 3 10 20 30
20 3 1.5 20 40 60
40 1.5 0.75 40 80 120
Table 4.2: Gas flow in litres per minute generated by the lung simulator.
4.1.1.2 Method
The GESV was connected to the MGU and 13 trials (Table 4.3 ) were used to simulate six
different flows and volumes that characterise the inspiratory flows and volumes of mechanically
ventilated patients. Each trial was conducted for five minutes and the average of the last three
measurements for both V˙O2 and V˙CO2 were used for comparison with the calculated expected
values.
Trial BPM VT Flow
(L) (L.min-1)
1 10 1 20
2 20 1.5 60
3 10 1 20
4 20 1.5 60
5 40 1.5 120
6 20 0.5 20
7 10 0.5 40
8 40 0.5 40
9 40 0.5 40
10 40 0.5 40
11 40 0.5 40
12 40 1 80
13 40 1 80
Table 4.3: GESV trials, VT , breaths per minute and flow.
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4.1.1.3 Analysis
4.1.1.4 Analysis
The mean values from the 13 tests were plotted as a percentage of the expected values for each
individual test. (Appendix A.1). No analysis was carried out to establish bias in the mean
percentage error as a result of increases or decreases of the individual variables.
4.1.1.5 Results
The mean percentage error (presented as a percentage of the expected value) for the V˙O2
and V˙CO2 values obtained during the tests are shown in Figure 4.2. Within the anticipated
patient flow range (30-90 L.min-1), there was <10% error in V˙O2 values when compared to
those expected. However, there was up to a 15% error between expected and obtained values
for V˙CO2.
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Figure 4.2: Percentage V˙O2 and V˙CO2 error for (a). respiratory rate (bpm), (b). tidal
volume (VT ) and (c). inspiratory flow (L.min
-1). The potential peak inspiratory flow range
for mechanically ventilated patients (30-90 L.min-1) is illustrated.
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4.1.1.6 Discussion
The developers of the GESV expect a intrinsic ± 2% error from the device itself and an
additional ± 1% for flow and gas concentration error. In line with this, the American College
of Chest Physicians suggest 3% accuracy should be maintained for exercise testing in non-
ventilated patients [230]. Most, if not all BBGEA systems (and the GSEV devices used to
test them), have been developed for exercise testing in athletes who generate V˙E ≥100 L.min-1,
i.e. considerably greater than the <20 L.min-1 V˙E anticipated for patients.
4.1.1.7 Conclusion
While relatively straightforward to provide in vitro validation of such devices, in vivo val-
idation techniques lack a standard, accurate reference tool. However, in vivo validation is
essential as mechanical ventilation introduces significant inconsistencies.
4.1.2 MGU flow sensor placement
During the process of familiarisation with the MGU, I observed that placing the flow sensor on
the ventilator side of the the heat moisture exchanger (HME)2 resulted in a 20-45% reduction
in values obtained for both V˙CO2 and V˙O2, (Figure 4.4 and Table 4.4). Two plausible
explanations for the discrepancy were;
i) the way the device handles the different conditions the gas is exposed to, resulting in
mis-representation of gas volumes. The HME removes water vapour from exhalate.
Therefore, if the flow sensor was placed on the ventilator side (Figure 4.3b) rather
than the patient side (Figure 4.3a) of the HME, the gas would be closer to ambient
temperature and not fully saturated i.e. a smaller volume. If, however, the flow sensor
were placed on the patient side of the HME then the gas would be closer to Body
Temperature and Pressure, fully Saturated (BTPS), i.e. a larger volume.
ii) the extra dead space created by the catheter mount and the HME may be altering the
phase alignment of the gases (Figure 3.1).
The following observations were carried out as figure (Figure 4.5).
4.1.2.1 Objective
To establish if the difference in V˙CO2 and V˙O2 when the flow sensor was placed on the patient
or ventilator side of the HME was due to misrepresentation of gas volumes.
2HME, a device used to humidify the patient’s breathing circuit, which exchanges the heat and moisture
in expired gas with the dry cold gas delivered by the ventilator.
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(a) Flow sensor on the patient side of the HME. (b) flow sensor on the ventilator side of the HME.
Figure 4.3: Different positions of the MGU flow sensor.
4.1.2.2 Method
The MGU was set up and calibrated in-line with the manufacturer’s instructions. Repeated
tests were carried out on five additional patients with the flow sensor placed on the patient
side of the HME (Figure 4.3a) and then with the device placed on the ventilator side of the
HME (Figure 4.3b). Breath-by-breath VT data were downloaded from the patient’s Servo-i
ventilator (Maquet, Solna, Sweden). The Servo-i presents gas as ambient temperature and
pressure saturated at 21℃ (ATP21). The Servo-i data was then time-aligned with the MGU
VT data which were presented as either body temperature pressure saturated (BTPS) or
ambient temperature pressure saturated (ATPS). Resulting in five sets of data per patient.
Patient
 Side Ventilator
 Side
Patient
 Side Ventilator
 Side
Patient
 Side Ventilator
 Side
Patient
 Side Ventilator
 Side
A B
C D
200
400
600
200
400
600
0 100 200 300 0 100 200 300
Breath
V⋅ O
2 
 
a
n
d 
 
V⋅ C
O
2 
(m
L.
m
in
−
1 )
Gas Oxygen Carbon Dioxide
Figure 4.4: V˙O2 and V˙CO2 with changing the placement of the MGU flow sensor.
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Patient V˙CO2 V˙O2
VS PS % difference VS PS % difference
A 135 195 30.77 139 189 26.46
B 227 286 20.63 256 334 23.35
C 178 326 45.40 175 319 45.14
D 263 377 30.24 287 427 32.79
Table 4.4: V˙CO2 and V˙O2 values on changing the location of the MGU flow sensor. VS =
flow sensor ventilator side of HME, PS = flow sensor ventilator side of HME.
18 patients  
Ventilated >1 day with a tracheostomy.  
Pressure support ventilation range 5-20 cmH2O,  
PEEP range 5-15,  
FiO2 0.35-0.45. 
4 patients 
 (A-D)  
Figure 4.4: Observed VO2 and 
VCO2 difference with MGU flow 
sensor placement. 
5 patients  
(E-I)  
Figure 4.5: Tidal volume differences 
with placement of  MGU flow sensor. 
9 patients 
 (J-R)  
Figure 4.6: MGU intra-
patient repeatability 
Figure 4.5: Consort diagram for MGU pre-validation observations.
4.1.2.3 Results
Tidal volumes with the flow sensor on the patient side of the HME were consistently greater
than those when the flow sensor was on the ventilator side of the HME (Figure 4.5 and Table
4.5 ).
4.1.2.4 Discussion
In four of the five patients studied the variation in VT did not account for the total discrepancy
in V˙CO2 and V˙O2 values. Subsequent consultation with MedGraphics recommended flow
sensor placement on the patient side of the HME. Consideration must then be given to the
conditions the gas is exposed to, with both HME and humidified Fisher Paykel circuits (which
warm and humidify inspired gas using a heated water bath). Additionally, the dead-space
before and after the flow sensor must be accounted for. Internal dead-space refers to the
distance between the sampling line and the patient. This volume only affects the dead-space
calculations (V˙E / V˙CO2 and V˙E / V˙O2) made by the Breeze Suite software when it corrects
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Figure 4.6: Tidal volume differences with placement of MGU flow sensor the patient side (PS)
and the ventilator side (VS) of the HME. Each panel is one patient.
Patient ATP21 PS-VS PS-VS
PS.ATPS BTPS ATPS
% difference % difference % difference
E -1.76 3.54 3.50
F -7.12 2.53 2.11
G -7.96 23.86 23.87
H -3.78 4.28 4.36
I -3.33 5.78 5.60
Table 4.5: Percentage difference in V˙T with the flow sensor in different positions. PS = flow
sensor patient side of the HME, VS = flow sensor ventilator side of the HME.
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for dead-space. External or mechanical dead-space is the distance from the sampling line to
the ventilator circuit and has a considerable impact. The dead-spaces of the respective circuits
were obtained by filling them with water and weighing them. Values are shown in Table 4.6.
Of interest, the Servo-i3 delivers a breath 10-20% larger than most clinicians would expect
(Table 4.7).
4.1.2.5 Conclusion
The flow sensor should be placed the patient side of the HME.
Circuit type Dead-space Relative Temperature
after flow sensor humidity (℃)
(mL) (%)
Fisher Paykel
44 75 37
(Heated Humidifier)
Dar
80 83 35
(HME)
Pall
60 83 30
(HME)
Table 4.6: Environmental conditions for the MGU.
Patient E F G H I
MGU.BTPS
608 351 469 396 453
Mean VT (mL)
SI.ATP21
550 301 357 355 404
Mean VT (mL)
% difference 10 17 11 12 12
Table 4.7: VT differences when changing how the data is presented; SI.ATP21 (Ambient
Temperature and Pressure Saturated at 21°C reported by the Servo-i) and MGU.BTPS (Body
Temperature and Pressure Saturated, measured by the MGU).
4.1.3 MGU intra-patient repeatability
At a very basic level, within patient repeatability would give an indicator of the system preci-
sion. These repeatability tests were performed recognising that patients’ metabolic demands
are not stable over time.
3The specifications of the Servo-i are ± 7% for VT [231].
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4.1.3.1 Objective
To investigate the repeatability of the VO2, VCO2, VE , RQ and resting energy expenditure
(REE) measurements.
4.1.3.2 Method
Repeated tests were carried out in an additional nine mechanically ventilated patients. The
MGU was set up and calibrated in line with the manufacturers instructions. Up to 3 tests for
each patient were carried out within a single data collection session. Each test ran until 10
minutes of steady state data was obtained. Steady state was defined as a within test covariance
<10% of V˙O2 and V˙CO2. The MGU was recalibrated prior to each individual test.
4.1.3.3 Analysis
Coefficients of variation (COV)4 were calculated for REE, RQ, V˙E , V˙O2 and V˙CO2.
4.1.3.4 Results
The coefficients of variation for V˙O2,V˙CO2,V˙E , REE, and the RQ are displayed in Tables
4.8a-e. Graphical representation is given in Figure 4.6. Greater variation was seen in the V˙O2
values compared to the V˙CO2 values.
4.1.3.5 Discussion
Seven of nine completed tests demonstrated good repeatability (COV <4%). The remaining
two tests demonstrated COV of <14%.
4.1.3.6 Conclusion
Repeatability was grossly demonstrated to be acceptable within the limits of patient stability.
4.2 Reference device calibration studies
4.2.1 Douglas bag collections
Douglas bag collections and the calculations required for subjects breathing room air are re-
latively straightforward. When the subject is receiving mechanical ventilation, calculation of
V˙O2 and V˙CO2 from the expired gas requires that both FiO2 and flow-by are taken into
account. Flow-by effectively adds (in the case of the Servo-i) 2 L.min-1 of the gas the patient
is breathing. The formulae for calculating V˙O2 and V˙CO2 in mechanically ventilated patients
4COV = standard deviation/mean*100
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Subject V˙O2 (mL.min
-1) COV
Mean SD (%)
J 225.50 6.36 2.82
K 256.00 5.29 2.07
L 187.00 2.83 1.51
M 177.00 6.56 3.70
N 214.33 6.51 3.04
O 206.00 1.41 0.69
P 392.00 33.06 8.43
Q 238.00 21.53 9.04
R 274.75 37.69 13.72
(a) V˙O2
Subject V˙CO2 (mL.min
-1) COV
Mean SD (%)
J 185.00 2.83 1.53
K 240.00 3.46 1.44
L 166.00 8.49 5.11
M 173.67 5.77 3.32
N 190.33 3.21 1.69
O 196.00 1.41 0.72
P 338.00 30.51 9.03
Q 205.25 6.40 3.12
R 240.25 27.93 11.63
(b) V˙CO2
Subject RQ COV
Mean SD (%)
J 0.82 0.01 1.72
K 0.94 0.02 1.84
L 0.89 0.03 3.18
M 0.99 0.02 2.11
N 0.89 0.02 1.95
O 0.96 0.00 0.00
P 0.86 0.02 1.77
Q 0.87 0.05 6.34
R 0.88 0.02 2.85
(c) RQ
Subject V˙E (L.min
-1) COV
Mean SD (%)
J 7.15 0.07 0.99
K 7.27 0.15 2.10
L 8.05 0.07 0.88
M 7.80 0.10 1.28
N 10.07 0.97 9.65
O 7.60 0.00 0.00
P 9.97 0.50 5.05
Q 14.88 0.29 1.93
R 10.55 0.25 2.39
(d) V˙E
Subject REE (kCal/day) COV
Mean SD (%)
J 1577.00 39.60 2.51
K 1835 30.62 1.67
L 1324 28.28 2.14
M 1279 44.00 3.44
N 1519 42.19 2.78
O 1483 11.31 0.76
P 2764 236.61 8.56
Q 1683 135.91 8.08
R 1944 255.70 13.15
(e) REE
Table 4.8: Coefficients of variation for intra-patient reliability.
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are given in Appendices A.3. These formulae have been adapted from measurements in indi-
viduals breathing room air [232].
The potential sources of error and the subsequent impact on V˙O2 and V˙CO2 are given
in Table 4.9. In order to minimise these errors, I carried out a series of calibration tests of
the aspects that were potentially controllable. i.e. mixing of expired gas with room air when
sampling the gas, the accuracy of the gas analyser, the accuracy of the Harvard dry gas meter
and the relative humidity of the expired gas.
Source of error V˙O2 V˙CO2 RQ
mL.min-1(%) mL.min-1(%)
0.1 Kpa increase in Fe02 -16.42 (-6.67) 0 -0.05
0.1 Kpa increase in FeC02 -5.34 (-2.17) 12.45 (7.11) 0.07
1 L increase in V˙E 4.09 (1.66) 2.91 (1.66) 0
5% increase in humidity -0.62 (-0.25) -0.44 (-0.25) 0
0.1% increase in Fi02 15.79 (6.41) 0 -0.08
0.5℃ increase in temperature -1.43 (-0.58) -0.29 (-0.17) 0.00
Table 4.9: Potential sources of error associated with Douglas bag calculations.
4.2.1.1 Evaluation of gas sampling from the Douglas bags using a 3-way tap and
syringe
Objective. To establish the extent of contamination of sampled gas with room air when
extracting a gas sample from the Douglas Bag using a 50 mL Luer-lock syringe and 3-way-
tap.
Method. A 5% CO2, 55% O2, balanced N2 precision gas was used(General Electric, Bucks,
UK).
Sample 1: Forty mL of precision gas was drawn into a 50 mL Luer lock syringe through
a 3-way-tap without purging either the syringe or the tap. This was then analysed with an
ABL735 Radiometer Blood Gas Analyser (NNU).
Sample 2: The 50 mL Luer lock syringe and 3-way tap were purged with sample gas and
then 40 mL was drawn into the syringe. This was then analysed with the ABL735 Radiometer
(NNU).
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Sample 3: The same procedure as sample 2, but the sample was analysed using the
ABL735 Radiometer (A/E).
Results. There was significant dilution of the expired gas with room air if the syringe and
3-way tap were not purged with expired gas from the Douglas Bags (Table 4.10 ).
Sample O2 CO2
Fraction % Fraction %
1. Unpurged (NNU) 49.6 52.4 4.18 4.4
2. Purged (NNU) 52.8 55.8 4.62 4.9
3. Purged (A/E) 53.2 55.7 4.62 4.8
Table 4.10: Gas concentrations with purged and unpurged syringe.
Discussion. There was evidence of mixing of the precision gases when the 3-way tap and
syringe were not purged. There was a 3.2-3.6 kPa and a 0.42 kPa difference between purged
and unpurged O2 and CO2 samples, respectively. Given a 0.1 kPa error in the FeO2 would
result in a 6.67% change in V˙O2 and a 0.1 kPa error in FeCO2 would result in a 2% V˙O2 and
7% V˙CO2 error, this needed to be controlled.
Conclusion. The 3-way tap and syringe must be purged with expired gas prior to gas
sampling.
4.2.1.2 Calibration of the Radiometer blood gas analysers
The accuracy of the gas sampling analysis is integral to the accuracy of the Douglas bag
collection (DBC) technique.
Objective. To establish if calibration equations were required for the Radiometer blood gas
analysers used for the DBC gas analysis.
Method. Four, 50 mL samples of the two precision gases (5% CO2 and 55% O2, balanced N2
(General Electric, Amersham, UK) and 1.5% CO2 and 21% O2, balanced N2 (BOC, Windle-
sham, UK)) were analysed using two Radiometer blood gas analysers. Two gas analysers were
used as the NNU735 broke part way through the study and was replaced by the NNU835.
Results. At 21.273 kPa and 56.045 kPa O2 (test gas) there was a 1.473 to 1.491 kPa and
2.845 to 2.795 kPa difference. At 1.521 kPa and 5.045 kPa CO2 (test gas) there was a -0.039
to -0.2095 kPa and a 0.4 kPa difference for CO2. The % differences are given in Table 4.11.
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Sample Device Precision Measured
Gas (%) value (%)
1 NNU7 5 5.90
2 NNU7 55 57.91
3 NNU8 5 6.14
4 NNU8 55 57.87
(a) O2
Sample Device Precision Measured
Gas (%) value (%)
1 NNU7 1.50 1.58
2 NNU7 21.00 23.30
3 NNU8 1.50 1.52
4 NNU8 21.00 23.37
(b) CO2
Table 4.11: Precision gas results
Discussion. Given the potential impact of inaccuracy of the ABG machine gas measure-
ments, calibration equations were required for the gas machines.
Conclusion. Equations were generated to provide calibration factors for CO2 and O2 for
each machine. (Figure 4.7).
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Figure 4.8: Gas machine calibration equations.
4.2.1.3 Harvard dry gas meter
A Harvard dry gas meter (HDGM) was used to measure the expiratory gas volume collected
in the Douglas bags. The gas meter requires a low flow vacuum to draw the gas through the
meter. The company claim that it is accurate to 1.5% [233]
Objective. To establish the accuracy of the HDGM, assuming the accuracy of the MGU
flow sensor.
Method. The flow sensor for the MGU was attached to the inlet of the HDGM and the
HDGM joined to the low-flow wall vacuum unit. The low-flow suction was titrated to created
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a flow of 0.25 L.min-1. Suction was applied until the DGM registered that 50 L had been
drawn through the device.
Results. Across the four tests the HDGM gave volumes that were within 2% of the expected
value (Table 4.12 ).
Test HDGM (L) MGU (L) Error
(ATPS) (%)
1 50 49 2
2 50 49.5 1
3 50 49.5 1
4 50 49 2
Table 4.12: Precision of the Harvard dry gas meter with respect to the MGU flow sensor.
Discussion. The precision of this device would only have a 1-2% per L impact on the final
V˙O2 and V˙CO2 values.
Conclusion. I decided not to include a correction for the HDGM.
4.2.2 Deltatrac II calibration tests
As described previously, the Deltatrac II (DTII) calculates V˙CO2 by measuring CO2 concen-
tration by a flow dilution technique. The accuracy of the system’s flow generator is imperative.
This requires regular calibration, and the flow settings to be changed appropriately.
4.2.2.1 Flow calculations
1g of Ethanol produce 0.973 litres of CO2.
5 mL of pure Ethanol produces 3820 mL of CO2.
If the Ethanol concentration is 99.7%, then
99.7
100
∗ 3820 = 3808.54 mL of CO2 is produced.
The total V˙CO2 produced during the test is calculated by summing all V˙CO2 values.
The new flow will be
3808.54
total V˙ CO2 (in mL)
∗ old flow
Objective. Calibration of the DTII flow generator.
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Method.
i) The DTII was warmed up for 30 minutes and the pressure and gas calibrations performed.
The tests were run in canopy mode, with averaging and artefact suppression turned off.
ii) The set-up was prepared as in Figure 4.8a, with the alcohol burn kit within a fume hood.
iii) The alcohol burner vessel was filled with 5 mL of 99.7-100% Ethanol (Figure 4.8b, Figure
4.8c, component 4 ).
iv) The test was started, the alcohol ignited 30 sec later and the cover placed over the top
of the burner (Figure 4.8b, component 1).
v) The test was run until the flame was extinguished. V˙CO2 values were recorded from the
DTII until they reached 10 mL.min-1 when the test was stopped.
(a) DTII flow and RQ calibration set up. (b) Alcohol burn kit.
(c) Alcohol burn kit schematic. Burner cover
(1), Wick (2), Base (3), Burner vessel (4),
Deltatrac Attachment(5/6).
Figure 4.9: Laboratory DTII calibration set up.
The first seven flow calibration tests were carried out with the incorrect set-up of the testing
equipment. The corrections made were for the size of the burner receptacle and the plug
removed from the base to allow sufficient flow of clean air through the system.
Results. The recorded values are given in Appendix A.2. The sum of the V˙CO2 values was
3684 mL.
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4.2.2.2 New flow calculation
Old flow value = 36.2 L.min-1
3808.54
3684
= 1.03
1.03 ∗ 36.2 = 37.3
Conclusion. The new flow setting was 37.3 L.min-1
4.2.2.3 Respiratory Quotient Test
To check that the flow setting is acceptable, the RQ of a known chemical compound such as
Ethanol should be measured.
The RQ of C2H5OH + 3O2 = 2CO2 + 3H2O
V˙ CO2
V˙ O2
=
2
3
= 0.67
(The average RQ from the last 15 minutes of the test should be between 0.64 - 0.69.)
(As steps i− ii)
iii) The set up was prepared as Figure 4.8a, with the alcohol burn kit within the fume
hood. The alcohol burner (Figure 4.8b, component 3) was filled with 10 mL of 99.7-
100% Ethanol. The alcohol was ignited and the glass placed over the burner (Figure
4.8b component 1).
iv) The test was carried out for 30 minutes recording the RQ each minute (Appendix A.2).
Results. The average of the last 15 RQ values was 0.67.
Conclusion. The new flow setting was acceptable.
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4.3 Clinical comparison of the MedGraphics Ultima with
Douglas bag collections and the Deltatrac II
4.3.1 Method
Ethical approval was granted for the study (REC reference number: 09/H1307/107) and in-
formed consent or surrogate approval obtained from all patients or their next-of-kin. Patients
mechanically ventilated on stable settings were recruited from the ICU at University College
Hospital, London. Patients were excluded if they had burns, endotracheal or tracheal leaks
>10%, open chest drainage, an inspired oxygen FiO2≥0.6, were pregnant, <18 years of age,
or had cardiorespiratory instability requiring frequent changes in ventilator settings, FiO2,
inotropic or sedative drug dosages. The measurements were taken simultaneously therefore
factors such as room temperature and nutritional status were not controlled. The mechanical
ventilator used in all studies was the Servo-i (Maquet, Solna, Sweden). Before each test the
DTII and MGU machines were warmed up for 30 minutes and calibrated in line with the man-
ufacturers’ instructions. Patients were clinically stable for 30 minutes preceding measurement
(<20% variation in heart rate, blood pressure or oxygen saturation). Mechanical ventilation
settings were kept stable over the hour preceding and during the test period. Oxygen consump-
tion (V˙O2) carbon dioxide production (V˙CO2), REE, RQ were recorded breath-by-breath by
the MGU over a 30-75 minute period. During this time simultaneous measurements were taken
using the DTII and/or the Douglas bag. The tests were repeated, where possible, at different
time points over the subsequent month to collect up to three paired measurements per patient
using both MGU and DTII, and MGU and Douglas bag collection techniques (Figure 4.9).
(a) MGU DTII Schematic. (b) MGU and DDBC schematic
Figure 4.10: Schematics of expired gas collection and measurement.
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4.3.1.1 Douglas bag collection
For the current study, gas was collected over three five-minute periods from the expiratory
exhaust of the ventilator, into separate pre-labelled 100 litre PVC gas collection bags (Harvard
Apparatus Ltd, Edenbridge, UK). Pre-labelled 50 mL syringes and three-way taps were purged
with 100 mL of expired gas from the respective gas collection bags, prior to aspiration of 50
mL of gas for analysis from each bag. Twenty mL of this gas was then analysed using a blood
gas analyser (ABL735 or 825, Radiometer, Brønshøj, Denmark). Two precision gases; 5%
CO2 / 55% O2 (General Electric, Amersham, UK) and 1.5% CO2 / 21% O2 balanced with N2
(BOC, Windlesham, UK) were used to create reference equations for the gas analysers before
the study began. The gas collection bags were emptied using a wall-mounted suction unit set
at low flow, through a Harvard dry gas meter (Harvard Apparatus, Holliston, USA) calibrated
at the beginning of the study. V˙O2, V˙CO2 and REE of the Douglas bags were then calculated
(Appendix A.3) (Figure 4.10).
(a) Douglas bag attachment to
the Servo-i. (b) Douglas bags. (c) Douglas bag exchange valves.
Figure 4.11: Douglas bag collections.
4.3.1.2 Deltatrac II
The mean of the values obtained over the first five-minute period where the coefficients of
variation of both V˙CO2 and V˙O2 were ≤5% was used in the analysis [234–236].
4.3.1.3 MedGraphics Ultima
The flow sensor was calibrated using a 3 L syringe and the gas analysers calibrated with
precision gas before each individual test. Data points within the MGU tests were excluded if
the RQ was <0.6 or >1.2, the VT was <150 mL, or the V˙O2 or V˙CO2 were <50 mL.min
-1.
Collected data were then averaged as the middle five of seven breaths.
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4.3.2 Analysis
Simultaneous MGU recordings were used for comparison against both DTII and Douglas Bag
measurements. Measurements were discarded if the mean RQ value obtained from either the
five minute DTII or the three Douglas bag collections were <0.6 or >1.2. Data were excluded
if the coefficient of variation was >10% for individual Douglas bag collection or >5% for the
DTII tests. All coefficients of variation for the MGU tests were <14%. Bland Altman plots
(mean measurements made by the two devices vs. the difference in measurements between
the devices) were used to calculate precision and bias. I decided a priori that a 30% error was
acceptable, as recommended by Critchley and Critchley [237].
4.3.3 Results
Sixteen patients were recruited and tested on 39 occasions. Patient characteristics and ventil-
ator settings for each test are given in Table 4.13. Comparisons between techniques, number of
tests performed and proportion of excluded tests are shown in Table 4.14, while the reliability
of the individual techniques is shown in Table 4.15. Bland Altman plots of V˙O2, V˙CO2, REE
and scatter plots for RQ are presented in Figure 4.11, with bias and precision (95% limits of
agreement) shown in Table 4.16.
4.3.3.1 MedGraphics Ultima (MGU) vs. Douglas Bag
Nineteen valid tests were carried out in ten patients. Although bias was good for V˙O2, V˙CO2
and REE, precision was weak with wide levels of agreement and a maximum random error
of 54% for V˙O2, 51% for V˙CO2 and 43% for REE. If proportionality of the measurements is
taken into account and the percentage error for each individual dataset calculated, then the
random error is 42% (-27-15%) for V˙O2, 57% (-17-40%) for V˙CO2 and 32% (-9-23%) for REE
(Appendix A.5).
4.3.3.2 MedGraphics Ultima (MGU) vs. Deltatrac II
Nineteen valid tests were carried out in nine patients. Overall bias was good for V˙O2, V˙CO2
and REE however, yet again, there were wide limits of agreement for all three measures. It
was superior to the comparison between MGU and the Douglas bag techniques with random
errors of 33%, 27%, and 31% for V˙O2, V˙CO2 and REE, respectively. If proportionality of
measurements is taken into account, and the percentage error for each dataset calculated,
then the random error widens to 41% (-13 to 28%) for V˙O2, 31% (2 to 29%) for V˙CO2, and
37% (-28% to 9%) for REE (Appendix A.5).
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Patient Test Reason for admission Age BMI Gender
Pressure
support
PEEP FiO2
1
1 Abdominal Aortic
82 29 M
12 5 0.35
2 Aneurysm Repair 12 5 0.40
2 1 Pneumonia 45 14 F 9 2 0.35
3
1
Gastric resection
79 25.7 F
5 5 0.40
2 12 5 0.45
3 12 5 0.45
3
1
Pneumonia 70 30 M NAVA 5 0.302
3
5
1
Pneumonia 71 20 M 13 5 0.25
2
6
1
Coronary artery
bypass graft
78 - M
12 10 0.50
2 12 10 0.55
3 6 10 0.45
7 1 Whipple’s procedure 66 - M 10 5 0.30
8
1
Hemicolectomy 75 21.7 F
13 5 0.35
2 12 5 0.25
3 10 5 0.30
9
1
Pancreatitis 79 27.7 M
10 5 0.25
2 15 5 0.25
3 0 0 0.28
10
1
Small bowel resection 79 19.7 F
5 5 0.28
2 5 5 0.28
3 5 5 0.30
11
1 Thrombotic
thrombocytopenic
purpura
58 35 F
10 5 0.30
2 10 5 0.35
3 0 5 0.35
12 1 Pleurodesis 76 34 M 8 5 0.30
13
1
Small bowel
ischemia
69 - F
14 5 0.35
2 5 5 0.30
3 0 5 0.30
14
1
Urosepsis and
heart failure
74 - F
20 5 0.40
2 20 8 0.30
3 15 5 0.30
15
1 Femoral artery
aneurysm
69 - M
0 5 0.25
2 0 5 0.30
16
1
Pneumonia and
heart failure
61 47.3 M
0 5 0.30
2 0 5 0.30
3 5 5 0.30
NAVA = neurally adjusted ventilatory assist. PEEP = positive end expiratory pressure.
Table 4.13: Patient characteristics
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Comparison Number of Number of Number of Reason for not
patients tested tests tests used using tests
MGU vs. DB 10 25 19 3 RQ errors with DB
3 COV errors of MGU
MGU vs. DTII 9 24 19 2 RQ errors and
1 COV error with DTII
TOTAL 16 39 35 4
RQ = Respiratory quotient, COV = Coefficient of variation.
Table 4.14: Distribution of tests across patients and why the tests were not used.
Technique Unusable data Reason why unusable
MGU 3/39 (7%) Unstable V˙O2
DB 26/75 (34%)
of bags collected
19 RQ unacceptable
6 volume loss from Douglas Bags,
1 expiratory gas analysis error.
DTII 3/24 (12%) of tests 2 RQ unacceptable,
1 COV error.
Table 4.15: Reliability of the individual techniques.
Comparison Parameter Mean Bias Precision Maximum
% error
MGU vs. DB V˙O2
(mL.min-1)
231 +7.0 -56 to +70 54
MGU vs. DTII 272 -10.3 -56 to +35 33
MGU vs. DB V˙CO2
(mL.min-1)
208 +31 -22 to +85 51
MGU vs. DTII 249 +34 -0.6 to +68 27
MGU vs. DB REE
(kCal.day-1)
1655 +93 -263 to +449 43
MGU vs. DTII 1812 +28 -249 to +305 31
Table 4.16: Precision and bias for V˙O2 V˙CO2 and REE measurements made between the
MedGraphics Ultima (MGU) Deltatrac II (DTII), and Douglas bag techniques. Maximum %
error = 2SD/µ
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4.3.4 Discussion
This study describes the unique comparison of a currently available device the MedGraph-
ics Ultima (MGU) with traditional “reference standards”, namely the Deltatrac II and the
Douglas bag technique, in mechanically ventilated patients at rest. While the systematic error
(bias) between the MedGraphics Ultima measurements of V˙O2, V˙CO2 and REE, and between
those of the Deltatrac II and the Douglas bag, was acceptable, the limits of agreement were
wide. Comparison between the MGU and the DTII was more acceptable but at the margins
of acceptability for measurement of metabolic activity, either for research or clinical purposes,
albeit assuming that the Deltratrac II represents an accurate gold standard.
Accepting that these reference devices have their limitations (see later), there is a remark-
able lack of consistency in the criteria deciding comparability between a reference technique
and new devices. Using cardiac output measurement techniques as an example, Critchley and
Critchley [237] proposed that the accuracy of both devices should be taken into account. Thus
if the reference device, in this case the DTII, was considered to have an accuracy of ± 20%
and the test method, in this case the MGU, a similar accuracy, then the combined limits of
agreement would be ± 28%.
The MedGraphics Ultima (MGU) is predominantly used in exercise testing in spontan-
eously breathing patients [238]. Validation for this device is relatively scanty, even in spon-
taneously breathing subjects. Cooper et al compared the MGU and four other devices against
the DTII in resting subjects and found all were inferior in terms of within-patient coefficient
of variation for resting metabolic rate, ranging from 4.8-10.9% compared to 3% for the DTII
[239]. Other studies in healthy self-ventilating individuals using the MedGraphics CCM Ex-
press, a device similar to the MGU, have shown acceptable agreement, though lower absolute
values compared to the reference technique [240, 241].
V˙O2 in mechanically ventilated patients at rest is relatively low (approximately 250 mL.min
-1),
in comparison to the 2-5 L.min-1 values seen at peak exercise in ambulant healthy individuals
[242]. Therefore, the signal to noise ratio is far greater in resting mechanically ventilated
patients than that recommended by the exercise testing literature [230].
Data directly validating indirect calorimetry devices in mechanically ventilated patients
are also scarce, despite their promotion as a tool to titrate nutritional input. A recent study
[243] in 24 ICU patients reported mean REE values as 64% higher for the CCM Express
compared against the Deltratrac. Repeated readings from the same instrument gave a coef-
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ficient of variation of 4.1% and 7.9% for Deltatrac and CCM Express, respectively. In the
present study, I did not find a systematic bias, although limits of agreement were wide. The
coefficients of variation for V˙O2 were <5% between each minute of the 5-minute test for the
DT II, <10% between each bag in a single Douglas bag collection test and <14% for breath-
to-breath measurements with the MGU. However, despite my measurements being taken at
rest, the pattern of breathing of most patients was irregular. This may have contributed to
the intra-device differences, in particular the MGU measures breath-by-breath and the DTII
measures over 1 minute while the DB measurement is averaged over a 5 minute collection.
This is consistent with the lack of bias but poor precision seen between techniques.
The accuracy of the reference standard must be taken into account. Tissot et al [221]
directly compared the Deltatrac II with either Douglas bag gas collections or mass spectro-
scopy in 35 mechanically ventilated patients, and found both excellent bias and precision. On
the other hand, Takala et al found V˙O2 values obtained from the Deltatrac were consistently
higher than pulmonary artery catheter-obtained indirect Fick measurements in ICU patients
following cardiac surgery [223]. These ranged from 16 ± 9% during controlled ventilation, 21
± 8% during synchronized intermittent mandatory ventilation, to 25 ± 8% during spontan-
eous breathing. Levinson et al also found that V˙O2 measured by indirect calorimetry (using a
Douglas bag and mass spectrometry) was 15% higher than that measured by thermodilution
in 29 mechanically ventilated patients [224]. In part, this discrepancy may be related to lung
oxygen consumption which is not measured by thermodilution and estimated to be 14 ± 3% of
whole body V˙O2 [244]. Other studies also report inconsistent findings regarding the accuracy
of newer devices compared against the DTII, e.g. the M-COVX device [225–227]. Many of
these studies were performed using mechanical ventilators that did not use bias flow (flow-by).
This is a continuous flow of gas, usually in the order of 2 L.min-1 of the pre-set level of inspired
O2 that is incorporated into most, if not all, modern ventilators. Depending on the device
being utilised for oxygen consumption, mishandling of this extra volume of oxygen added to
the expired volume can significantly impact on the values obtained. Both the MGU and DTII
are unaffected by bias flow; the MGU utilises a flow sensor sited at the endotracheal tube
within the ventilator circuit while the DT II measures neither flow nor volume as part of its
calculation technique. However, this is a potential source of error for Douglas bag collection
or any other device that relies on expiratory volumes.
On the other hand, the dead-space created by ventilator tubing and heat moisture ex-
change systems must be adequately accounted for so that the MGU correctly phase aligns
the flow, oxygen and carbon dioxide signals. For reliable measurements, scrupulous attention
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needs to be paid to the performance of the different techniques, and awareness of the many
potential pitfalls. For example, both the Douglas bag technique and indirect calorimetry have
multiple potential sources of error (Tables 4.1 and 4.9). While every attempt was made to
control these errors during this study, the Bland Altman plots illustrate considerable random
rather than systematic error. A 16% measurement error for V˙O2 is recognised for the Douglas
bag technique [224].
I reduced the potential physiological variability of the tests by performing measurements
simultaneously. The possibility that the sampling techniques bias each other was small. The
DTII samples inspiratory gas continuously at 150 mL.min-1 against a V˙E of 12 L.min
-1 giving,
at worst, a reduction of 1.25% of V˙E . The MGU samples gas continuously, both during inspir-
ation and expiration, at a maximum of 130 mL.min-1, potentially creating a 0.36% inspiratory
volume error and a 0.72% expiratory volume error.
The accuracy of the FiO2 displayed by the Servo-i was not established at the beginning of
the study. The manufacturer of the Servo-i specifies a ± 5% error from the displayed value.
Subsequent investigation in five patients has found a mean ± SD of 0.58% ± 0.29% difference
in the FiO2 displayed by the Servo-i and the MGU (Table 4.17). This may have lead to
considerable inaccuracies in the DB calculations.
Patient Mean FiO2 % difference Standard Deviation
(Servo-i-MGU) of mean difference
A 0.64 0.07
B 0.55 0.29
C 0.66 0.25
D 0.35 0.06
E 0.71 0.33
Table 4.17: Percentage variation in Servo-i FiO2 reading.
As a clinical tool, changes in V˙O2 may be more relevant and reliable than absolute values,
e.g. in response to a physiological challenge (e.g. sitting on edge of bed, change of ventilator
settings). This study enrolled relatively low numbers of patients with a limited range of V˙O2,
but it serves to highlight some of the issues and pitfalls that must be addressed in order
to develop a metabolic monitoring device that is fit for purpose. Such a device needs to be
integrated into a mechanical ventilator, accommodate the challenges of temperature, humidity,
dead space, and tidal volume entropy and specifically have precision at low levels of V˙O2.
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4.3.4.1 Potential tolerable errors of V˙O2 for exercise in mechanically ventilated
patients
Assuming a 70 Kg person, in order to track change when used with;
1. unloaded cycling, V˙O2 for a 70 Kg person = 150 +(6*70)=570 mL.min
-1, with an ex-
pected ∆V˙O2 of 10 mL.min
-1.watt-1, i.e. 5 watts = 50 mL increase, 10 watts = 100 mL
increase.
Therefore the device would need to pick up a 50 mL V˙O2 change.
2. Lying to sitting = 3.5 mL.Kg-1.min-1 (245 mL) to 4.25 mL.Kg-1.min-1 (297.5 mL).
Therefore the device would need to pick up a 53 mL V˙O2 change.
3. Sit to stand = 4.25 mL.Kg-1.min-1 (297.5 mL) to 8.75 mL.Kg-1.min-1 (612.5 mL).
Therefore the device would need to pick up a 315 mL.min-1 V˙O2 change.
4. Standing to walking at 3mph = 8.75 mL.Kg-1.min-1 (612.5ml) to 10.5 mL.Kg-1.min-1.
Therefore the device would need to pick up a (735ml/min) a 123 mL.min-1 change.
4.3.5 Conclusion
Although showing low bias when compared to the reference methods of the Douglas bag
technique and the Deltatrac II indirect calorimeter, the MGU lacks precision. This may
be due, in part to limitations of the reference methods. For this field to move forward,
industry must collaborate with clinicians and researchers to improve the accuracy of devices
that monitor gas exchange in mechanically ventilated patients. Despite the limitations and
complexity of the measurements, I decided that it would still be possible to identify a change
in V˙O2 given that the expected increase in V˙O2, as a result of exercise, was greater than the
limits of agreement of the MGU.
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Figure 4.12: Bland Altman plots of V˙O2, V˙CO2 and REE, and RQ scatter plot.
108
Chapter 5
The feasibility of measuring
oxygen consumption during
rehabilitation interventions in
mechanically ventilated patients
The next stage in establishing a method of measuring exercise intensity in mechanically vent-
ilated patients was to ascertain if the MGU could track changes in V˙O2 during exercise.
However, as there are currently no standardised exercise stimuli for mechanically ventilated
patients, it was also necessary to evaluate the usefulness of different exercise stimuli in mech-
anically ventilated patients.
5.1 The properties required of physiologically and clin-
ically useful measurement tools
Tools to measure exercise intensity and capacity in mechanically ventilated ICU patients re-
quire robust clinimetric properties [245]. As such the ideal tool should have concurrent and
construct validity, that is it should measure what it is intended to measure. It should be
able to generate data similar to that of a gold standard and also that of a tool measuring a
similar construct. In this case, BBGEA would be the gold standard for measuring absolute
exercise intensity. It would also be the gold standard for estimating relative exercise intensity
and exercise capacity in either incremental or a series of constant load tests. The tool used
would need to demonstrate intra-patient repeatability and would need to have the sensitivity
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to respond to clinically important differences in exercise intensity and capacity. Ideally such a
tool should respond in a linear manner, with minimal bias at low and high end of the exercise
intensity and capacity range. It should also have a minimal floor and ceiling effect. The tool
should also be user-friendly; acceptable both to patients and clinicians and have good intra-
tester reliability.
A feasibility study “Quantifying exercise capacity and intensity in ICU” was therefore
carried out to investigate the feasibility of measuring exercise capacity and intensity in mech-
anically ventilated patients recovering from critical illness. The primary objective was to
investigate the feasibility of measuring exercise capacity and intensity using BBGEA during
cycle arm ergometry in such patients. The secondary objectives were to characterise normal
rehabilitation interventions in mechanically ventilated ICU patients and to provide data to
inform sample size calculations for future studies validating measurement tools of exercise
capacity and intensity.
5.2 Feasibility study
During the feasibility study, I aimed to observe patients three times in the first week and then
twice a week for the following two weeks. I anticipated that all patients would be studied
during normal rehabilitation on day 1 and undertake a constant load test on days three and
five. Patients who completed three minutes of exercise on either days 3 or 5 would then be
randomised to either continue the constant load test or to undertake a ramp test. Patients
who did not complete three minutes of exercise on both day 3 and day 5 would continue with
the constant load test. This was done to ensure that the incremental group did not become
a self-selecting group of patients with potentially greater exercise capacity. Therefore three
groups were created: (i) those unable to cycle ≥3 minutes and who only had constant load
exercise; (ii) those who could cycle ≥3 minutes but remained in the constant load group;
and (iii) those who could cycle ≥3 minutes and had incremental exercise. A 3 minute cut-
off was chosen as an acceptable length of time to reach a steady state of V˙O2. This is the
recommended duration of unloaded cycling at the beginning of an incremental test [246]. The
study design is summarised in Table 5.1.
5.2.1 Anticipated recruitment and sample size calculation
Approximately eighty patients per year are ventilated for more than fourteen days on the ICU
at UCH. The current recruitment rate of studies on the ICU is 50%. Therefore I anticipated
that up to forty patients could be recruited in one year. It was expected that this design
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would result in approximately equal number of patients in each of the three groups. It was
anticipated that one third of patients randomised to cycling would not achieve 3 minutes of
exercise on day 3 or on day 5 and the rest would be randomised on equal basis to either the
constant load or ramp test from day 10. Thus, if 30 patients were recruited, there would be
ten patients per group.
5.2.2 Outcomes
Primary outcomes.
i) Whether or not the patient was able to complete three minutes of constant load exercise
at any time point.
ii) From incremental exercise: whether or not it was possible to identify the patient’s an-
aerobic threshold from BBGEA using the V-slope method [246].
iii) From incremental exercise: whether or not it was possible to identify the patient’s lactate
threshold, taken as a sustained increase in blood serum lactate concentration.
Secondary outcomes. I aimed to collect the following during every constant load, ramp
test and rehabilitation session:
i) peak V˙O2 (mL.min
-1)
ii) excess post-exercise oxygen consumption (mL)
iii) heart rate recovery (bpm.min-1)
iv) peak lactate concentration (mmol.L-1)
v) rate of perceived exertion using the Borg 6-20 ordinal scale
vi) heart rate variability (ms).
I aimed to collect the following during each incremental test:
vii) peak work rate (watts).
I aimed to calculate the following:
viii) the mean response time of V˙O2 uptake, from all constant load tests that achieved a
steady-state.
ix) the mean V˙O2 (mL.Kg.
-1min-1) of the session,
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x) the total VO2 (mL.Kg.
-1) for each level of rehabilitation achieved at each rehabilitation
session,
xi) the relationship of V˙O2 (mL.min
-1) to HR bpm,
xii) the relationship of V˙O2 (mL.min
-1) to RPE,
xiii) the intra-patient reliability of the above values,
xiv) the sensitivity to change over time of the above values.
Ethical approval was granted for the study (REC reference number 11/LO/1646) and
informed consent or surrogate approval was obtained from all patients or their next-of-kin.
Patients were recruited from the intensive care unit at University College Hospital if they had
been mechanically ventilated for over seven days via a tracheostomy, were adults aged 18 years
or over, the patient or patient’s representative was able to give informed consent/advice, and
the patient was anticipated to be able to use an arm ergometer. I expected that some patients
would be unable to use the ergometer in the very early stages of their rehabilitation. These
patients were screened out, but could be included later on during their ICU admission. Pa-
tients were excluded if they were: aged under 18, mechanically ventilated via a tracheostomy
for over seven days but still unable to use an ergometer on discharge from ICU, pregnant,
unable to exercise due to pre-existing conditions or current morbidity; e.g. severe demen-
tia, motor neurone disease, severe stroke, severe critical illness neuro-myopathy, moderate to
severe stenotic valvular heart disease, primary pulmonary hypertension, hypertrophic cardi-
omyopathy, or unstable angina; or if the patient (or their representative) was unable to give
informed consent or advice.
5.2.3 Methods and materials
Patients were assessed for suitability to exercise by the ICU physiotherapist, as per normal
practice for the ICU (Appendix B.1), before each exercise/rehabilitation session.
5.2.3.1 Normal rehabilitation sessions
Normal rehabilitation sessions consisted of sitting the patient over the edge of the bed, pro-
gressing the patient to standing, transferring and walking, as is normal practice in the ICU
at UCLH. Exercise was terminated, if indicated, as it would be in normal clinical practice
(Appendix B.2 ). Blood pressure was recorded from either an indwelling arterial cannula or
using a non-invasive cuff. A Polar heart rate monitor and a MGU flow-sensor were attached to
the patient’s chest and ventilator circuit, respectively. The patient’s ECG leads remained in
situ throughout. To allow retrospective analysis of HR and V˙O2 for each activity, time points
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Visit Week Day Patients recruited to study
1 1 1 All normal rehabilitation
2 1 3
Constant Load Constant Load
Did not achieve 3 min exercise Did achieve 3 min exercise
3 1 5
Constant load.
Did not achieve
3 min
Constant load.
Did achieve
3 min
Constant load.
Did achieve
3 min
Constant load.
Did not achieve
3 min
Randomised to constant load or ramp 1:1 ratio
Constant load Constant load Ramp
(Group 1) (Group 2) (Group 3)
4 2 8
Normal
rehabilitation
Normal
rehabilitation
Normal
rehabilitation
5 2 10 or 12 Constant load Constant load Ramp
6 3 15
Normal
rehabilitation
Normal
rehabilitation
Normal
rehabilitation
7 3 17 or 19 Constant load Constant load Ramp
8 4 22
Normal
rehabilitation
Normal
rehabilitation
Normal
rehabilitation
Cycling. Did
not achieve
3 min constant
load on day 3
or 5 Constant
load
throughout
Cycling. Did
not achieve
3 min constant
load on day 3.
Did achieve
3 min constant
load on day 5.
Constant load
throughout
Achieved 3 min constant load
on visit 3 and 5. Ramp from
day 10 or 12
Estimated number 10 10 10
Table 5.1: Original protocol.
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were recorded when the following activities were carried out: organising the bed space, pro-
cess of SOEB, STS, standing, BCT, sitting in a chair, transferring from chair to bed, moving
themselves horizontally up the bed, from sitting to lying and recovery.
5.2.3.2 Symptom-limited constant unloaded exercise test
Arterial/non-invasive blood pressure (ABP/NBP) measurements were recorded. A Polar heart
rate monitor and MGU flow-sensor were attached to the patient. The patient was transferred
into a chair through whatever means was normal for them, i.e. hoist, sliding, horizontal or
standing transfer. Following the transfer, when V˙O2, V˙E and HR had stabilized to within
10% of values at baseline, the patient was guided to cycle for 1 minute at 35 RPM. They were
then asked to rest to allow their HR and V˙O2 to return to baseline and then to cycle at 35
RPM for as long as they are able, but for a maximum of eight minutes. The symptoms that
patients were asked to report were fatigue and breathlessness.
5.2.3.3 Symptom-limited incremental exercise test
This consisted of 1 minute of exercise at 35 RPM unloaded, 1 minute at 10 watts.min-1, then
increasing by 5 watts.min-1 until the end of exercise. Sampling and data collection were for
the symptom-limited, constant, unloaded exercise test.
5.2.3.4 ICU functional status score
The ICU-FSS was measured for all patients at each testing session. The ICU-FSS contains
two functional tasks from the FIM and three additional tasks that are relevant and feasible to
perform in the ICU setting. All five functional tasks are evaluated using the 7-point scoring
system of the FIM, with higher scores indicating higher function [247]. The full description
and scoring of the ICU-FSS is shown in Appendix B.3.
5.2.3.5 General practice physical activity questionnaire
The patient’s pre-admission activity levels were estimated from their GPPAQ score (Appendix
B.4 ). This information was taken from the patient and/or their relatives.
5.2.3.6 Borg rate of perceived exertion
Patients were asked to report their perceived exertion using the original Borg category scale
(6 to 20 points) [174], at the beginning and end of the exercise sessions (Appendix B.5 ).
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5.2.3.7 Ergometry validation
A Monark Cardio Rehab 831E ergometer (Monark, Vansbro, Sweden) was used for the arm
cycle ergometry. The power output of cycle ergometers can vary considerably depending on
the RPM at which they are used. I anticipated that patients would only be able to cycle at 40
RPM or lower. Monarch were requested to test both the lowest RPM at which a stable power
output could be achieved and the accuracy of this power output, before the ergometer was
shipped. This testing was carried out in June 2011. The ergometer was re-calibrated after
shipping, before the feasibility study began. The testing details from Monarch are shown in
Appendix B.6. Monarch advised that the lowest RPM at which a stable power output could
be assured was 31 RPM. However, the device only provided a stable RPM output at 33 RPM.
I therefore chose 35 RPM as the lowest RPM that was acceptable. At 35 RPM the lowest
work output from the device was 4 watts (when the ergometer was programmed at 0 watts).
5.2.3.8 Polar heart rate monitor
A Polar RS800CX heart rate sensor (Polar, Kempele, Finland) was used to record continuous
heart rate data. These data were used for heart rate variability analysis and HRrec.1 The
sensor attached to the anterior aspect of the patient’s chest via an elasticated strap. The
device recorded data at 60 Hz and was downloaded and viewed using Polar software (Polar
Protrainer 5).
5.2.3.9 Patient experience of exercise questionnaire
A pre- and post-exercise questionnaire was designed to gather information to generate themes
for a semi-structured interview to conduct with patients during follow-up. It was hoped that
the questionnaire could compare the patients’ experience of cycle ergometry with normal
rehabilitation. The questionnaire is in Appendix B.7.
5.2.4 Results
5.2.4.1 Recruitment
Thirteen patients were recruited between December 2011 and July 2012. Data were collected
on 12 patients. The Consort diagram is shown in Figure 5.1. Forty-one sessions were recorded;
21 rehabilitation, 11 cycling and 9 both.
5.2.4.2 Feasibility of arm ergometry
Ten of the 13 enrolled patients were able to participate in arm cycle ergometry. Six of the
10 patients were able to complete three minutes of arm cycling on or by their 3rd cycle test.
1HRrec, the rate of heart rate deceleration. See chapter 3.
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71 patients ventilated >7 days with a tracheostomy. 
December 2011- 25th July 2012 
50 patients did not meet 
eligibility criteria. 
CVA      1 
Bronchopleural fistula  1 
Low GCS     7 
Delirium   12 
No active  movement    2 
Palliative Care    2 
Pre-existing diagnosis   9 
Spinal Injury     2 
Unstable     6 
Unstable airway    2 
Weaned     5 
21 eligible patients 
4 patients 
unable to gain 
consent 
4 patients 
unable to test 
due to staff  
annual leave 
13 patients recruited 
2 patients 
rehabilitation 
only (101 and 
102) 
1 patient 
weaned 
before first 
test (110) 
10 patients 
able to 
cycle 
1 patient 
cycled for 
>3 minutes 
on the 1st 
test (113) 
5 patient cycled for 
> 3 minutes on 2nd 
test 
(103,108,111,112) 
or 3rd test (105) 
2 patients 
able to cycle > 
3 minutes  on 
5th test 
(106,107) 
2 patients 
unable to cycle 
> 3 minutes on 
any occasion 
(104,109) 
Figure 5.1: Pilot Consort diagram.
Four of the patients achieved 35 RPM. Two patients completed three minutes of cycling on
subsequent cycle tests. Therefore, four of the ten patients met the randomisation criteria for
the incremental protocol. Two patients (0105 and 0108) were randomised to the constant
load group, the third patient (111) weaned before the incremental test session and the fourth
declined to participate in further tests.
5.2.4.3 Breathlessness measured by the Borg breathlessness scale
Three of the ten patients were able to report their breathlessness on the Borg scale on one or
more occasions. The remaining patients were either unable to comprehend the scale or were
too fatigued to comply with the process after the rehabilitation session.
5.2.4.4 Patient experience of exercise questionnaire
Five questionnaires out of 41 were completed. Again, most patients were either too fatigued
at the end of a session or did not appear to understand the questions.
5.2.4.5 Timing and duration of enrolment
While it was possible to test patients three times per week, low staffing levels often prevented
completing the cycling session on the days stated within the protocol. Additionally, only being
able to follow the patients for three weeks also limited the amount of data that was collected.
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5.2.4.6 Heart rate
Placing the polar heart rate monitor on patients was challenging. In some patients it was
necessary to roll the patient to get the monitor in place, which in itself would have a metabolic
cost. Continuous heart rate data were obtained for 12 of 41 tests in seven of the 12 patients.
In one patient (3 tests) there were no data as the Polar strap was too small. One patient
(4 tests) declined to have the Polar strap placed. In three patients (6 tests) no data were
obtained due to excessive noise in the recording. The remaining absent data (28 tests) were
spread over the other seven patients and were again due to excessive noise within the data.
5.2.4.7 Heart rate variability
There was too much noise within the polar data to be able to isolate the clear five minute
segments required to compare at rest, during exercise and then during recovery data, in any
of the recordings.
5.2.4.8 Lactate
Only one patient, from whom I gained consent for blood sampling, had arterial access on the
test days.
5.2.4.9 Intra patient repeatability of values
Generating data to test the repeatability of values was challenging. Patients were too fatigued
following one single cycle or rehabilitation session to be able to repeat the same challenge.
5.2.5 Discussion
The feasibility study highlighted a number of factors that required addressing. Despite a 61%
recruitment rate of eligible patients, far fewer patients were enrolled than anticipated. Only 21
(29%) of the 71 patients ventilated via a tracheostomy in the 7 month period were eligible for
recruitment, with nearly a quarter excluded due to delirium which precluded rehabilitation.
It was anticipated that two thirds of the patients would be able to cycle for ≥3 minutes and
be randomised into the constant load or incremental groups. However, only 4 of 13 patients
(30%) were randomisable. Therefore, a further 66 patients would need to be recruited (roughly
a further three years of data collection) to gain ten patients per group. However, if only 30%
of the rehabilitation population were able to meet the criteria for an incremental test, then
any model or test created would not be generalisable to the current ICU population at UCH.
I therefore conclude from the results of this pilot investigation that an incremental ergometry
test was not feasible and eliminated incremental tests as a method of establishing exercise
118
intensity in mechanically ventilated patients.
The low consent rate for blood sampling during exercise raised two challenges. The first
was that this led to lack of my exposure to the process of obtaining blood samples mid-exercise
while also running the MGU, recording stages of the tests and supervising the exercise ses-
sion. This lack of practice resulted either in samples not being taken in a timely manner,
or in written data not being recorded precisely. The latter, more ethical issue, was that few
samples would be obtained so that no useful comparisons could be made. Therefore, with
only one person performing data collection, regular lactate measurements were infeasible due
to the complexity of the data collection process.
Surprisingly few patients reported their breathlessness using the Borg scale both before
and after exercise. This may have in part been due to the original 6-20 scale that was being
used. A majority of patients did not want to rate their breathlessness as they were too fatigued
at the end of the session. I therefore changed to the modified Borg scale, with the expectation
that it would increase the number of patients able to report their breathlessness.
Similarly, no useful data were being obtained from the questionnaire. Few patients felt
able to complete a questionnaire after exercise. This process was also abandoned.
There were several challenges associated with the Polar heart-rate monitor. The first was
that it was not possible to record HRV data from the Polar monitor. Despite the monitor
being used widely and with an extensive literature base, I was unable to isolate the two 5
minute segments, one during rest and one during recovery, required for comparison in any of
the 12 recording sessions. Secondly, having the HR monitor placed to record resting, exercise
and recovery HR was a considerable effort for the patient, even before the exercise session had
started. Although abandoning the Polar monitor meant that I would be unable to calculate
HRrec in future patients, I decided to record resting and peak exercise HR from the patient’s
ECG monitor and to investigate the feasibility of downloading continuous data from the ECG
monitor.
5.3 Modification of protocol
I decided that more information would be obtained by concentrating on gaining constant
load data. Therefore I submitted a major amendment to the ethics committee to change the
protocol.
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5.3.1 Outcomes
Primary outcomes.
i) Whether or not the patient was able to complete 3 minutes of constant load exercise at
any time point.
ii) Whether or not it was possible to estimate the patient’s anaerobic threshold from con-
stant load data [246].
iii) Whether or not it was possible to calculate the patient’s mean response time from
constant load data.
Secondary outcomes. To assess the following during every constant load and rehabilitation
session:
i) peak V˙O2 (mL.Kg.
-1min-1),
ii) excess post-exercise oxygen consumption (mL),
iii) rate of perceived exertion using the Borg 0-10 (ordinal) scale.
I aimed to calculate:
iv) the mean response time of the V˙O2 uptake kinetics, from any constant load test that
achieved a steady state,
v) the mean V˙O2 (mL.Kg.
-1min-1) and total VO2 (mL.Kg.
-1) for each level of rehabilitation
achieved at each session,
vi) the sensitivity to change over time of; the patient’s mean response time from constant
load data, peak V˙O2 (mL.Kg.
-1min-1), excess post-exercise oxygen consumption (mL),
rate of perceived exertion using the Borg 0-10 (ordinal) scale, and for each level of
rehabilitation achieved at each session, total VO2 (mL.Kg.-1 ).
5.3.2 Materials and methods
I amended the protocol to observe patients on three occasions per week until they were lib-
erated from mechanical ventilation. No arterial blood gases were to be taken mid-exercise.
If consent was gained from patients with arterial access then samples would be taken at the
beginning and end of the exercise sessions. HRrest and HRpeak during exercise would be
recorded from the patient’s bedside monitor. Patients would be asked to rate their perceived
exertion using the modified Borg scale.
120
5.3.3 Analysis
5.3.3.1 MedGraphics Ultima data averaging
The previously validated MGU device was used to measure oxygen consumption via a flow-
sensor. When patients are at rest the MGU displays V˙O2 data with relatively little noise.
However, exercise increases VT , V˙E and flow entropy. This increase in entropy is associated
with an escalation in the noise of the recorded data as seen in Figure 5.3. Fluctuations in VT
and in delivered FiO2 are in part responsible for the noise. The MedGraphics software Breeze
Suite allows basic filtering of low VT , V˙O2 and V˙O2 data and low and high RQ. The majority
of the fluctuations in FiO2 can be filtered out using the RQ filter (Figure 5.3 (filtered)), as
a low FiO2 results in an unphysiologically elevated RQ. Removing the low VT values further
reduces the noise of the recorded data. The Breeze Suite software allows further smoothing
of the data by creating a moving average. Moving or rolling averages are used to reduce the
amount of noise within recorded data. The Breeze Suite inbuilt averaging methods are the
middle 5 of 7 breaths, median of 7 breaths or mean of 8 breaths. However, it was unclear if
removing the low but not the high values through the in-built filtering method, increased the
minimum, maximum and/or mean values.
Objective. To establish if the inbuilt software analysis elevated mean, minimum and max-
imum values as a result of filtering only low V˙O2 V˙CO2 and VT values.
Methods. I wrote a PASW 21 (IBM) script (Appendix B.8 ) to filter and average the raw
data of ten rehabilitation sessions of patients recruited in the pilot study. The same time
segment of each test was used for analysis in both PASW 21 and Breeze Suite. An example
of the raw plots of each parameter V˙O2, FiO2, VT , RQ, and the final V˙O2 plot are shown in
Appendix B.9.
Analysis. Comparisons were made between the mean, minimum and maximum V˙O2 values
obtained from the PASW 21 and Breeze Suite smoothing. Bland Altman plots were created
(Figure 5.2) and the bias and precision calculated (Table 5.2).
Results. The Breeze Suite averaging and filtering gave mean values that were minimally
higher than the PASW 21 values, minimum values that were lower and maximum values
that were higher. In terms of establishing values for area under the curve (total VO2 during a
rehabilitation session) the mean value would be the most important, followed by the maximum
value. Therefore, using the middle 5 of 7, mean values had a 0.72% positive bias with narrow
95% LOA (7.02% to 8.47%). Minimum values would have a -6.5% bias, and 95% limits of
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agreement (LOA) of -18.67% to 5.56%. Maximum values would have a 8.3% positive bias with
95% LOA of -4.11% to 20.7%.
Conclusion. The middle 5 of 7 breath technique was chosen over the other averaging tech-
niques as it provided the values with the least bias and the narrowest 95% confidence interval
for the difference between PASW 21 and Breeze Suite values.
.
Mean values (%) Min values (%) Max values (%)
Mid 8BM Median Mid 8BM Median Mid 8BM Median
5 of 7 of 7 5 of 7 of 7 5 of 7 of 7
Bias 0.72 2.19 0.28 -6.55 -3.85 -7.2 8.3 7.77 11.92
Upper 95% LOA 7.02 -7.96 -6.14 -18.67 -13.19 -19.12 -4.11 -5.95 1.26
Lower 95% LOA 8.47 12.34 6.71 5.56 5.5 4.72 20.7 21.5 22.59
8BM = 8 breath mean, LOA = limits of agreement.
Table 5.2: Level of agreement as a percentage for the three averaging methods.
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Figure 5.2: Bland Altmam plots of three potential averaging methods in Breeze Suite. Filtered
V˙O2≥175, VT≥240, RQ = 0.9-1.2
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Figure 5.3: Breeze Suite filtering and averaging graphs.
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5.3.3.2 Arm cycle ergometry data
The cycle tests were categorised as to whether or not the patient managed ≥3 minutes of
ergometry or not. Factors that might influence a patient’s ability to cycle ≥3 minutes were
explored using a multilevel, univariate, generalised linear mixed effects model [11, 248]. The
binary outcome was the ability to cycle for 3 minutes or not on one or more occasions. A
maximum of two tests were entered per patient. The tests were chosen as follows:
i) if the patient only completed 1 cycle test, this was used,
ii) if the patient either managed to cycle for ≥3 minutes on every occasion or if they were
unable to cycle ≥3 minutes on any occasion, then the first and last tests were used, or
iii) if the patient was unable to cycle on their first attempt but was able to do so on sub-
sequent attempts, then the patient’s first test and the first test where they managed ≥3
minutes were used.
Explanatory factors and variables were; i) age, ii) gender, iii) weight, iv) the patient’s pre-ad-
mission GPPAQ score2, v) the patient’s highest SOFA score [249], vi) the duration of mechan-
ical ventilation at recruitment. vii) ICU-FSS3 viii) SOFA on the day of test, ix) lactate, x) Hb,
xi) HRrest, xii) HRrest / calculated HRmax (cHRmax)4, xiii) HRpeak / cHRmax. As only
one factor was found to be statistically significant, no multivariate regression was performed.
Analysis of the residuals was performed to identify outliers, by calculating DFBETA’s5 and
Cook’s distance6 [250].
Estimation of anaerobic threshold. An inability to reach steady-state (identified as a
plateau in V˙O2) during a constant load ergometery test is reported to be indicative of a
workload above the subject’s anaerobic threshold [242, 251]. Therefore, unless a subject
has abnormally low V˙O2 uptake kinetics, a plateau in V˙O2 should be established by three
minutes during a constant load exercise-test, provided the workload is below the subject’s AT.
In patients who did not reach a plateau (making the assumption that V˙O2 uptake kinetics
were not so abnormal to have not reached steady state within the duration of the test), it is
possible to estimate their anaerobic threshold. Arm cycle ergometry is considered to consume
2GPPAQ. General practice physical activity questionnaire, see Appendix B.4
3ICU-FSS, ICU functional status score, see Appendix B.3.
4cHRmax = 220-age
5DFBETA’s are a measure that standardises the absolute difference in parameter estimates between a
(mixed effects) regression model based on a full set of data, and a model from which a (potentially influential)
subset of data is removed. DFBETA refers to how much a parameter estimate changes if the observation in
question is dropped from the data set.
6Cook’s distance refers to how far, on average, predicted values move if the observation in question is
dropped from the data set.
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oxygen as follows [252];
V˙ O2 (mL.kg.
−1min−1) = 3 ∗ work rate
body mass
+ resting V˙ O2 (mL.kg.
−1min−1) (5.1)
where work rate is in kg.m.−1min−1, or 1 watt = 6.12 kgm.min−1
Mean response time. Calculation of the mean response time of V˙O2 assumes it is
possible to model the V˙O2 response during phase I and II of exercise, to a mono-exponential
curve. Tau (the time constant), i.e. the time taken for V˙O2 to increase by a proportion of 0.63,
can then be estimated. None of the six tests that reached a plateau fitted a mono-exponential
curve. Therefore this calculation would not give a justifiable estimation of tau. Although it
should be possible to estimate tau from individual graphs, the quality of the data is such that
I could not accurately determine the plateau value.
Excess post-exercise oxygen consumption. Given that the uptake kinetics of those
who reached a plateau in their V˙O2 are not mono-exponential, is is not justifiable to equate
the O2 deficit and the O2 debt. As patients who did not reach a plateau were also most likely
to be over their AT, this also suggests that O2 deficit and O2 debt would not equate.
5.3.3.3 Analysis of rehabilitation data
The total session VO2 (mL.Kg
-1) was estimated by calculating the area under the individual
V˙O2 (mL.Kg.
-1min-1) curves bound by the start of the rehabilitation session (defined as the
time the patient initially began to SOEB) and the time V˙O2 returned to within 10% of the
value at rest (Figure: 5.4).
total session V O2 (mL.kg.
−1) = (5.2)
duration of the session (minutes) * mean V˙ O2 (mL.Kg.
−1min−1) of the session
The VO2 (mL.Kg
-1) attributable to the rehabilitation session itself, i.e. the VO2 (mL.Kg
-1)
consumed above that consumed at rest, was calculated by subtracting the equivalent VO2
(mL.Kg-1) at rest from the total session VO2 (mL.Kg
-1) (Figure 5.4). V˙O2 (mL.Kg.
-1min-1)
at rest was calculated as the mean V˙O2 (mL.Kg.
-1min-1) during 10 minutes where there was a
<10 % change in V˙O2 at rest prior to the rehabilitation session. The VO2 values attributable
to the rehabilitation are presented as a percentage of the resting VO2.
% change in VO2 =
Total session V O2 − Rest V O2
Rest V O2
∗ 100 (5.3)
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Figure 5.4: Oxygen consumption calculation for rehabilitation sessions. a = VO2 attributable
to exercise session, b = Total VO2 at rest, a + b = Total session VO2.
In order to make comparisons between the percentage change in VO2 between different
rehabilitation activities, the rehabilitation activities needed to be categorised. This was done
by categorising as they would be in clinical practice; i) sit over the edge of the bed, ii) sit
over the edge of the bed and balance exercises, iii) sit to stand, iv) sit to stand >1, v) bed
chair transfer. To increase the robustness of the analysis, the 5 categories were then collapsed
down into 3 and then 2 groups. (Table 5.8 ). Multilevel univariate regression was carried out
with the data grouped by patient and the percentage change in VO2 as the dependent variable.
Further multilevel univariate regression was carried out to explore other potential explan-
atory factors or variables for the percentage change in total session VO2 (or mean session
V˙O2). I again grouped the data by patient, with the dependent factor as percentage change
in session VO2 and the explanatory variables and factors as; i) test number, ii) test day,
iii) rehabilitation activity (sitting or standing), iv) number of prior rehabilitation sessions,
v) ICU-FSS on the day of testing, vi) time to first rehabilitation session, vii) current pres-
sure support, viii) exercise pressure support, ix) FiO2, x) the increase in pressure support
from resting level, xi) CRP, xii) Hb, xiii) temperature, xiv) WCC, xv) SOFA, xvi) HRrest,
xvii) HRmax, xviii) HR change, xix) weight, xx) gender, xxi) age, xxii) height, xxiii) GPPAQ,
xxiv) HRrest/ cHRmax, xxv) HRpeak / cHRmax.
The factors reaching the 95% statistical significance level were added to a multilevel mul-
tivariate linear mixed effects model. Interaction terms were compared using ANOVA of the
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log-likelihoods of the relevant models. AIC7 and BIC8 values were used to select the best
model fit. The residuals of the final model were then plotted and examined for influential
cases.
5.3.4 Results
5.3.4.1 Recruitment
A further 31 patients were recruited between August 2012 and March 2015, giving 44 patients
and 127 tests in total. No data were collected for two patients, as one weaned from mechanical
ventilation on the morning of the first test and the other became cardiovascularly unstable
on the morning of the first test and remained so beyond the study duration. See Figure 5.5
for the consort diagram of the analysis. There were two periods of non-recruitment: February
2013 - November 2013 (maternity leave), and July 2014 - September 2014 (equipment failure).
44 patients 
127 sessions 
2 patients  
2 sessions 
No data  
1 weaned on day of  first test 
1 CVS unstable 
11 sessions 
Rehab and cycling 
(6 patients) 
2 unusable  
rehabilitation and cycling 
sessions 
(in 2 patients) 
See figure 5.14 for exclusions 
Leaving 9 sessions 
(5 patients) 
93 sessions 
Rehabilitation only 
(38 patients) 
50 unusable 
 rehabilitation sessions 
(in 26 patients) 
See figure 5.14 for 
exclusions 
Leaving 43 sessions 
(21 patients) 
4 sessions 
Bed exercises only 
(in 3 patients) 
42 patients 
125 sessions 
15 SOEB 
11 SOEB BE 
7 single STS 
10 STS>1 
9 BCT 
52 rehabilitation 
 sessions analysed 
(in 26 patients) 
17 sessions 
Cycling only 
(10 patients) 
2 unusable  
cycle sessions 
(in 1 patient) 
2 unstable FiO2 
Leaving 15 sessions 
(10 patients) 
 
24 cycle sessions 
analysed 
(in 15 patients) 
Comparison with  
7 healthy volunteers 
(section 5.3) 
Figure 5.5: Consort diagram of rehabilitation and cycle data analysis. SOEB = sit over edge
of bed, BE = balance exercises, STS = sit to stand, BCT = bed chair transfer.
7AIC: Akaike’s information criterion.
8BIC: Bayesian information criterion.
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5.3.4.2 Cycle ergometry
Fifteen patients (7 male and 8 female) cycled in total (Table 5.3 ), giving 24 cycle tests, 12
of which lasted ≥3 minutes. Eleven of the 12 tests where patients achieved ≥3 minutes of
arm ergometry are plotted in Figure 5.8. There were no V˙O2 data for one patient (103)
who weaned from mechanical ventilation on the morning of the first cycle test. A total of 10
patients were able to cycle for ≥3 minutes on one or more occasions.
Characteristics of patients able to cycle ≥3 minutes The only variable significantly
associated with an ability to cycle ≥3 minutes was the patient’s physical function level (ICU-
FSS) on the day of testing (Table 5.4 ). Of note, there is no variance in the random (patient
grouping) part of the model, showing that it was not necessary to use a multilevel model in
this instance. The DFBETA’s and Cook’s distance indicated that none of the patients were
overly influencing the model (Figure 5.7 ). The odds of being able to cycle for ≥3 minutes
increased by 14% (95% CI: 0.003 to 27%) for every point increase in ICU-FSS (p = 0.05)
(Figure 5.6 ).
Variable n Median Min Max
Age (years) 15 70 50 80
weight (Kg) 15 70 40 119
MV prior to recruitment 15 23 16 61
Highest SOFA 15 8 2 13
GPPAQ 15 2 1 4
MV = mechanical ventilation
GPPAQ = General practice physical assessment questionnaire
Table 5.3: Cycle patient characteristics.
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Figure 5.6: ICU-FSS and ability to cycle ≥3 minutes.
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M18
Intercept −2.25
(1.20)
ICU-FSS 0.14∗
(0.07)
AIC 31.41
BIC 34.68
Log Likelihood −12.71
Num. obs. 22
Num. groups: pid 15
Variance: pid.(Intercept) 0.00
Variance: Residual 1.00
∗p < 0.05. M18 = ICU-FSS as the fixed effect.
Table 5.4: Multilevel logistic regression estimate for ability to cycle ≥3 minutes.
DFBETA
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−0.4−0.2 0.0 0.2 0.4
(Intercept)
−0.4−0.2 0.0 0.2 0.4
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Cook's distance
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Figure 5.7: DFBETA’s and Cook’s distance for ICU-FSS model (M18) of ability to cycle
≥3 minutes. DFBETA’s standardise the absolute difference in parameter estimates between
a (mixed effects) regression model based on a full set of data, and a model from which a
(potentially influential) subset of data is removed. DFBETA refers to how much a parameter
estimate changes if the observation in question is dropped from the data set. Cook’s distance
refers to how far, on average, predicted values move if the observation in question is dropped
from the data set.
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Figure 5.8: V˙O2 plots for individual cycle tests where ≥3 minutes ergometry was achieved
during an exercise session. STS = sit to stand, BCT = bed chair transfer.
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Estimation of anaerobic threshold. Reviewing the plots of the patients who cycled for≥3
minutes (Figure 5.8 ), six patients did not reach a plateau in their V˙O2 (E4/E5,F5,G5,K2,M1,P1)
and while three did (H2/H3,L2,W4). If the assumption is made in the case of patients who
did not reach a plateau, that their V˙O2 uptake kinetics were not so abnormal as to have not
reached steady state within the duration of the test, then the estimation for AT in the six
patients who cycled for ≥3 minutes but who did not reach steady state by the end of their
cycle duration are given in Table 5.5.
Patient Anaerobic threshold (mL.Kg.min) Duration
7 watts 10 watts 15 watts (Min) RPM
105 4.81 6.22 7.64 5:00 30
106 4.71 6.02 7.33 6:00 30
107 4.09 5.19 6.28 3:00 30
111 7.54 9.58 11.62 3:00 30
113 5.48 7.21 8.95 3:00 40
116 4.16 5.42 6.67 4:00 40
Table 5.5: Estimated anaerobic thresholds, with the assumption that patients should have
reached a plateau in V˙ O2 within the duration of the test.
5.3.4.3 Normal rehabilitation sessions
A total of 104 rehabilitation sessions were assessed in 38 patients. Two patients were not as-
sessable (see earlier). Patients were ventilated a median of 22.5 (range 4-175) days before their
first rehabilitation session and a median of 30 (range 11-175) days before their first measured
exercise session. It was possible to calculate the percentage change in V˙O2 from rest in 52 of
the 104 tests. Of these, there were 15 SOEB episodes, 11 SOEB and balance work, 7 single
STS and 10 STS ≥1 and 9 bed chair transfers (Table 5.7 ). The reasons why some of the data
were unusable are shown in Table 5.13. The minimum rehabilitation session duration was 5:35
minutes to transfer from bed to chair. The maximum duration was 39:21 to SOEB and to
stand one or more times.
Box plots of the rehabilitation categories and i) the mean V˙O2 (mL.Kg.
-1min-1) of the
session, ii) the total VO2 of the session (mL.Kg
-1), iii) the percentage change in VO2 of the
session, are shown in shown Figure 5.9. Discrimination between rehabilitation activities was
only possible when the rehabilitation activities were categorised into sitting or standing (Table
5.9). The mean percentage increase in VO2 from rest to SOEB ± balance exercises was 23.25%
(SD 11.16%) and the mean percentage increase from rest to standing and or transferring from
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bed to chair was 34.8% (SD 13.34%).
The only factors that demonstrated a statistically significant univariate association with
the percentage change in the total session VO2 (or mean session V˙O2), were rehabilitation
activity, ICU FSS, the number of prior rehabilitation sessions the patient had received, and
the pressure support increment (Table 5.10 ). ICU-FSS was highly correlated with the rehab-
ilitation activity, presumably because the patient’s physical function (measured by ICU-FSS)
improvement, meant they were more likely to engage in a higher level of activity (Figure
5.10 ). When activity and ICU-FSS were added individually (M28) to the analysis and then
compared to a model with the interaction term ICU-FSS:Rehabilitation activity (M27) (Table
5.11), analysis of the variance of the log-likelihoods of M27 and M28 demonstrated that the in-
teraction was statistically insignificant (p = 0.31). The removal of prior rehabilitation sessions
from activity, ICU-FSS and pressure support increment (M29 vs. M30) (Table 5.11), did not
significantly change the model fit (p = 0.79). When the residuals of M30 were plotted (Figure
5.11), patient 137 was identified as a significant outlier. The factors that most influenced the
percentage change in V˙O2 (and VO2) were ICU-FSS, the pressure support increment and the
rehabilitation activity. Therefore a patient who could SOEB with an ICU-FSS of 0 and a
pressure support increment of 0 would expect an 11.88% (95% CI: 4.45 - 19.31%) increase in
their V˙O2. A patient standing with an ICU-FSS of 0 and no increase in their pressure support
would expect a 1.53% (95% CI: -10.95 to 7.89%) decrease in their V˙O2. It is worth noting this
is a very unlikely event i.e standing a patient with no muscle activity, as the lowest ICU-FSS
that patients stood with was 10. For every point increase in ICU-FSS a 1.21 % (95%CI: 0.50;
1.93%) increase in V˙O2 could be expected. For each cm H2O increase in pressure support, a
further 1.41% (95% CI: 0.79-2.03%) increase in V˙O2 could be expected.
The calculated pseudo R2 for this model is 0.63. This suggests that the activity, patients’
functional status and pressure support increment explain up to 63% of the change seen in V˙O2
during rehabilitation sessions in the ICU. The remainder of the explanation is elusive.
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Variable n Median Min Max
Age (years) 38 69 31 86
weight (Kg) 38 70 35 119
MV prior to recruitment 38 28 11 175
Highest SOFA 38 10 2 14
GPPAQ 38 2 1 4
MV = mechanical ventilation
GPPAQ = General practice physical assessment questionnaire
Table 5.6: Rehabilitation patient characteristics.
Rehabilitation n Session Duration Rehabilitation Duration Recovery Proportion
Activity Min Median Max Min Median Max Min Median Max
SOEB 15 06:11 15:00 36:36 04:34 08:46 23:28 0.20 0.51 0.69
SOEB & balance 11 13:19 21:04 31:45 06:51 13:38 17:38 0.18 0.34 0.59
STS x1 7 10:55 18:32 26:19 05:06 10:17 16:11 0.29 0.37 0.72
STS > 1 10 07:44 22:04 39:21 05:53 15:13 25:10 0.22 0.31 0.47
MOS or BCT 9 05:35 12:07 28:04 02:52 07:43 28:04 0.00 0.35 0.49
SOEB = sit over the edge of bed, STS = sit to stand, MOS = march on spot, BCT = bed chair transfer.
Table 5.7: Rehabilitation session characteristics.
Categories Rehabilitation activity
5 categories SOEB SOEB with BE STS x1 STS>1 BCT
3 categories SOEB and SOEB with BE STS x1 STS>1 and BCT
2 categories SOEB and SOEB with BE STS x1 and STS>1 and BCT
SOEB = sit over edge of bed, STS = sit to stand, BE = Balance exercises, BCT = bed chair transfer.
Table 5.8: Rehabilitation activity classification codes. Grouping rehabilitation activities to
give five, three or two categories.
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Figure 5.10: Rehabilitation activity and ICU-FSS interaction.
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5 categories 3 categories 2 categories
Intercept 23.53∗∗∗ 22.85∗∗∗ 23.25∗∗∗
(2.95) (2.40) (2.63)
SOEB with balance exercises (5 category ) −1.65
(4.37)
STSx1 (5 category) 4.02
(5.03)
STS>2 (5 category) 6.76
(4.57)
BCT (5 category) 22.00∗∗∗
(4.74)
SOEB or SOEB with balance exercises (3 category) 2.40
(5.03)
STS>2 or BCT (3 category) 14.52∗∗∗
(3.56)
STS or BCT (2 category) 11.56∗∗
(3.45)
AIC 406.78 411.08 414.25
BIC 420.44 420.84 422.06
Log Likelihood −196.39 −200.54 −203.13
Num. obs. 52 52 52
Num. groups 26 26 26
∗∗∗p < 0.001, ∗∗p < 0.01, ∗p < 0.05. SOEB = sit over edge of bed, STS = sit to stand, BCT = bed chair transfer.
Table 5.9: Univariate linear regression estimates and and standard error of the means (SEM)
for percentage change in VO2 and the method of classifying the rehabilitation activity. SOEB
is the reference category for the 5 category model. SOEB and SOEB with balance exercises
represents the reference category for the 2 and 3 category models.
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Rehabilitation activity ICU-FSS Prehab PSinc
Intercept 23.25∗∗∗ 14.74∗∗∗ 25.84∗∗∗ 26.73∗∗∗
(2.63) (3.52) (2.95) (2.57)
STS or BCT 11.56∗∗
(3.45)
ICU-FSS 1.14∗∗∗
(0.25)
Prior rehabilitation 1.28∗
(0.57)
PS increment 1.67∗
(0.73)
AIC 414.25 406.21 416.35 415.35
BIC 422.06 414.02 424.00 423.00
Log Likelihood −203.13 −199.11 −204.18 −203.68
Num. obs. 52 52 52 52
Num. groups 26 26 26 26
∗∗∗p < 0.001, ∗∗p < 0.01, ∗p < 0.05. SOEB = sit over edge of bed, STS = sit to stand, BCT = bed chair transfer.
Table 5.10: Univariate linear regression estimates for percentage change in VO2. The reference
category for rehabilitation activity is SOEB or SOEB with balance exercise.
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Figure 5.11: Final model (M30) ICU-FSS, rehabilitation activity and pressure support incre-
ment residuals. Patient 137 is outside the 95% confidence interval of the standardised residuals.
Standardised residuals = residual/SD of all residuals. Quantities of standard normal are those
values expected if the residuals were normally distributed.
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Rehab activity ICU-FSS M27 M28 M29 M30
Intercept 23.25∗∗∗ 14.74∗∗∗ 19.98∗∗ 14.89∗∗∗ 11.80∗∗ 11.88∗∗
(2.63) (3.52) (6.19) (3.72) (3.84) (3.79)
STS or BCT 11.56∗∗ −7.86 0.74 −1.48 −1.53
(3.45) (9.80) (4.92) (4.86) (4.81)
ICU-FSS 1.14∗∗∗ 0.38 1.09∗∗ 1.20∗∗ 1.21∗∗
(0.25) (0.80) (0.38) (0.38) (0.37)
ICU-FSS:STS or BCT 0.90
(0.90)
PS increment 1.44∗ 1.49∗
(0.67) (0.63)
Prior rehabilitation 0.12
(0.49)
AIC 414.25 406.21 409.16 408.19 406.41 404.48
BIC 422.06 414.02 420.87 417.95 420.07 416.19
Log Likelihood −203.13 −199.11 −198.58 −199.10 −196.21 −196.24
Num. obs. 52 52 52 52 52 52
Num. groups 26 26 26 26 26 26
∗∗∗p < 0.001, ∗∗p < 0.01, ∗p < 0.05. BCT = bed chair transfer.
Table 5.11: Multilevel, multivariate, linear regression estimates and standard error of the
means (SEM) for the percentage change in V O2. The reference group for the rehabilitation
actvity model is SOEB±balance exercises. M27 = Rehabilitation activity and ICU-FSS as an
interaction term, the reference category is ICU-FSS:SOEB±balance exercises. M28 = Activity
and ICU-FSS. M29 = Rehabilitation activity, ICU-FSS, PS increment and prior rehabilitation
sessions. M30 = Rehabilitation activity, ICU-FSS and PS increment.
137
5.4 Changes in V˙O2 during rehabilitation activities
performed by healthy individuals
A convenience sample of seven healthy, non-age or gender-matched individuals were recruited
in order to draw comparisons against the patients’ V˙O2 during rehabilitation activities (Table
5.12). STS x1 was chosen as the rehabilitation activity to compare as it had the narrowest
95% confidence intervals for V˙O2 during rehabilitation activities. Also it was very difficult to
record a V˙O2 change in normals for any activity less than STS x1, possibly due to the brevity
of the sessions.
5.4.1 Method
The V˙O2 of the healthy subjects was measured using the MGU via a face mask. Subjects were
requested to sit in a semi-recumbent position, 30° head-up until there was a <10% variation
in resting V˙O2. They were then asked to SOEB, stand and then sit down and return to the
semi-recumbent position.
5.4.2 Analysis
The healthy individuals’ data were analysed in the same way as the patient data. As their
data were not normally distributed, comparisons between patients and healthy individuals
were performed using Wilcoxon signed rank tests of;
i) resting V˙O2 in mL.Kg.
-1min-1,
ii) total session VO2 in mL.kg
-1,
iii) rehabilitation VO2 (total session VO2 - resting VO2),
iv) percentage change in VO2.
Patient efficiency was calculated using healthy individuals as the reference category.
Session power = Total session VO2 (mL.kg
-1) (5.4)
Total session VO2 (mL.kg
-1) = session V˙ O2 (mL.kg
−1min−1) ∗ session duration (min)
Rehabilitation power = Rehabilitation VO2 (mL.kg
-1) (5.5)
Rehabilitation VO2 (mL.kg
-1) = rehabilitation V˙ O2 (mL.kg
−1min−1) ∗ session duration (min)
5.4.3 Results
There was a significant difference between the time taken for patients and healthy individuals
to SOEB, stand and return to bed (Table 5.12 ). Box plots of resting V˙O2, total session VO2
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and rehabilitation VO2 are shown in Figure 5.12.
Group Number Session Duration Age Weight (Kg)
Min Median Max Mean SD Mean SD
Healthy 7 02:48 05:38 07:02 34 4 70 17
Patients 7 10:55 18:32 26:19 68 11 80 12
Table 5.12: Time required to sit-to-stand for healthy volunteers and patients.
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Figure 5.12: Healthy individual and patient V˙O2 during a sit-to-stand manoeuvre.
There was no statistical difference between the resting V˙O2 of the patients and healthy
individuals (Figure 5.12a), the mean V˙O2 of the session (Figure 5.12b), or the percentage
session change (Figure 5.12c). The Wilcoxon Signed Rank estimate of the difference in V˙O2
at rest was -0.177 mL.Kg.-1min-1 (95% CI: -0.740 to 0.533 mL.kg.-1min-1) (p = 0.62). The
estimate of the difference between the mean session V˙O2 was -0.482 mL.Kg.
-1min-1 (95%
CI: -1.214 to 0.380 mL.kg.-1min-1) (p = 0.2593). The estimate of the difference between the
patient and healthy percentage session change was -7.872% (95% CI: -19.59 to 5.218%) ( p
= 0.1649). There was a significant -68.69 mL.kg-1 (95% CI: -77.08 to -53.37 mL.kg-1) (p
= 0.0006) difference between the healthy volunteer and patient session VO2 (mL.kg
-1). For
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patients, efficiency for the whole session was 24.23% and for the rehabilitation component
19.43%. Patients consumed, on average, 4.12 times more oxygen to SOEB, stand and then
return to bed compared to healthy individuals (95% CI: 0.82 to 17.07).
5.4.3.1 HR data
Heart rate data are the most often cited way to decide when to start and when to stop
rehabilitation sessions [143, 146, 164]. However, a frequent oversight is that many patients are
receiving rate limiting-drugs (RLD), such as beta-adrenergic blockers.
Analysis. As the data were normally distributed, unpaired Student’s t-tests of the percent-
age change in heart rate, HRrest as a percentage of cHRmax, and HRpeak as a percentage of
cHRmax were carried out in patients receiving beta-adrenoceptor blocker (BB) vs. no RLD
as well as other RLD vs. no RLD.
Results. Of the 42 patients who were enrolled and had ≥1 exercise sessions recorded; 20
(48%) patients were receiving a rate-limiting drug (RLD); 16 (38%) were taking a beta-
adrenoceptor blocker and 4 (10%) another rate limiting drug e.g digoxin or amiodarone. The
resting and peak HR of the 33 patients who had both values recorded for ≥1 tests are plotted
and grouped by the use of BB, other RLD or no RLD (Figure 5.13a). Three of the patients
in the RLD group were in atrial fibrillation. The patients receiving a RLD had a greater
percentage change in HR than the non-RLD patients with a 13.7 % (95 CI: 0.23 to 27.30 %)
(p = 0.046) increase in heart rate (Figure 5.13b). There was a 6.75 % (95 CI: -0.4 to -13.10 %)
(p = 0.04) increase in heart rate between the BB and non-RLD patients, with the non-RLD
patients having a greater percentage increase in HR compared to the BB patients (Figure
5.13c). One-third of patients had resting heart rates >60% of their cHRmax (26% of BB,
31% of No RLD and 38% of other RLD patients) (Figure 5.13d). Twenty percent reaching a
HRpeak >75% of their cHRmax (3% of BB, 20% of No RLD, and 50% of other RLD patients).
5.4.4 Discussion
5.4.4.1 Technique
Measuring V˙O2 during rehabilitation interventions in mechanically ventilated patients is tech-
nically challenging, time consuming and, given that 52 (41%) of the tests were unusable,
frustrating (Table 5.13). Depending on the rehabilitation activity, tests took between 1 and
2 hours, with a further 20-30 minutes to analyse each test. From a technical perspective, the
instability of the FiO2 delivered by the Servo i ventilator resulted in data being inadequate in
10 (7%) of the sessions. Incompatibility of NHS security software and the driver for the MGU
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Figure 5.13: Heart rate changes during rehabilitation.
***p <0.001, p ** <0.01, *p <0.05.
resulted in a further 14 (11%) tests being lost (six where there was no useful data and eight
where there was incomplete patient recovery data). The written records of the session were
inadequate in 8 (6%) tests, preventing retrospective identification of activity timings. Only
five patients declined to continue a session once the equipment was set up. The remaining
issues were most probably unavoidable or happened very infrequently; these included the need
to increase the patient’s FiO2, and persistent coughing. The time-consuming nature and un-
reliability of the technique in this patient group preclude its use in routine clinical monitoring
of rehabilitation sessions.
5.4.4.2 Repeatability and sensitivity of the technique
It was not possible to test the repeatability of the measurements for either the cycle tests or
the rehabilitation sessions. Patients were too fatigued at the end of a rehabilitation session to
repeat the same activity. The few comparisons that were possible between different days were
not valid comparisons due to changes in patients physiological status. There were insufficient
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Reasons tests not analysed Number
FiO2 increased during test 2
Flow sensor blocked during session 1
No recovery data 8
Patient coughing 2
Patient declined 5
Patient vomited no rehab 1
Unable to identify 8
Unstable FiO2 10
VO2 erratic 7
Weaned 1
NHS firewall software 6
Withdrawn 1
Table 5.13: Reasons tests not analysed.
repeated tests over time to test the sensitivity of the tests to measure change over time.
Ergometry was chosen as an exercise stimulus as it was expected to be a standardisable
method to quantify exercise load. Upper-limb, cycle ergometry was chosen as it was an exercise
method that had previously been employed with success in a number of patients on the ICU.
I anticipated that more patients would be able to cycle actively with their arms than their
legs.
RPM. In order to generate comparable workloads both between and within patients a con-
sistent pedal frequency (RPM) had to be generated on the ergometer. No currently published
studies have sought to standardise this [128, 171]. 35 RPM was the minimum the manufac-
turer recommended for reliable comparisons of the Monarch ergometer. However, of the nine
patients with V˙O2 data who cycled for ≥3 minutes, only 3 of them managed ≥35 RPM. From
the manufacturers data, this suggests that these patients were working at 4 watts. Unfor-
tunately at lower RPM’s the work rate increases due to the need to overcome inertia of the
ergometer. So it is likely that those patients with a low RPM were working harder than those
with a high RPM. With respect to the anaerobic threshold calculations, 3 work rates were
used (5, 10 and 15 watts) to estimate the anaerobic thresholds. Even a generous estimate of
15 watts suggests extremely low AT’s. Estimating that, with the exception of one patient, all
would have reached their AT by the equivalent of a healthy person standing (2 METS or 7
mL.Kg.-1min-1). However, it is not possible to exclude slow V˙O2 uptake kinetics as a reason
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for not reaching a plateau in V˙O2 in the time course of the test. An unloaded ergometer with
an accurate power output at low RPM’s would be essential for any future study.
ICU-FSS cycling model. The association between physical function status (measured by
ICU-FSS) and the ability to cycle for 3 minutes was not surprising. The odds of being able
to cycle increased by 14% (95% CI: 0.003 to 27%) (p = 0.05) for every point increase in
ICU-FSS. However, patient motivation can not be excluded as a confounder. The main reason
patients gave for stopping the cycle session was“fatigued”, rather than breathlessness. The
way the patients were added to the model may also have influenced the estimates. Patients
had between one and 5 cycle tests recorded each. No more than 2 tests per patient could be
added to the model without one patient becoming overly influential. While it is not possible
to get accurate estimation of patients’ exercise capacity or intensity from this data, it does
highlight how deconditioned patients are and how difficult it is to find ways to measure exercise
capacity and intensity at very low levels of physical function.
Cycling recruitment. Between December 2011 and March 2013, 21 patients were recruited
and 12 cycled. Between November 2013 and March 2015, 23 patients were recruited and 3
patients cycled. From November 2013 I was no longer working clinically on the ICU and
relied on the ICU team for information on patients who were suitable to recruit and on their
readiness to cycle. Additionally, as cycling was more labour intensive for the team, low staffing
levels influenced the numbers of patients recruited who went on to cycle.
5.4.4.3 Rehabilitation.
Extrapolating from the the univariate regression analysis, including just the rehabilitation
activity, SOEB increased a patient’s V˙O2 from 3.5 mL.Kg.
-1min-1 to 4.29 (95% CI: 4.10-
4.51mmL.Kg.-1min-1), while standing increased the V˙O2 to 4.72 mL.Kg.
-1min-1 (95% CI:
4.15-5.28 mL.Kg.-1min-1). These mean values for sitting and standing activities are under the
estimated anaerobic thresholds for the six patients who performed the cycling tests (if a power
output of 10 watts is assumed). The peak values of sitting and standing are considerably
greater (Table 5.14 ). This suggests that patients may be exercising above their anaerobic
threshold for at least part of their rehabilitation sessions. The importance of this requires
further investigation.
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Activity n Peak V˙ O2 (mL.Kg.
-1min-1)
Mean SD Min Max
Sitting 25 6.49 2.40 3.76 15.63
Standing 27 7.26 1.58 4.68 11.23
Table 5.14: Peak V˙ O2 for sitting and standing activites
The large standard deviation of the sample data reflects not only the small sample size
but also the heterogeneity of the patients recruited and the multiplicity of factors influencing
energy expenditure during a rehabilitation session. The main factor that influenced the re-
gression model was the patient’s physical function status, rather than the actual rehabilitation
activity. There are several plausible explanations for the relationship between ICU-FSS and
the change in V˙O2. Less able patients may consume less O2 because they are utilising less
muscle, and/or, they have less muscle to recruit, and/or the muscle is less able to utilise O2
due to bioenergetic failure or changes in fibre type composition as a result of ICUAW. It is
likely to be a combination of these factors. While ICU-FSS in isolation might be associated
with V˙O2, it does not help in estimating an individual patient’s exercise capacity nor the
intensity at which they are working.
The suggestion that an increment in ventilatory support could influence the change in V˙O2
further complicates the issue. It is not uncommon for ventilatory support to be increased
during a rehabilitation session. The assumption is that off-loading the patient’s mechanical
respiratory load and/or reducing a patient’s perception of breathlessness enables the patient
to achieve more in a rehabilitation session. There is a trend towards an increase in rehabil-
itation duration for those patients who have their pressure support increased (Figure 5.14).
Why this happens is unclear. It may be that as the therapist has increased the ventilatory
support, they push the patients harder or it may suggest that the perception of breathless or
mechanical respiratory load are important manipulatable factors in mechanically ventilated
patients. Further investigation into this process is warranted, but also challenging. It would
necessitate a patient carrying out the same rehabilitation activity twice, once with no increase
in the pressure support and again with an increase in support.
The regression analysis did not pick up any alteration in the percentage change in V˙O2
over time. This is likely due to insufficient numbers of patients repeating the same activity
over time. Given the nature of rehabilitation in the ICU, patients were rehabilitated to their
maximum functional level on each occasion. Ideally patients with high ICU-FSS scores would
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Figure 5.14: Pressure support increment and rehabilitation duration.
have had repeats of their low level activities to observe if the V˙O2 changed over time.
Patients vs. healthy individuals. One of the striking features of my findings was the
difference in the time taken to stand between patients and healthy individuals. Patients took,
on average, 3.5 times as long to stand and return to bed than healthy individuals. This
mostly explains the quadruple decrease in session and rehabilitation efficiency VO2 between
the patients and healthy individuals.
5.4.4.4 HR measurement
The different heart rate response to exercise in BB, Non-RLD and RLD patients would suggest
that heart rate is not a reliable or valid way to measure an exercise response in the majority
of mechanically ventilated ICU patients. Additionally none of the heart rate variables added
to to the regression model demonstrated an association with the percentage change in V˙O2.
5.4.4.5 Reasons for cessation of exercise
Unfortunately the reasons for ceasing exercise were not recorded for either the cycle or the
rehabilitation sessions. This would have been an interesting variable to have collected and may
have provided a useful insight into the limitations to exercise experienced by the patients.
5.4.5 Conclusion
Breath-by-breath gas exchange analysis provides valuable information regarding the patient’s
oxygen consumption during rehabilitation. However, it is not a practicable method for mon-
itoring rehabilitation interventions in routine clinical practice.
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Incremental tests to measure exercise capacity and intensity were not possible in this par-
ticular patient cohort. However, constant load tests are feasible for a subgroup of patients.
This subgroup may be identifiable for future studies by their ICU-FSS.
Absolute exercise intensity, as measured by V˙O2, is not activity-dependent, highlighting
the need to monitor individual patient’s workload in real time. This need is intensified by the
finding that some patients have AT’s as low as 6-8 mL.Kg.-1min-1.
In future studies it would be useful to establish the reasons for cessation of exercise.
Given that it was not possible to use conventional methods to estimate exercise intensity,
I decided to look at the possibility of estimating a patient’s V˙O2 from other, more easily
measured values. The starting point was the oxygen uptake efficiency slope (OUES).
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Chapter 6
Potential methods of estimating
oxygen consumption during
rehabilitation of mechanically
ventilated patients
The previous chapter illustrated that a specific rehabilitation activity, e.g. sitting over the
edge of the bed, does not have the same oxygen cost for every patient, or indeed for an in-
dividual patient on different rehabilitation occasions. This highlights the need, at the very
least, to identify the absolute intensity at which a patient is working and ideally, the intensity
relative to an individual patient’s maximum capacity. This would enable individualised exer-
cise regimens to be created for patients and quantification of rehabilitation interventions.
During the BBGEA data collection, I noted how closely V˙E mapped V˙O2 and that recovery
of V˙E to the pre-exercise state was indicative of the V˙O2 returning to baseline. However,
while V˙E could potentially be used as an indicator of recovery between exercise bouts during
a rehabilitation session, the complexity of the relationship between V˙E and V˙O2 currently
negates its use as a direct estimate of absolute exercise intensity. The oxygen uptake efficiency
slope (OUES) is a useful sub-maximal indicator of cardiorespiratory reserve, representing the
absolute increase in V˙O2 associated with a 10 fold rise in V˙E (Equation 3.1 ). The logarithmic
transformation of V˙E effectively linearises the relationship when ∆V˙E exceeds ∆V˙O2 above
the AT [176]. Although there is evidence that the exercise intensity at which the OUES is
generated may also influence the slope [253], the OUES does provide a starting point for the
development of a model to estimate V˙O2 from other, more readily available parameters.
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6.1 Physiological rationale for model creation
A great deal of attention is now given to the relationship between V˙E and V˙O2 [254], however
there is a much clearer relationship between V˙E and V˙CO2. As can be seen from Equation 6.1,
alveolar ventilation (V˙A) is modified by both the PaCO2 set point and V˙CO2 (or metabolic
load). That is, the higher the PaCO2 set point, the lower the required alveolar ventilation
for a given V˙CO2, while the greater the metabolic load (greater V˙CO2) then the higher the
required V˙A. The actual V˙E necessary to maintain the PaCO2 set point is then modulated
by the dead space:tidal volume ratio, i.e the greater the dead space:tidal volume ratio, the
greater the V˙E required to achieve the necessary alveolar ventilation for a given V˙CO2 and
PaCO2 set point (Equation 6.2 ). This relationship is however confined to exercise between
the initial kinetic phase and that occurring below the lactate threshold [255].
V˙A =
863 ∗ V˙ CO2
PaCO2
(6.1)
V˙E =
863 ∗ V˙ CO2
PaCO2 ∗ (1− VDVT )
(6.2)
Where 863 is the correction for V˙E to BTPS,
V˙ CO2 to STPD and CO2 as partial pressure.
VD =
PaCO2 − PETCO2
PaCO2
(6.3)
V˙ O2 =
V˙ CO2
RQ
(6.4)
I did not have the contemporaneous PaCO2 and PETCO2 values required to calculate dead
space. Additionally, this model would require continuous V˙CO2 monitoring and knowledge of
the RQ. This would generate multiple sources of error and two further variables to monitor.
Given that the only other option for gauging a patient’s exercise intensity is the physio-
therapist’s best guess, in the absence of such data, I opted to establish whether modelling
V˙O2 from V˙E using resting V˙CO2 and resting PETCO2 (both values are readily obtainable
with a PETCO2 monitor), was significantly inferior to estimating V˙O2 during rehabilitation
by monitoring V˙CO2 and assuming a fixed RQ (Equation 6.4).
Below the anaerobic threshold, V˙O2 and V˙CO2 are coupled by substrate metabolism. For
the majority of patients, the RER1 during rehabilitation is parabolic, starting high (usually
around 1.1, presumably related to anxiety or possibly due to over-ventilation), dropping to
a nadir of 0.7-0.8 during the exercise component of the session and returning to 1 during
1The ratio of CO2 output to O2 uptake per unit time. The RER reflects both the metabolic exchange of
gases and transient changes in CO2 and O2 storage, hence RER can exceed RQ during hyperventilation where
a greater volume of CO2 is removed from the body than is produced.
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recovery. This is similar to that seen in healthy individuals as a result of pre-test anxiety
[256]. The mean RER of the analysable tests was 1.012 with a SD of 0.086. Clearly, this
variability will introduce a significant bias. The relationship between resting V˙CO2, resting
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Figure 6.1: V˙E model. Pairs plots. V˙E in L.min
-1, Rest V˙CO2 in mL.min
-1, Rest PETCO2
in mm Hg, V˙O2 in mL.Kg.
-1min-1. The lower quadrant shows each variable plotted against
the remaining variables, the upper quadrant provides the correlation coefficient for the corres-
ponding lower quadrant. Highlighting a potential interaction between V˙E and resting V˙CO2.
PETCO2, V˙E and V˙O2 are plotted in pair plots in Figure 6.1. There is a trend towards a
greater exercise V˙E values with higher resting V˙CO2. In the absence of the PaCO2 set point,
it is not clear whether for some patients this increase in V˙E is due to a lower PaCO2 set point
or a higher metabolic rate (V˙CO2). PETCO2, which is often used as an indicator of PaCO2
in clinical practice, has an anticipated negative correlation with exercise V˙E , i.e. as resting
PETCO2 increases, exercise V˙E tends to decrease. However, again in the absence of a PaCO2
value, it is not clear whether for some patients this lower exercise V˙E is due to a higher PaCO2
set point or a lower dead space (Equation 6.3 ). The purpose of including resting V˙CO2 and
PETCO2 was therefore not to influence the estimate of the slope but to explain some of the
variation in the intercepts both within and between patients.
6.2 Rehabilitation data segment definitions
It was unclear how the choice of different segments of the rehabilitation sessions would influence
the final regression models. The segment of the rehabilitation data to be used for both models
required an even spread of values in each of a low, medium and high category, to prevent
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excessive representation of high or low values. For the V˙E model, the data needed to have
acceptable agreement between V˙O2 and V˙E . Therefore, the segments of the rehabilitation
sessions were labelled as (Figure 6.2):
Segment a: all data,
Segment b: all rehabilitation data,
Segment c: exercise-only rehabilitation data, excluding rest data between parts of the re-
habilitation sessions, and
Segment d: incremental data only.
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Figure 6.2: Example of rehabilitation data segments. (a) = all data, (b) = all rehabilita-
tion data, (c) = exercise only rehabilitation data, excluding rest data between parts of the
rehabilitation sessions, and (d) = incremental data only.
In order to decide which segment of the data to use, I collated the number of data points for
each segment (Table 6.1). I then plotted V˙O2 against V˙E for each segment with computation
of the corresponding linear regression line, coefficient estimate for V˙E and r
2 value (Figure
6.3). Segment b provided the most even spread of data points. Segment b also lost fewer data-
sets when using an r2≥0.45 cut off for the V˙O2:V˙E relationship. The standard deviation of
the estimates of the coefficient for V˙E was also smaller in segment b than in the other segments.
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I did this work with a view to being able to create a model to estimate V˙O2 during
rehabilitation, given a future bigger sample size. The following sections aim to explore the
relationship between V˙CO2 and V˙O2 and between V˙E and V˙O2 during the rehabilitation of
mechanically ventilated patients.
Segment Low Medium High
(<3.5 mL.Kg.-1) (3.5-4.4 mL.Kg.-1min-1) (≥4.5 mL.Kg.-1min-1)
a 22083 20855 14286
b 10168 12889 11051
c 2015 6529 7188
d 433 2077 1946
Table 6.1: Data counts for each rehabilitation segment.
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Figure 6.3: Rehabilitation data segments (panels a,b,c and d), with regression estimated
coefficients of V˙O2 vs. V˙E plotted against the corresponding r
2 value. A cut point of r2≥ 0.45
is shown.
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(a) Rehabilitation segments. V˙O2 vs. time.
y = −9.2 + 22 ⋅ x,  r2 = 0.544
y = −219 + 37 ⋅ x,  r2 = 0.65
y = −218 + 38 ⋅ x,  r2 = 0.639
y = −188 + 36 ⋅ x,  r2 = 0.561
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(b) Rehabilitation segments. V˙E vs. V˙O2.
Figure 6.4: Example of data segments. (a) = all data, (b) = all rehabilitation data, (c)
= exercise only rehabilitation data, excluding rest data between parts of the rehabilitation
sessions, and (d) = incremental data only. The shading of the data points corresponds in
each of the panels, illustrating the origin of the V˙E vs. V˙O2 data points in the rehabilitation
session.
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6.2.1 Glossary of statistical terms
Multilevel linear mixed effects modelling. A form of regression analysis describing the relation-
ship between a response or dependent variable and covariates that have been measured
or observed along with the response, while allowing grouping of the data by a categorical
covariate.
Random effects. Categorical covariates representing the observational units; in this instance
patients or sessions. They are randomly sampled from a population of all levels being
studied.
Fixed effects. Parameters associated with the particular levels of a random effect, they can
be categorical or continuous.
Caterpillar plots. A method of visualising the random effects of a multilevel mixed effects
model. They illustrate the distance the estimate of the intercept of the individual levels
lie from the estimate of the intercept of the whole model.
Residuals. The difference between the calculated values from the model and the actual
observed values. They are often standardised as the residual divided by the the standard
deviation of all the residuals.
QQnorm plots. A visual comparison of 2 probability distributions. In this case the QQnorm
plot is used to evaluate the normality of the residual distributions. If the residuals are
normally distributed they will lie on the x=y line.
Confusion matrices (or contingency tables). Display the proportion of values that are cat-
egorised by the predicted class (in columns), while each row represents the proportion
in the actual class.
Collinearity. A phenomenon where covariates in a multiple regression model are highly
correlated, such that one can be predicted from the other. In this situation the coefficient
estimates of the multiple regression may change erratically in response to small changes
in the model or the data.
Interaction terms. Terms that are added to a model if two covariates affect the response
variable in a way that is non-additive.
6.2.2 Principles of model development
The data collected from the rehabilitation and cycle sessions is hierarchical; each patient has
multiple sessions, each session has multiple data points. Therefore modelling the data using
a single linear model e.g. y=ax+b, not only violates the assumption of independence between
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observations, but risks the Simpsons paradox where “erroneous conclusions can be drawn if
grouped data, drawn from heterogeneous populations are collapsed and analysed as if from a
single population” [257]. An alternative approach is to create separate linear models for each
patient or each session e.g. y=an+bn where n is the number of patients or sessions. However
this does not allow a clear summary of the results.. Multilevel linear mixed effects modelling
allows resolution of non-independence by assuming a different “baseline” (intercept) response
variable value (in this case V˙O2) for each patient or session (level).
Multilevel linear mixed effects modelling is a form of regression analysis describing the
relationship between a response or dependent variable and covariates that have been meas-
ured or observed along with the response, while allowing grouping of the data by a categorical
covariate. These categorical covariates represent observational units; in this instance patients
or sessions. They are randomly sampled from a population of all levels being studied and are
known as random effects. The parameters associated with the particular levels of a random
effect are “fixed effects” and can be categorical or continuous.
In the first instance it is necessary to ensure that the extent of the between-group variability
is sufficient to warrent incorporation as a “random effect”. This is done by estimating the
variance around the “baseline” (intercept) response variable value (in this case V˙O2) when the
data is grouped. If there is no variance between groups then the “random effect” should not be
included. The “random effects” can be further visualised by caterpillar plots, which plot the
distance for each individual patient the estimated “baseline” (intercept) is from the estimated
model “baseline” (intercept). The impact on the estimated intercept of adding “fixed effects”
to the model can be also be visualised.
Once the final model has been selected then the residuals of the model can then used to
analyse how well the overall model fits each individual patient or session. These are usually
plotted as standardised residuals. Plotting the residuals against the individual covariates allows
visualisation of any bias or non-linear relationship that has been introduced. Finally QQnorm
plots can be used to evaluate the normality of the residuals. If the residuals do not follow
a normal distribution, this might indicate that one or more of the covariates is not linearly
related to the response variable.
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6.3 Using V˙CO2 as an estimate of V˙O2
6.3.1 V˙CO2 model creation
6.3.1.1 Method
Data from 48 sessions in 19 patients, where there was a mean RER of <1.1, were added to
a linear-mixed effects multilevel model [248]. The random effects of the model were selected
first. In model RE1 each patient is allowed their own intercept while in RE2 each patient and
each session have their own intercept (Table 6.2 ). All variables with a statistically significant
linear association (p<0.05) with the dependent variable (V˙O2 measured in mL.Kg.
-1min-1),
were added to the model as the fixed terms (Table 6.3 ).
Caterpillar plots were created to illustrate the distance, the estimate of each coefficient of
the intercept for both each patient, or session, lie from the estimated coefficient of the inter-
cept for the the empty model (RE2) (Figure 6.6a) and the final model (M4) (Figure 6.6b).
The final model (M4) residuals were first visualised with a QQnorm plot2 (Figure 6.7 ).
Figure 6.8 shows the residuals with respect to the patient and Figure 6.9 with respect to
the particular rehabilitation session. Then the model residuals were plotted against the fitted
values (Figure 6.10a), weight (Figure 6.10b), V˙CO2 (Figure 6.10c) and RER (Figure 6.10d).
6.3.1.2 Interpretation of V˙CO2 model
The session, nested within the patient as the random effects of the model, substantially de-
creases the variance of both the intercept and the residuals of the model (Table 6.2 ). V˙CO2,
age, and weight were the only factors univariately associated (p <0.05) with V˙O2 (Table 6.3 ).
All variables entered into the model were essentially normally distributed. However, V˙O2 and
V˙CO2 are somewhat left-skewed with age right-skewed with RER (Figure 6.5).
For every 100 mL.min-1 increase in V˙CO2 there is a 0.012818 mL.Kg.
-1min-1 increase in
V˙O2. For every Kg increase in body mass there is a 0.008 mL.Kg.
-1min-1 decrease in V˙O2.
For every year increase in age there is a 0.055 mL.Kg.-1min-1 decrease in V˙O2. Interestingly,
the variance of the random effect patient is zero suggesting that, in this instance, the random
effect of the patient is redundant (Table 6.4, M4 ).
As can be seen from Figure 6.8, patient 137 and 134 contribute considerably towards the
2QQnorm plots illustrate the residuals plotted against the expected residuals if they were normally distrib-
uted.
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residuals. Patient 137 was the heaviest patient at 109 Kg, but also had the highest peak
V˙CO2 values (not adjusted for weight). Session 117 (Figure 6.9) for patient 134 had an RER
towards the lower end of the dataset.
The residuals increase as RER increases above 1 and as RER decreases below 1. There is
less accuracy for low RER than high RER values (Figure 6.10b). Thus, as expected, assuming
a common RER introduces a significant bias.
The standardised residuals plotted against V˙CO2 (Figure 6.10d) show that for V˙CO2 val-
ues above 550 mL, the residuals increase considerably. These high values may be due to
patients exercising above their AT, where the relationship between V˙O2 and V˙CO2 is not
linear. Further corroboration with lactate values is required to establish this.
The heavy tailed QQnorm plot shows a non-normal distribution (Figure 6.7 ). This suggests
that either patients 134 and 137, for whom the biggest residuals are apparent, are significant
outliers or that there is not a linear relationship between the fixed effects (weight, age and
V˙CO2) and V˙O2. Simple measures such as logarithmic transformation of the independent
variables do little to normalise the residuals.
Removing patients 134 and 137 from the model significantly reduces the residuals but has
little impact on the overall model estimates. (Figure 6.11 and Table 6.4, M5).
The simulation of values (n = 50) and the 95% confidence intervals [17] that could be
expected from the final V˙CO2 model (M4) are shown in Figure 6.12. This illustrates that
predicted values have a wide confidence interval.
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RE1 RE2
(Intercept) 4.33∗∗∗ 4.34∗∗∗
(0.18) (0.17)
AIC 50426.88 45073.49
BIC 50450.77 45105.35
Log Likelihood −25210.44 −22532.74
Num. obs. 21276 21276
Num. patients 19 19
RE variance: patient 0.62 0.42
Residual variance 0.62 0.48
Num. sessions 48
RE variance: session 0.26
∗∗∗p < 0.001, ∗∗p < 0.01, ∗p < 0.05
Table 6.2: Random effects for V˙ CO2 modeling sample. RE1 = Patient, RE2 = Patient and
Session. AIC = Akaike’s information criterion, BIC = Bayesian information criterion, RE =
Random effect, refering to the grouping structure; patient or session.
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Figure 6.5: V˙CO2 model. Histograms of dependent and independent variables and RER. V˙O2
and V˙CO2 are left skewed and age right skewed with RER.
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RE2 M1 M2 M3 M4
Intercept 4.339∗∗∗ 0.307 4.316∗∗∗ 1.507 4.886∗∗∗
(0.169) (0.230) (0.190) (1.462) (0.302)
V˙ CO2 12.812
∗∗∗ 12.820∗∗∗ 12.812∗∗∗ 12.818∗∗∗
(0.048) (0.048) (0.048) (0.048)
Weight −0.054∗∗∗ −0.055∗∗∗
(0.002) (0.002)
Age −0.018 −0.008∗
(0.021) (0.004)
AIC 45073.490 14159.406 14099.174 14160.727 14096.733
BIC 45105.351 14199.233 14146.966 14208.519 14152.491
Log Likelihood −22532.745 −7074.703 −7043.587 −7074.363 −7041.367
Num. obs. 21276 21276 21276 21276 21276
Num. sessions 48 48 48 48 48
Num. patients 19 19 19 19 19
RE variance: session 0.261 0.057 0.059 0.057 0.061
RE variance: patient 0.418 0.972 0.008 0.939 0.000
Residual variance 0.480 0.112 0.112 0.112 0.112
∗∗∗p < 0.001, ∗∗p < 0.01, ∗p < 0.05, ·p < 0.1
Table 6.3: V˙ CO2 model. RE2 = Random effects (patient and session) only, M1 = V˙ CO2
(L), M2 = V˙ CO2 (L) and weight (Kg). M3 = V˙ CO2 (L) and age, M4 = V˙ CO2 (L), age and
weight (Kg). AIC = Akaike’s information criterion, BIC = Bayesian information criterion.
RE = Random effect, refering to the grouping structure; patient or session.
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(a) Model RE2. Patient and session as random ef-
fects.
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(b) Model M4. Patient and session as random effects,
V˙CO2, age and weight as fixed effects.
Figure 6.6: V˙CO2 model. Random effects. Caterpillar plots to illustrate the distance, the
estimate of the coefficient of the intercept for each patient, or session, lie from the estimated
coefficient of the intercept for (a.) the empty model and (b.) the final model.
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Figure 6.7: V˙CO2 model. QQnorm of V˙CO2 model. Illustrating the actual residuals plotted
against the expected residuals if they were normally distributed. The residuals should lie along
the straight line.
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Figure 6.8: V˙CO2 model. Standardised residuals by patient.
Standardised residuals = residual/SD of all residuals. Thus illustrating how far the estimates
lie from the actual values for each patient.
8 11 12 13 16 17 18 19 20 21 22 24 27 28 30 31 32 33 34 35 37 39 40 42 49 51 52 53 78 79 88 90 91 11
0
11
1
11
3
11
6
11
7
12
2
12
3
12
7
12
8
13
2
13
4
13
5
13
7
13
8
14
4
−2
−1
0
1
2
27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27
Fitted values V⋅ O2  (mL.Kg.−1min−1)
St
an
da
rd
ise
d 
re
sid
ua
ls
Patient 101 105 106 107 108 109 111 112 114 115124 130 131 133 134 135 137 138 142
Figure 6.9: V˙CO2 model. Standardised residuals by session. Standardised residuals = resid-
ual/SD of all residuals. Thus illustrating how far the estimates lie from the actual values for
each session.
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Figure 6.10: V˙CO2 model. Exploration of standardised residuals, plotted against (a). Fitted
values, (b). RER, and the independent variables (c). weight, (d). V˙CO2 and (e). age. There
is no observable bias with the fitted values, weight or age but RER and V˙CO2 demonstrate
some bias.
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Figure 6.11: V˙CO2 model with 134 and 137 removed. QQnorm. Illustrating the actual resid-
uals plotted against the expected residuals if they were normally distributed. The residuals
should lie along the straight line.
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M4 M5
Intercept 4.886∗∗∗ 5.244∗∗∗
(0.302) (0.349)
V˙ CO2 12.818
∗∗∗ 12.753∗∗∗
(0.048) (0.047)
Weight −0.008∗ −0.010∗∗
(0.004) (0.004)
Age −0.055∗∗∗ −0.057∗∗∗
(0.002) (0.003)
AIC 14096.733 10426.050
BIC 14152.491 10481.284
Log Likelihood −7041.367 −5206.025
Num. obs. 21276 19742
Num. sessions 48 44
Num. patients 19 17
RE variance: session 0.061 0.058
RE variance: patient 0.000 0.000
Residual variance 0.112 0.098
∗∗∗p < 0.001, ∗∗p < 0.01, ∗p < 0.05
Table 6.4: V˙ CO2 model. M4 = with and M5 = without patients 134 and 137. AIC = Akaike’s
information criterion, BIC = Bayesian information criterion. RE = Random effect, refering
to the grouping structure; patient or session.
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Figure 6.12: V˙CO2 model. Simulated values and 95% confidence interval.
163
6.3.1.3 Categorising the V˙CO2 model into three and four factors
Leaving aside the sample size that the model is derived from, the clinical utility of a continu-
ous scale is limited. In practice it may be easier to work with a categorised low, medium or
high intensity paradigm. This provides a range of values that a patient should work within to
exercise at a categorised intensity.
The reference (actual) and predicted (model) V˙O2 values were classified as low (<3.5
mL.Kg.-1min-1), mid (3.5-4.4 mL.Kg.-1min-1) and high (≥4.5 mL.Kg.-1min-1) workloads (Table
6.5). A confusion matrix3 was created (Figure 6.13) and multi-group receiver operated char-
acteristic (MROC) [14] values calculated for the ability of the model to predict the actual
V˙O2 values. Similarly, this was done again, this time creating four categories, low (<3.5
mL.Kg.-1min-1), mid (3.5-4.24 mL.Kg.-1min-1), high (4.25-4.9 mL.Kg.-1min-1) and very high
(≥5 mL.Kg.-1min-1) workloads (Table 6.7).
Stratification of the V˙CO2 model into three categories (low, mid and high), has positive
predictive values (PPV) of 0.87, 0.82 and 0.86 respectively and negative predictive values
(NPV) of 0.95, 0.87 and 0.95 respectively (Table 6.6). The overall multi-class area under the
curve is 97.45%. With four categories (low, mid, high and very high), the PPV is 0.87, 0.76,
0.64 and 0.84 respectively and NPV is 0.95,0.87, 0.82 and 0.97 respectively (Table 6.8). The
multi-class area under the curve is 96.42%.
While the three category model has remarkably good predictive performance, how useful
and easy it is to use in the clinical setting remains to be investigated. The four category model,
which would probably be more useful in the clinical setting, performs well at the extremes but
less well at defining the mid-range values. The three category model is thus more accurate
than the four category model but probably has less clinical utility, as three categories would
offer limited flexibility for exercise prescription.
3Confusion matrices display the proportion of values that are categorised by the predicted class (in columns),
while each row represents the proportion in the actual class. The right diagonal represents the ideal.
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Class Category Range
(mL.Kg.-1min-1)
1 Low <3.5
2 Mid 3.5-4.4
3 High ≥4.5
Table 6.5: V˙CO2 model.
Three categories.
0.258 0.038 0
0.038 0.303 0.047
0 0.031 0.286
Lo
w
Me
diu
m
Hig
h
Lo
w
Me
diu
m
Hig
h
Predicted category
Ac
tu
al
 c
at
og
or
y
0.0
0.1
0.2
0.3
Proportion
 of values
Figure 6.13: V˙CO2 model. Confusion matrix
three categories.
Sensitivity Specificity Pos Pred Neg Pred Prevalence Detection Detection Balanced
Value Value Rate Rate Prevalence Accuracy
Low 0.87 0.95 0.87 0.95 0.30 0.26 0.30 0.91
Medium 0.78 0.89 0.82 0.87 0.39 0.30 0.37 0.83
High 0.90 0.93 0.86 0.95 0.32 0.29 0.33 0.92
Table 6.6: Performance of V˙CO2 model with three categories.
Class Category Range
(mL.Kg.-1min-1)
1 Low <3.5
2 Mid 3.5-4.24
3 High 4.25-4.9
4 Very high ≥5 mL.Kg.-1min-1
Table 6.7: V˙CO2 model. Four
categories.
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Figure 6.14: V˙CO2 model. Confusion matrix
four categories.
Sensitivity Specificity Pos Pred Neg Pred Prevalence Detection Detection Balanced
Value Value Rate Rate Prevalence Accuracy
Low 0.87 0.95 0.87 0.95 0.30 0.26 0.30 0.91
Medium 0.71 0.90 0.76 0.87 0.31 0.22 0.29 0.81
High 0.68 0.90 0.64 0.92 0.20 0.14 0.21 0.79
Very high 0.86 0.96 0.84 0.97 0.20 0.17 0.20 0.91
Table 6.8: Performance of V˙CO2 model with four categories.
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6.4 Using V˙E as estimate of V˙O2
6.4.1 V˙E model creation
Forty-four datasets from nineteen patients, with a V˙E :V˙O2 r
2 >0.45 were used to create the V˙E
model. The random effects were evaluated first. The interactions between V˙E and PETCO2
and V˙E and V˙CO2 were evaluated. This was done as there was significant collinearity between
V˙E and resting PETCO2, and between V˙E and resting V˙CO2 (Figure 6.1). All variables with
a statistically significant (p<0.05) linear association with the dependent variable (V˙O2), were
added to the model as the fixed terms. REMB is the empty model with patient and session as
random effects(Table 6.9). There was a significant interaction between V˙E and V˙CO2 (MB3d)
and between V˙E and PETCO2 (MB3b), (Table 6.10), chi-squared p<0.0001. Therefore both
were added to the model as fixed effect interaction terms (MB3e). Age and weight were added
to the model as the fixed terms (MB5c), (Table 6.11). Gender was also added as the OUES
has been demonstrated to be gender-specific [243]. However, as can be seen from Table 6.11,
gender makes little difference to this model (MB5d). Histograms of V˙E , age, V˙O2 and weight
show an essentially normal distribution (Figure 6.15).
6.4.1.1 V˙E model interpretation.
Therefore, in the final model (MB5c), for every;
• L.min-1 increase in V˙E there is a 0.54 (95% CI: 0.52-0.55) increase in V˙O2 (measured in
mL.Kg.-1min-1).
• mm Hg increase in resting PETCO2 there is a 0.08 (95% CI: 0.05-0.11) increase in V˙O2
(mL.Kg.-1min-1), for every mm Hg increase in resting PETCO2 there is a 0.01 (95%CI-
0.01 to -0.01) multiplied by V˙E (L) decrease in V˙O2.
• mL increase in resting V˙CO2, there is a 0.01 (95% CI:-0.01 to 0.02 ) increase in V˙O2
and a 0.02 (95% CI: -0.02 to -0.02) multiplied by V˙E (L) decrease in V˙O2.
• Kg increase in body mass there is a 0.02 mL.Kg.-1min-1(95% CI: -0.04-0.01) decrease in
V˙O2.
• year increase in age there is a 0.04 mL.Kg.-1min-1 (95% CI: -0.08; -0.00) decrease in
V˙O2.
Simulation (n = 50) of the V˙E model with 95% confidence intervals is given in Figure 6.21.
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REMB V˙E Age Weight
Intercept 4.32∗∗∗ 0.56∗ 7.17∗∗∗ 5.57∗∗∗
(0.17) (0.25) (0.90) (0.67)
V˙E 0.30
∗∗∗
(0.00)
Age −0.04∗∗
(0.01)
Weight −0.02·
(0.01)
AIC 39785.92 23682.97 39779.64 39784.46
BIC 39817.27 23722.16 39818.83 39823.65
Log Likelihood −19888.96 −11836.48 −19884.82 −19887.23
Num. obs. 18745 18745 18745 18745
Num. sessions 44 44 44 44
Num. patients 19 19 19 19
RE variance: session 0.24 0.12 0.24 0.24
RE variance: patient 0.42 1.15 0.23 0.34
Residual variance 0.48 0.20 0.48 0.48
∗∗∗p < 0.001, ∗∗p < 0.01, ∗p < 0.05, ·p < 0.1
Table 6.9: V˙E model. Random effects (patient and session) and univariate associations, V˙E ,
age and weight. AIC = Akaike’s information criterion, BIC = Bayesian information criterion,
RE = Random effect, refering to the grouping structure; patient or session.
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Figure 6.15: V˙E model. Histograms of dependent and independent variables and RER.
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V˙E MB3a MB3b MB3c MB3d MB3e
Intercept 0.56∗ 0.03 −2.76∗∗∗ 0.57∗ 0.58∗ −2.54∗∗∗
(0.25) (0.66) (0.70) (0.25) (0.25) (0.65)
V˙E 0.30
∗∗∗ 0.30∗∗∗ 0.52∗∗∗ 0.30∗∗∗ 0.30∗∗∗ 0.54∗∗∗
(0.00) (0.00) (0.01) (0.00) (0.00) (0.01)
Rest PETCO2 0.01 0.08
∗∗∗ 0.07∗∗∗
(0.01) (0.02) (0.01)
V˙E :Rest PETCO2 −0.01∗∗∗ −0.01∗∗∗
(0.00) (0.00)
Rest V˙ CO2 −0.23∗ −0.09 −0.04
(0.12) (0.11) (0.12)
V˙E :Rest V˙ CO2 −0.01∗∗∗ −0.02∗∗∗
(0.00) (0.00)
AIC 23682.97 23684.24 22651.78 23681.20 23641.23 22502.23
BIC 23722.16 23731.27 22706.65 23728.23 23696.10 22572.78
Log Likelihood −11836.48 −11836.12 −11318.89 −11834.60 −11813.61 −11242.12
Num. obs. 18745 18745 18745 18745 18745 18745
Num. sessions 44 44 44 44 44 44
Num. patients 19 19 19 19 19 19
RE variance: session 0.12 0.11 0.14 0.10 0.10 0.11
RE variance: patient 1.15 1.12 1.04 1.10 1.11 1.00
Residual variance 0.20 0.20 0.19 0.20 0.20 0.19
∗∗∗p < 0.001, ∗∗p < 0.01, ∗p < 0.05
Table 6.10: V˙E interaction terms. MB3a = V˙E and Rest PETCO2 as independent variables,
MB3b = V˙E and Rest PETCO2 as an interaction term, MB3c = V˙E and Rest V˙ CO2 as
independent variables, MB3d = V˙E and Rest V˙ CO2 as an interaction term, MB3e = both V˙E
and Rest PETCO2 and V˙E and Rest V˙ CO2 as interactions terms. AIC = Akaike’s information
criterion, BIC = Bayesian information criterion, RE = Random effect, refering to the grouping
structure; patient or session.
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MB3e MB5a MB5b MB5c MB5d
Intercept −2.54∗∗∗ −1.21 0.61 1.33 1.43
(0.65) (1.05) (1.51) (1.52) (1.63)
V˙E 0.54
∗∗∗ 0.54∗∗∗ 0.54∗∗∗ 0.54∗∗∗ 0.54∗∗∗
(0.01) (0.01) (0.01) (0.01) (0.01)
Rest V˙ CO2 −0.04 0.05 −0.08 0.01 0.01
(0.12) (0.13) (0.12) (0.13) (0.13)
Rest PETCO2 0.07
∗∗∗ 0.08∗∗∗ 0.07∗∗∗ 0.08∗∗∗ 0.08∗∗∗
(0.01) (0.01) (0.01) (0.01) (0.01)
V˙E :Rest V˙ CO2 −0.02∗∗∗ −0.02∗∗∗ −0.02∗∗∗ −0.02∗∗∗ −0.02∗∗∗
(0.00) (0.00) (0.00) (0.00) (0.00)
V˙E :Rest PETCO2 −0.01∗∗∗ −0.01∗∗∗ −0.01∗∗∗ −0.01∗∗∗ −0.01∗∗∗
(0.00) (0.00) (0.00) (0.00) (0.00)
Weight −0.02 −0.02 −0.02
(0.01) (0.01) (0.01)
Age −0.05∗ −0.04∗ −0.04∗
(0.02) (0.02) (0.02)
Gender −0.07
(0.42)
AIC 22502.23 22501.80 22499.38 22499.41 22501.38
BIC 22572.78 22580.19 22577.77 22585.63 22595.44
Log Likelihood −11242.12 −11240.90 −11239.69 −11238.70 −11238.69
Num. obs. 18745 18745 18745 18745 18745
Num. sessions 44 44 44 44 44
Num. patients 19 19 19 19 19
RE variance: session 0.11 0.11 0.11 0.11 0.11
RE variance: patient 1.00 0.82 0.76 0.66 0.66
Residual variance 0.19 0.19 0.19 0.19 0.19
∗∗∗p < 0.001, ∗∗p < 0.01, ∗p < 0.05
Table 6.11: V˙E model. Fixed effects, age, weight. AIC = Akaike’s information criterion, BIC
= Bayesian information criterion, RE = Random effect, refering to the grouping structure;
patient or session.
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(a) Random effects only (Patient and session)
Patient
142
106
101
114
124
105
115
109
107
138
130
135
108
137
112
111
133
134
131
−2 −1 0 1
(Intercept)
Session
20
32
33
123
19
91
138
144
132
27
8
42
13
40
53
135
51
128
78
90
22
113
49
134
116
52
34
11
111
37
117
31
127
79
28
39
21
17
88
137
35
122
30
110
−1.0 −0.5 0.0 0.5 1.0
(Intercept)
St
an
da
rd
 n
or
m
a
l q
ua
nt
ile
s
−2
−1
0
1
2
−2 0 1
(Intercept)
St
an
da
rd
 n
or
m
a
l q
ua
nt
ile
s
−2
−1
0
1
2
−1.0 0.0 0.5 1.0
(Intercept)
(b) Impact of V˙E , weight, age, V˙CO2 and PETCO2
on the random effects.
Figure 6.16: V˙E model. Random effects. Caterpillar plots to illustrate the distance, the
estimate of the coefficient of the intercept for each patient, or session, lie from the estimated
coefficient of the intercept for (a.) the empty model and (b.) the final model.
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Figure 6.17: V˙E model. QQnorm. Illustrating the actual residuals plotted against the expec-
ted residuals if they were normally distributed. The residuals should lie along the straight
line.
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Figure 6.18: V˙E model. Residuals grouped by patient. Standardised residuals by session.
Standardised residuals = residual/SD of all residuals. Thus illustrating how far the estimates
lie from the actual values for each patient.
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Figure 6.19: V˙E model. Residuals grouped by session. Residuals grouped by patient. Stand-
ardised residuals by session. Standardised residuals = residual/SD of all residuals. Thus
illustrating how far the estimates lie from the actual values for each session.
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Figure 6.20: V˙E model. Exploration of standardised residuals by (a). fitted values, (b).RER,
and the independent variables (c). V˙E , (d). weight, (e). PETCO2, (f). age, and (g). V˙CO2.
There is no observable bias with the fitted values, weight, V˙E or age but RER demonstrates
bias.
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Figure 6.21: V˙E model. Simulation of values and 95% confidence interval.
6.4.1.2 Categorising V˙E model into three and four factors.
Reference (actual) and predicted (from the model) V˙O2 mL.Kg.
-1min-1 values were classified
as low (<3.5 mL.Kg.-1min-1), mid (3.5-4.4 mL.Kg.-1min-1) and high (≥4.5 mL.Kg.-1min-1)
(Table 6.12 ). Confusion matrices were again created (Figure 6.22 ) and multi-group ROC
values calculated for the ability of the model to predict the actual V˙O2 values. The same
was then done this time creating four categories low (<3.5 mL.Kg.-1min-1), mid (3.5-4.24
mL.Kg.-1min-1) and high (4.25-4.9 mL.Kg.-1min-1) and very high (≥5 mL.Kg.-1min-1), (Table
6.14 ).
The stratification of the V˙E model into three categories (low, mid and high), has positive
predictive values (PPV) of 0.83, 0.74 and 0.84 respectively and negative predictive values
(NPV) 0.92, 0.83 and 0.94 respectively (Table 6.13 ). The overall multi-class area under the
curve is 95.22%. With four categories (low, mid, high and very high), the PPV’s were 0.83,
0.74, 0.60 and 0.77 respectively and NPV’s 0.92, 0.83, 0.92 and 0.96 respectively (Table 6.15 ).
The multi-class area under the curve is 94.83%.
6.5 Summary
Both models to produce relatively similar performance statistics when categorised into three
levels. The MROC for the V˙CO2 model 97.45% vs. V˙E model 95.22% and more usefully into
four categories. 96.42% vs. 94.83% respectively.
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Class Category Range
(mL.Kg.-1min-1)
1 Low <3.5
2 Mid 3.5-4.4
3 High ≥4.5
Table 6.12: V˙E model. Three
categories.
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Figure 6.22: V˙E model. Confusion matrix
three categories.
Sensitivity Specificity Pos Pred Neg Pred Prevalence Detection Detection Balanced
Value Value Rate Rate Prevalence Accuracy
Low 0.79 0.93 0.83 0.92 0.29 0.23 0.27 0.86
Medium 0.74 0.83 0.74 0.83 0.40 0.29 0.39 0.78
High 0.87 0.91 0.82 0.94 0.32 0.27 0.33 0.89
Table 6.13: Performance of V˙E model with three categories.
Class Category Range
(mL.Kg.-1min-1)
1 Low <3.5
2 Mid 3.5-4.24
3 High 4.25-4.9
4 Very high ≥5 mL.Kg.-1min-1
Table 6.14: V˙E model. Four cat-
egories.
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Figure 6.23: V˙E model. Confusion matrix four
categories.
Sensitivity Specificity Pos Pred Neg Pred Prevalence Detection Detection Balanced
Value Value Rate Rate Prevalence Accuracy
Low 0.79 0.93 0.83 0.92 0.29 0.23 0.27 0.86
Medium 0.74 0.83 0.74 0.83 0.40 0.29 0.39 0.78
High 0.69 0.88 0.60 0.92 0.20 0.14 0.24 0.79
Very high 0.65 0.97 0.77 0.96 0.11 0.07 0.10 0.81
Table 6.15: Performance of V˙E model with four categories.
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6.6 Pilot validation sample
The model will obviously perform well when using its own data. While there is little utility in
running a model created from such a small data set, I was curious to see how it would perform.
I thus had a preliminary look at the performance of the two models, acknowledging that the
original model data set is too small to use for anything other than hypothesis generation. The
validation sample is an unusual collection of patients, which may render the sample clinically,
if not statistically different from the model sample. This sample comprises of patients for
whom there was only one test. Therefore they are either patients at the end of their ICU
admission, or patients who had one test and then became too unwell to continue with further
rehabilitation, or in whom other tests had unphysiological RER or VE: V˙O2 r
2 values that
had to be excluded.
Data from 12 patients with mean RER <1.1 (V˙CO2 model) or a V˙E : V˙O2 r
2≥0.45 (V˙E
model) were entered into the previously generated models. M4 = V˙CO2, age and weight.
MB5c = V˙E :Rest V˙CO2, V˙E :PETCO2, age and weight and V˙O2 (mL.Kg.
-1min-1) predictions
calculated. Residuals were plotted and the data re-categorised into three categories. The
MROC values and performance statistics were then calculated.
As can be seen from Figure 6.24 the standardised residuals for the V˙CO2 model validation
sample are greater than for the original sample. The V˙CO2 model tends to over estimate
the sample values. This is highlighted by the confusion matrix (Figure 6.28), where a greater
proportion of actual low level activities are predicted as medium level rather than low level
and a greater proportion of medium level as high level. The PPV’s for the low and medium
activities are less than 0.48 (Table 6.16).
From Figure 6.26 it can be seen that the standardised residuals in V˙E model validation
sample are considerable, with the bias possibly related to the V˙E values (Figure 6.27c). The
model is over-predicting for medium and low V˙E values (Figure 6.29 ). The NPV’s are similar
to the V˙CO2 model but both low- and medium-level activity PPV’s are less than 0.5 (Table
6.17).
6.6.1 Summary
The residuals of both models are large. This is unsurprising given the limited numbers in
the model creation. However, both models warrant further investigation to establish if this
is due to a non-linear relationship between the dependent and independent variables. Per-
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Figure 6.24: V˙CO2 model validation sample, standardised residuals for each patient.
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Figure 6.25: Exploration of standardised residuals of V˙CO2 validation model,standardised
residuals plotted against (a). Fitted values, (b). RER, and the independent variables (c).
weight, (d). V˙CO2 and (e). age.
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Figure 6.26: V˙E model validation sample. Residuals by patient.
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Figure 6.27: V˙E model validation sample. Standardised residuals by (a). fitted values,
(b).RER, and the independent variables (c). V˙E , (d). weight, (e). PETCO2, (f). age,
and (g). V˙CO2
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Figure 6.28: Confusion matrix V˙CO2 model
in validation sample with three categories.
Sensitivity Specificity Pos Pred Neg Pred Prevalence Detection Detection Balanced
Value Value Rate Rate Prevalence Accuracy
Low 0.22 0.94 0.49 0.83 0.20 0.04 0.09 0.58
Medium 0.39 0.70 0.46 0.64 0.39 0.15 0.34 0.55
High 0.79 0.57 0.56 0.80 0.41 0.32 0.57 0.68
Table 6.16: Performance of V˙CO2 model in validation sample with three categories.
0.061 0.106 0.044
0.052 0.166 0.183
0.027 0.073 0.288
Lo
w
Me
diu
m
Hig
h
Lo
w
Me
diu
m
Hig
h
Predicted category
Ac
tu
al
 c
at
og
or
y
0.1
0.2
Proportion
 of values
Figure 6.29: V˙E model in validation sample,
confusion matrix with three categories.
Sensitivity Specificity Pos Pred Neg Pred Prevalence Detection Detection Balanced
Value Value Rate Rate Prevalence Accuracy
Low 0.29 0.90 0.44 0.83 0.21 0.06 0.14 0.59
Medium 0.41 0.70 0.48 0.64 0.40 0.17 0.35 0.56
High 0.74 0.63 0.56 0.79 0.39 0.29 0.51 0.69
Table 6.17: Performance of V˙E model in validation sample with three categories.
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haps a non-linear multilevel model should be used, or some other form of transformation will
be required. There were no statistically significant differences between patients in terms of
age, gender, weight, duration of mechanical ventilation at enrolment, days to liberations or
survival. However, the validation group were recruited slightly later in their ICU admissions
and a greater proportion of them survive their admission to ICU. The mean resting PETCO2,
resting V˙CO2, V˙E , V˙CO2 and V˙O2 values are all statistically different between the validation
and model samples. This will have influenced how the model fits the new data.
Sample Model Validation
n 19 13
Gender % male 53 46
% Survived 74 92
Mean SD Mean SD
Age 67.80 10.92 62.14 14.14
Weight 74.05 18.53 64.69 18.38
MV prior to enrolment 32.63 21.26 39.69 41.79
Days to liberation 55.95 35.75 55.38 63.34
Worst SOFA 8.58 3.11 9.54 3.28
MV = mechanical ventilation.
Table 6.18: Patient level variables
Sample Model Validation
n 21276 5534
Mean SD Mean SD
V˙CO2 308.31 83.77 273.65 63.79
Rest V˙CO2 246.96 65.04 209.84 45.72
Rest PETCO2 41.23 9.70 40.39 8.85
V˙E 12.79 3.32 11.82 3.31
V˙O2 4.13 1.07 4.32 1.00
Table 6.19: Session level variables.
6.6.2 Conclusion
Proxy values for V˙O2 can be generated from 2 models, one using V˙CO2 and the other using
V˙E . Both produce similar performance statistics when V˙O2 is categorised into three levels;
low, medium and high intensity. Categorising V˙O2 into four levels; low, medium, high and
very high, which probably has greater clinical utility, performs less well. When the models
are used to categorise a new set of data, the residuals of both models are large. Nevertheless,
given the limited numbers of subjects used for the model creation, both models are worthy of
further investigation.
Chapter 7
Summary and future work
Physical function deficits following an ICU admission are the result of a complex interaction
of critical illness, its consequent treatments, and bed rest on cardiac, respiratory, neurological
and neuromuscular function. Despite the lack of an adequate theoretical framework on which
to base rehabilitation strategies, exercise is widely “prescribed” to ameliorate these effects.
However, without a method to quantify exercise intensity in patients rehabilitating in the
ICU, there is no way of ensuring that some patients are not over-trained while others remain
under-trained. Similarly, we do not have a reliable way of establishing if patients enrolled in
an interventional limb of a rehabilitation study receive a significantly different exercise load
to those randomised to the control group.
The aim of my thesis was to establish a method of quantifying rehabilitation interventions
in mechanically ventilated patients with, and recovering from, critical illness (Table 7.1). I
have identified two potential methods, both of which require further validation. Breath-by-
breath gas exchange analysis is a useful but impractical tool in the ICU setting. While it
provides valuable information regarding the patient’s oxygen consumption, both at rest for
titration of nutritional requirements and during rehabilitation to monitor absolute exercise
intensity, the limited number of interpretable tests obtained during rehabilitation precludes
its use as a clinical tool.
BBGEA devices have been designed for use in athletes who generate a far higher minute
ventilation than patients. Therefore, the previously accepted inherent errors with the tech-
nique become magnified when transferred to an ICU patient population. Unfortunately, man-
ufacturers have failed to take this into account when adapting the technology to the critical
care setting. For such devices to be useful, industry needs to work with clinicians to create
a device that is portable, quick to set up and calibrate, is not influenced by flow-by circuits,
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Objective Comment Chapter
1. To validate a medical device to measure oxygen
consumption in mechanically ventilated patients.
Accomplished 4.5
2. To develop a
standardised,
reproducible
exercise stimulus.
a. Establish the feasibility
of BBGEA in MV patients
during rehabilitation.
b. Evaluate the
feasibility of arm cycle
ergometery in MV patients.
Sequential constant
load arm ergometry
tests identified as a
potential way to
measure anaerobic
threshold.
5.5
5.6
3. To identify a method of quantifying
rehabilitation interventions.
Two Methods
identified.
6.2
4. To validate the measurement tool. Partly accomplished.
Further work required.
6.5
MV = mechanically ventilated, BBGEA = Breath by breath gas exchange analysis.
Table 7.1: Thesis objectives and outputs.
does not get blocked by sputum, and whose precision remains unaffected at low levels of V˙O2
in the presence of an increased inspired oxygen concentration. However, given that the most
frequent source of error was the instability of the inspired oxygen concentration generated
by the ventilator, such a device would ideally be integrated into the ventilator itself, in con-
junction with improvements in the regulation of the delivered oxygen concentration. While
an error of 2-7% is accepted as a reasonable fluctuation in the delivery of oxygen in clinical
practice, this is not acceptable for most BBGEA devices. The accuracy of the MGU reported
here must be interpreted within the context of the limitations in the accuracy of the reference
devices (see Chapter 4).
7.1 Key outputs
Breath-by-breath-gas exchange analysis is a challenging technique during resting metabolic
studies, and one that becomes increasingly more challenging when patients begin to exercise.
Partly because of an increased cough frequency due to mobilisation of secretions, but also
as inspiratory flow rates become more erratic, the instability of the delivered FiO2 increases,
rendering some of the tests unusable. Therefore, the time-consuming nature of the technique
and the proportion of unusable data sets result in a technique that has little day-to-day utility.
From a research perspective, documentation of the session, monitoring the running of the MGU
device, and blood sampling were infeasible for one person alone. Despite these challenges, it
was still possible to identify several factors that are relevant to clinical rehabilitation practice
within the ICU.
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V˙O2 is not activity dependent. The V˙O2 of rehabilitation activities is not consistent
between patients, or indeed within patients when measured over time (see Chapter 5). Patients
with lower physical function levels (as measured by the ICU-FSS) utilise less oxygen than those
with higher physical function levels. Therefore, one cannot assume that the same rehabilitation
activity has the same oxygen cost for each patient. However, given the small numbers of
patients this study is based upon, further investigation is warranted. Especially as it raises the
question of why patients with lower functional capacity utilise less oxygen. Functional capacity
assessments evaluate limitations in activities and therefore takes into account a multitude of
both physical and psychological impairments. In the absence of contemporaneous lactate
measurements, it is impossible to begin to speculate on the point of limitation in the oxygen
consumption chain. Possibilities include decreased gas exchange, reduced cardiac output and
oxygen delivery to the exercising muscles, reduced muscle mass, more readily fatigable muscle,
and/or a bioenergetics-metabolic failure.
Pressure support. The regression analysis in Chapter 5 highlighted pressure support as a
variable that was associated with an increase in the oxygen consumed during a rehabilitation
session. How this occurs is difficult to pinpoint given the available data, but it could be due
to patients being able to exercise for longer if their breathing is oﬄoaded. Alternatively the
rate-limiting step in the ability to consume oxygen is related to lung mechanics and/or cardiac
function. This effect could be explored by repeating the same activity at different levels of
ventilatory support with concurrent lactate measurements.
Patient efficiency compared to healthy individuals. The decrease in patient efficiency
was almost, but not entirely, explained by the length of time to carry out an activity. One
hypothesis for the discrepancy could be the selective type I fibre atrophy seen in patients
with ICUAW, the bioenergetic consequences of which would be a reduction in V˙O2 for a
given workload, similar to that seen in COPD patients. To investigate this, the same activity
would ideally be repeated on different days, with comparison to an age- and gender-matched
population. Unfortunately, given the nature of rehabilitation in the ICU, i.e. the very low
exercise tolerance patients experience, those who can sit do not necessarily want to practice
sitting as they want to progress to standing and walking and not waste time and energy
repeating an activity they can already perform.
Heart rate. My original conjecture that heart rate would not be a useful indicator of exercise
intensity was well founded. None of the heart rate indicators used in my regression analysis had
univariate or multivariate associations with V˙O2. A large proportion of the patients enrolled
were receiving heart rate-limiting drugs. Indeed, their heart rate responses were similar to
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those reported in the free living population receiving such drugs. This reinforces my view that
HR indices are not useful in this population.
Heart rate variability. Heart rate variability measurement in the ICU setting is not readily
possible given the hardware currently available.
Sample size calculations. Sufficient data have been collected to enable me to make reas-
onable assumptions regarding sample size calculations for future studies involving V˙O2 meas-
urements during rehabilitation in mechanically ventilated patients.
Rate of percieved exertion. Accurate and repeatable reports of patient RPE were not
possible in this particular patient group.
Arm cycle ergometery as a standardised exercise test. Early on, it became apparent
to me that incremental arm cycle ergometry was non-feasible in this cohort of patients. How-
ever, it may be possible to identify AT through a series of constant load ergometery tests. To
generate comparable workloads both between and within patients, a consistent pedal frequency
(RPM) needs to be generated on the ergometer. At lower RPMs the work rate increases due
to the need to overcome the inertia of the ergometer. This issue is not unique to this study.
Ideally, a cycle ergometry device that could be used while the patient remained in bed, had a
powered fly-wheel to ensure accurate unloaded pedaling, was accurate at low RPMs, and that
could be either arm- or leg-propelled would be used.
Data from the cycle ergometry study provide a means of identifying those patients who
would be able to cycle the requisite three minutes. Although this would only capture patients
at the more physically able end of the spectrum in the ICU, it could establish the extent of their
deconditioning. This would provide a way of measuring exercise capacity that is comparable
both between and within patients over time, albeit in a subset of the ICU rehabilitation
population. Again, these V˙O2 data would need to be corroborated with lactate data.
V˙E as an indicator of V˙O2 returning to baseline. The return of V˙E to baseline is
indicative of V˙O2 returning to baseline. This is a very simple and easy way to establish
recovery from exercise bouts during rehabilitation.
Estimation of V˙O2 from V˙E or V˙CO2. The interpretation of the models for V˙E and
V˙CO2 estimation of V˙O2 are limited purely to exploration of the variables that might influ-
ence either model. This is due to the limited number of patients that the models are based
upon. From the data acquired from this study, a sample size of at least 60 patients would
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be required to establish clinical equivalence with 90% power, where equivalence is achieved
if a 95% confidence interval for the difference in the actual and predicted values is wholly
contained within ± 1 ml.Kg.-1min.-1 (25% limits, based on 4.5 ml.Kg.-1min.-1 V˙O2).
7.1.1 Limitations
7.1.1.1 MGU validation study
The validation study was based on a relatively small sample size. The inaccuracy of the
reference techniques also needs to be acknowledged. There are multiple potential sources of
error in the Douglas bag technique as well as multiple conversion of gas properties. As much
as possible was done to minimise the potential errors in the Douglas bag technique using
correction factors and pre-validation calibration. Two blood gas analysis machines were used
as one broke part way through the study, although calibration equations were performed for
both devices.
7.1.1.2 Rehabilitation studies
The sample size recruited was small but probably reflected the ICU rehabilitation population
at UCH. A large proportion of the data was not interpretable; is not possible to establish
whether this introduced any bias into the results. The high RER values are concerning, but
are likely explained by patients hyperventilating in anticipation of their rehabilitation session.
The repeatability of the tests within patients was not established. There were insufficient
repeated tests over time to establish wether the regression model was influenced by time.
7.1.2 Issues that require further investigation.
1. To what extent is the hyperbolic nature of RER during exercise influencing the non-linear
relationship between V˙O2 and V˙CO2?
2. Is it possible to transform the data to linearise this relationship, or is it possible to use
a non-linear-mixed-effects model?
3. Is the non-linear relationship between V˙O2 and V˙CO2 and between V˙O2 and V˙E due in
part to patients exercising above their AT?
4. Does the relationship between V˙O2 and V˙CO2 and between V˙O2 and V˙E change over
the course of a patient’s admission?
The huge variations in the exercise load of rehabilitation interventions between and within
patients highlights the need to establish personalised exercise regimens.
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Appendix A
MGU validation
A.1 GESV values for the 13 tests.
Test bpm VT Flow Gas Expected Actual % error
1 10 1 20 CO2 0.3 0.312 -4.00
6 20 0.5 20 CO2 1.694 1.597 5.73
6 20 0.5 20 O2 1.708 1.629 4.63
7 10 0.5 40 CO2 0.3 0.292 2.67
7 10 0.5 40 O2 0.303 0.29 4.29
8 40 0.5 40 CO2 2.834 2.674 5.65
8 40 0.5 40 O2 2.857 2.84 0.60
9 40 0.5 40 CO2 1.694 1.613 4.78
9 40 0.5 40 O2 1.708 1.756 -2.81
10 40 0.5 40 CO2 2.834 2.472 12.77
10 40 0.5 40 O2 2.857 2.669 6.58
11 40 0.5 40 CO2 1.69 1.642 2.84
11 40 0.5 40 O2 1.715 1.774 -3.44
1 10 1 20 O2 0.303 0.282 6.93
3 10 1 20 CO2 0.299 0.326 -9.03
3 10 1 20 O2 0.304 0.331 -8.88
2 20 1.5 60 CO2 1.694 1.684 0.59
2 20 1.5 60 O2 1.708 1.559 8.72
4 20 1.5 60 CO2 1.689 1.474 12.73
4 20 1.5 60 O2 1.713 1.573 8.17
5 40 1.5 120 CO2 2.825 2.54 10.09
Continued on the next page...
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Test bpm VT Flow Gas Expected Actual % error
5 40 1.5 120 O2 2.867 2.816 1.78
12 40 1 80 CO2 1.689 1.554 7.99
12 40 1 80 O2 1.713 1.589 7.24
13 40 1 80 CO2 2.825 2.558 9.45
13 40 1 80 O2 2.867 2.774 3.24
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A.2 Deltatrac II flow and RQ calibration V˙CO2 values.
Flow setting (L.min-1) RQ
Min 41.5 32.8 30.7 32.7 36.9 40.1 30.5 33.1 36.3
1 612 386 398 137 405 385 384 77 83
2 549 399 380 385 394 423 376 87 102
3 524 377 354 360 358 421 357 85 98
4 524 382 340 335 358 412 334 91 104
5 486 380 317 295 366 395 321 100 109
6 460 358 325 314 352 382 316 103 108
7 450 413 308 299 353 369 320 103 108
8 415 362 330 312 343 400 313 104 104
9 400 340 288 322 352 390 310 103 98
10 400 342 301 313 237 367 295 102 96
11 10 340 248 312 376 141 98 92
12 380 60 96 87
13 317 92 83
14 89 80
15 84 77
16 82 72
17 78 68
18 74 66
19 71 63
20 67 62
21 62 59
22 60 57
23 57 56
24 57 56
25 51 56
26 50 54
27 50 51
28 49 52
29 46 50
30 48 52
31 46 53
32 45 50
Continued on the next page...
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Flow setting (L.min-1) RQ
Min 41.5 32.8 30.7 32.7 36.9 40.1 30.5 33.1 36.3
33 45 50 0.66
34 45 48 0.66
35 30 48 0.67
36 42 48 0.66
37 42 48 0.66
38 42 47 0.65
39 42 48 0.68
40 39 47 0.66
41 40 46 0.66
42 39 46 0.66
43 39 48 0.63
44 40 45 0.66
45 25 47 0.66
46 39 45 0.66
47 40 46 0.66
48 38 46 0.66
49 38 45 0.66
50 37 45 0.65
51 38 44 0.66
52 38 4 0.66
53 38 44 0.66
54 36 43 0.65
55 38 45 0.66
56 37 44 0.66
57 38 43 0.66
58 36 42 0.75
59 38 42 0.68
60 37 43 0.71
61 41 0.72
Sum 4830 4079 3589 3384 3518 5017 3527 3483 3684
Correction 0.79 0.94 1.06 1.13 1.09 0.76 1.08 1.1 1.04
New flow 32.8 30.7 32.7 36.9 40.1 30.5 33.1 36.3 37.6 0.67
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A.3 Douglas bag calculations
A.3.1 V˙O2,V˙CO2, and REE calculations NOT accounting for flow-by.
Abbreviation Explanation
TET /TTOT Ratio of expiratory time to total breath-cycle time
VE Volume of gas collected in PVC collection bag
O2(E) Expired oxygen
VI Volume inspired
pH2O Water vapour pressure
FIO2 Inspired oxygen concentration
pH20 partial pressure of water
ST Standard temperature
BT Body temperature
AP Atmospheric pressure
SP Standard pressure
V˙ O2 (ATPS) = (V˙I ∗ FIO2)− (V˙E ∗ FEO2) (A.1)
Where
VI = V˙E ∗
(
1− FdbO2 − FdbCO2
1− FiO2
)

where
V˙E = V˙db
FECO2 = FdbCO2
FEO2 = FdbO2
Therefore
V˙ O2 =
(
V˙db ∗
(
1− FdbO2 − FdbCO2
1− FiO2
)
∗ FIO2
)
−
(
V˙db ∗ FdbO2
)
(A.2)
V˙ CO2 (ATPS) = V˙db ∗ FdbCO2 (A.3)
Conversion of ATPS to STDP (A.4)
V˙E (STPD) = V˙E (ATPS) ∗ ST
ST +BT
∗ AP − Inspiratory pH20 100 %RH
SP
REE = 1.44 ∗
(
3.9 ∗ V˙ O2 + 1.1 ∗ V˙ CO2
){
Weir equation (A.5)
216
A.3.2 V˙O2,V˙CO2, and REE calculations accounting for flow-by.
V˙ O2 (ATPS) = (V˙I ∗ FIO2)− (V˙E ∗ FEO2) (A.6)
V˙I = V˙E · (1− FECO2 − FEO2)
1− FiO2

Where
V˙E = V˙db − V˙fb
FEO2 =
(V˙db∗FdbO2)−(V˙fb∗FIO2)
V˙E
or
FEO2 =
(V˙db∗FdbO2)−(V˙fb∗FIO2)
V˙db−V˙fb
FECO2 =
(V˙db∗FdbCO2)
V˙E
FECO2 =
(V˙db∗FdbCO2)
V˙db−V˙fb
Substituting
V˙I = (V˙db − V˙fb) ∗
(
1−
(
(V˙db∗FdbO2)−(V˙fb∗FIO2)
V˙db−V˙fb
)
−
(
(V˙db∗FdbCO2)
V˙db−V˙fb
))
1− FIO2 (A.7)
Therefore
V˙ O2 (ATPS) = (A.8)(V˙db − V˙fb) ∗
(
1−
(
(V˙db∗FdbO2)−(V˙fb∗FIO2)
V˙db−V˙fb
)
−
(
(V˙db∗FdbCO2)
V˙db−V˙fb
))
1− FIO2 ∗ FIO2
−
(
(V˙db − V˙fb) ∗ (V˙db ∗ FdbO2)− (V˙fb ∗ FIO2)
V˙db − V˙fb
)
V˙ CO2 (ATPS) = V˙E ∗ FECO2
 WhereFECO2 = V˙db∗FdbCO2V˙db−V˙fb
Conversion of ATPS to STDP (A.9)
V˙E (STPD) = V˙E (ATPS) ∗ ST
ST +BT
∗ AP − Inspiratory pH20 100 %RH
SP
(A.10)
REE = 1.44 ∗
(
3.9 ∗ V˙ O2 + 1.1 ∗ V˙ CO2
){
Weir equation (A.11)
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A.3.3 Douglas bag calculations explanation.
A
Flow-by gas volume 2 L.min-1 of
the patients FiO2 is added for
the duration of expiration
TET/TTOT ∗ 2
B
Correction of V˙E for flow-by gas
volume
VE −A
C
Conversion of partial pressure of
O2 (Kpa) to % accounting for the
30 %RH (HME) and 100% RH
(Fisher Paykel) of the sample
FEO2
Ambientpressure−pH2O ∗ 100
D
Calibration factor for O2 elec-
trode of gas machine
y = 1.0403x + 0.6966 (ABL725)
y = 1.0346x + 0.9634 (ABL 835)
E Correction for flow-by (O2 )
(D∗VE)−(A∗FIO2)
B
F
Conversion of gas meter CO2
Kpa to % accounting for 30% RH
(HME) and 100% RH (Fisher
Paykel) of the sample.
FECO2
Ambientpressure−pH2O ∗ 100
G
Calibration factor for CO2 elec-
trode of gas machine.
y = 1.1264x - 0.107 (ABL725)
y = 1.1205x - 0.1584 (ABL835)
H Correction for flow-by (CO2)
(G∗VE)
B
I
Calculation of V˙I (ATPS) from
V˙E (ATPS) (B)
V˙E (ATPS)*
(1−FEO2−FECO2)
1−FIO2 Or B*
(1−E−H)
(1−FIO2)
J
Conversion of V˙I (ATPS)(I) to
V˙I (STPD)
V˙I (ATPS) ∗ STST+BT ∗ AP−Inspiratory pH20 100 %RHSP
K
Conversion of V˙E (ATPS) to
V˙E (STPD) (Oxygen consump-
tion only), where V˙E (ATPS)
V˙E (ATPS) ∗ STST+BT ∗ AP−Inspiratory pH20 100 %RHSP
L
Conversion of V˙E (ATPS) (B) to
V˙E (STPD) (CO2 only) where
V˙E (ATPS) = V˙E uncorrected for
flow-by (X)
V˙E (ATPS) ∗ STST+BT ∗ AP−Inspiratory pH20 100 %RHSP
M VO2 =((J ∗ FiO2)− (K ∗E)) ∗ 1000
N VCO2=(L*G)*1000
O RQ V CO2V O2
P REE Weir equation 1.44 ∗
(
3.9 ∗ V˙ O2 + 1.1 ∗ V˙ CO2
)
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A.4 Example Douglas bag calculation sheet.
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A.5 Bland Altman percentage difference plots
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Figure A.1: Bland Altman analysis plotted as percentage difference. V˙O2, V˙CO2 and REE.
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Appendix B
Quantifying exercise intensity in
ICU, protocol information
B.1 Screening patients prior to exercise
1. No drugs supporting blood pressure e.g., epinephrine, norepinephrine.
2. Resting HR <110 but >60 bpm.
3. No hypertension at rest (>180 mm Hg systolic or >120 mm Hg diastolic).
4. No syncope, multi-focal premature ventricular contractions, or high-degree atrio-ventricular
block.
5. FiO2 <0.6
6. P:F ratio >20
7. Hb >70 g/L
B.2 Indications for termination of rehabilitation sessions.
1. Chest pain suggestive of ischaemia.
2. Ischaemic ECG changes
3. Complex ectopy, second or third degree heart block
4. Fall in systolic pressure >20 mmHg from the highest value during the test
5. Hypertension (>200 mmHg systolic; >120 mmHg diastolic)
6. Severe desaturation: SaO2 <85%
7. Sudden pallor
8. Loss of coordination
9. Mental confusion
10. Dizziness or faintness
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B.3 ICU Functional Status Score
Rolling, Supine to sit, Sitting, Sit to stand, and Ambulation are scored as Table B.1.
Score Description
0 = unable to perform
1 = total assistance (subject 0%)
2 = maximum assistance (subject 25% +)
3 = moderate assistance (subject 50% +)
4 = minimum assistance (subject 75% +)
5 = supervision
6 = modified independence (requires assistive device)
7 = complete independence
Table B.1: ICU-FSS
General Practice Physical Activity Questionnaire
Date………………………
Name……………………..
1.
Please 
mark one 
box only
a
b
c
d
e
2. During the last week , how many hours did you spend on each of the following activities?
Please answer whether you are in employment or not
           
None Some but 
less than 
1 hour
1 hour but 
less than 
3 hours
3 hours or 
more
a
Physical exercise such as swimming, 
jogging, aerobics, football, tennis, gym 
workout etc.
b Cycling, including cycling to work and during leisure time
c Walking, including walking to work, shopping, for pleasure etc.
d Housework/Childcare
e Gardening/DIY
3. How would you describe your usual walking pace?  Please mark one box only.
Slow pace
(i.e. less than 3 mph)
Brisk pace
Steady average pace
Fast pace
(i.e. over 4mph)
I spend most of my time at work standing or walking. However, my work does 
not require much intense physical effort (e.g. shop assistant, hairdresser, 
security guard, childminder, etc.)
My work involves definite physical effort including handling of heavy objects and 
use of tools (e.g. plumber, electrician, carpenter, cleaner, hospital nurse, 
gardener, postal delivery workers etc.) 
My work involves vigorous physical activity including handling of very heavy 
objects (e.g. scaffolder, construction worker, refuse collector, etc.)
 Please mark one box only on each row
Please tell us the type and amount of physical activity involved in your work. 
I am not in employment (e.g. retired, retired for health reasons, unemployed, full-
time carer etc.)
I spend most of my time at work sitting (such as in an office)
223
B.4 General practice physical activity questionaire
	  
	  
Intensive	  Care	  Unit	  3rd	  floor	  University	  College	  Hospital	  235	  Euston	  Road	  
London   
NW1 2BU  
Telephone:	  020	  7380	  9012	  
Fax:	  020	  7691	  5732	  	  
Borg Rate of Perceived Exertion 
6 
7  Very, very light 
8 
9  Very light 
10 
11  Fairly light 
12 
13  Somewhat hard 
14 
15  Hard 
16 
19  Very very hard 
20 
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B.5 Borg RPE scale
Dynamic calibration
Model: 839 E Comments
Date: 2011-06-21
Serial number: Prod.bike
Executed by: AKV
Cycle constant: 1.05
Speed: 33 rpm
Min error ± 5 W
Max error ± 5 %
Force unit
W 1 2 3 4 5 6 7 8 9 10
0 4 3.5 3.5 3.5 3.5 3.5
5 4.2 3.7 3.5 3.5 3.5 3.5
10 7 7 7 7 7 7
15 12.3 12.2 12.2 12.2 12.2 12.2
25 23.7 22.8 22.8 22.8 22.8 22.8
50 51.9 51.9 51.3 51.9 51.9 52.8
70 74.5 75.2 75.3 74.6 74.9 75.3
30 31.7 31.3 31.7 31.7 31.7 31.7
0 3.5 3.5 3.5 3.5 3.5 3.5
Calibrator is calibrated daily before use
W set on 
bike
Aimed 
calibrator 
value W
Max error 
limit W
Min error 
limit W Average W
Average 
error W
Lowest 
reading W
Max error 
below W
Highest 
reading W
Max error 
above W
Average 
error %
0.0 0.0 5.0 -5.0 4 3.6 3.5 3.5 4 4.0 <Wmin
5.0 5.3 5.0 -5.0 4 -1.6 3.5 -1.8 4.2 -1.1 <Wmin
10.0 10.5 5.0 -5.0 7 -3.5 7 -3.5 7 -3.5 <Wmin
15.0 15.8 5.0 -5.0 12 -3.5 12.2 -3.6 12.3 -3.5 <Wmin
25.0 26.3 5.0 -5.0 23 -3.3 22.8 -3.5 23.7 -2.6 <Wmin
50.0 52.5 5.0 -5.0 52 -0.6 51.3 -1.2 52.8 0.3 <Wmin
70.0 73.5 5.0 -5.0 75 1.5 74.5 1.0 75.3 1.8 <Wmin
30.0 31.5 5.0 -5.0 32 0.1 31.3 -0.2 31.7 0.2 <Wmin
0.0 0.0 5.0 -5.0 4 3.5 3.5 3.5 3.5 3.5 <Wmin
Read values from calibrator (up to ten runs) W
Values from table aboveCalculated values
Production bike, no serial number. 
Stable rpm-value is obtained at 33 rpm.
Stable Watt-value is obtained at 31 rpm
0.0 5.0 10.0 15.0 25.0 50.0 70.0 30.0 0.0 
Average error W 3.6 -1.6 -3.5 -3.5 -3.3 -0.6 1.5 0.1 3.5 
Max error below W 3.5 -1.8 -3.5 -3.6 -3.5 -1.2 1.0 -0.2 3.5 
Max error above W 4.0 -1.1 -3.5 -3.5 -2.6 0.3 1.8 0.2 3.5 
Max error limit W 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 
Min error limit W -5.0 -5.0 -5.0 -5.0 -5.0 -5.0 -5.0 -5.0 -5.0 
-6.0 
-4.0 
-2.0 
0.0 
2.0 
4.0 
6.0 
Er
ro
r i
n 
W
at
ts
 
B.6 Monarch arm ergometer calibration.
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B.7 Pre- and post-exercise questionnaire
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B.8 PASW filtering and averaging
B.8.1 PASW script for data averaging
Command Explanation
1 Data exported from Breeze Suite to excel and
then imported to PASW 20.
2 DATASET ACTIVATE $DataSet. All data used.
3 USE ALL.
4 *Decimal time. Time transformed from
fraction of 24 hours to
decimal minutes.
5 COMPUTE Time 2=Time*24.
6 EXECUTE.
7 * A. Chart Builder. Graphs of VT, VE, VO2,
RQ and FIO2 created.
8 GGRAPH Upper and lower limits set
for each parameter. Fig-
ure B.1.
9 /GRAPHDATASET NAME=”graphdataset”
VARIABLES=Time 2 VtBTPS MISS-
ING=LISTWISE REPORTMISSING=NO
10 /GRAPHSPEC SOURCE=INLINE.
11 BEGIN GPL
12 SOURCE: s=userSource(id(”graphdataset”))
13 DATA: Time 2=col(source(s),
name(”Time 2”))
14 DATA: VtBTPS=col(source(s),
name(”VtBTPS”))
15 GUIDE: axis(dim(1), label(”Time 2”))
16 GUIDE: axis(dim(2), label(”Vt BTPS”))
17 ELEMENT: line(position(Time 2*VtBTPS),
missing.wings())
18 END GPL.
19
20 * Chart Builder.
21 GGRAPH
Continued on the next page...
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Command Explanation
22 /GRAPHDATASET NAME=”graphdataset”
VARIABLES=Time 2 FIO2dry MISS-
ING=LISTWISE REPORTMISSING=NO
23 /GRAPHSPEC SOURCE=INLINE.
24 BEGIN GPL
25 SOURCE: s=userSource(id(”graphdataset”))
26 DATA: Time 2=col(source(s),
name(”Time 2”))
27 DATA: FIO2dry=col(source(s),
name(”FIO2dry”))
28 GUIDE: axis(dim(1), label(”Time 2”))
29 GUIDE: axis(dim(2), label(”FIO2 (dry)”))
30 ELEMENT: line(position(Time 2*FIO2dry),
missing.wings())
31 END GPL.
32 * Chart Builder.
33 GGRAPH
34 /GRAPHDATASET NAME=”graphdataset”
VARIABLES=Time 2 VO2 MISS-
ING=LISTWISE REPORTMISSING=NO
35 /GRAPHSPEC SOURCE=INLINE.
36 BEGIN GPL
37 SOURCE: s=userSource(id(”graphdataset”))
38 DATA: Time 2=col(source(s),
name(”Time 2”))
39 DATA: VO2=col(source(s), name(”VO2”))
40 GUIDE: axis(dim(1), label(”Time 2”))
41 GUIDE: axis(dim(2), label(”VO2”))
42 ELEMENT: line(position(Time 2*VO2),
missing.wings())
43 END GPL.
44 * Chart Builder.
45 GGRAPH
46 /GRAPHDATASET NAME=”graphdataset”
VARIABLES=Time 2 RQ MISS-
ING=LISTWISE REPORTMISSING=NO
47 /GRAPHSPEC SOURCE=INLINE.
Continued on the next page...
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48 BEGIN GPL
49 SOURCE: s=userSource(id(”graphdataset”))
50 DATA: Time 2=col(source(s),
name(”Time 2”))
51 DATA: RQ=col(source(s), name(”RQ”))
52 GUIDE: axis(dim(1), label(”Time 2”))
53 GUIDE: axis(dim(2), label(”RQ”))
54 ELEMENT: line(position(Time 2*RQ), miss-
ing.wings())
55 END GPL.
56 DATASET ACTIVATE $DataSet.
57 * Chart Builder.
58 GGRAPH
59 /GRAPHDATASET NAME=”graphdataset”
VARIABLES=Time 2 VEBTPS MISS-
ING=LISTWISE REPORTMISSING=NO
60 /GRAPHSPEC SOURCE=INLINE.
61 BEGIN GPL
62 SOURCE: s=userSource(id(”graphdataset”))
63 DATA: Time 2=col(source(s),
name(”Time 2”))
64 DATA: VEBTPS=col(source(s),
name(”VEBTPS”))
65 GUIDE: axis(dim(1), label(”Time 2”))
66 GUIDE: axis(dim(2), label(”VE BTPS”))
67 ELEMENT: line(position(Time 2*VEBTPS),
missing.wings())
68 END GPL.
69 FILTER OFF. Data filtered using the up-
per and lower limits for
VT, VE, VO2, RQ and
FIO2.
70 EXECUTE. Filtered values labelled as
missing values
71 COMPUTE VO2A=VO2.
72 EXECUTE.
Continued on the next page...
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Command Explanation
73 IF (VtBTPS<270 OR VTBTPS>750 OR
VO2<250 OR VO2>710 OR RQ<0.8 OR RQ
>1.25 OR VEBTPS>22.5 OR VEBTPS<10
)VO2A=-99.
74 EXECUTE.
75 Missing Values VO2A(-99). Formatting of filtered
variables defined.
76 RMV /VO2A 1=MEAN(VO2A 10). Missing value replaced
with the mean of the 10
surrounding values.
77
78 CREATE Data averaged using a
rolling median of 10 val-
ues.
79 /VO2A SM=RMED(VO2A 1 10).
80 COMPUTE VO2ml.kg.min=VO2A SM /56. VO2 ml/min converted to
VO2 ml/Kg/min
81 EXECUTE.
82 GGRAPH Graph of VO2ml/Kg/min
created.
83 /GRAPHDATASET NAME=”graphdataset”
VARIABLES=Time 2
VO2ml.kg.min[name=”VO2ml kg min”]
84 MISSING=LISTWISE REPORTMISS-
ING=NO
85 /GRAPHSPEC SOURCE=INLINE.
86 BEGIN GPL
87 SOURCE: s=userSource(id(”graphdataset”))
88 DATA: Time 2=col(source(s),
name(”Time 2”))
89 DATA: VO2ml kg min=col(source(s),
name(”VO2ml kg min”))
90 GUIDE: axis(dim(1), label(”Time”))
91 GUIDE: axis(dim(2), la-
bel(”VO2ml/kg/min”))
Continued on the next page...
231
Command Explanation
92 ELEMENT: line(position(Time 2*VO2ml kg min),
missing.wings())
93 END GPL.
B.8.2 Example of PASW filtering and averaging
Figure B.1: Medgraphics Breeze Suite filtering and averaging graphs.
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Metabolic monitoring in the intensive care unit: a comparison
of the Medgraphics Ultima, Deltatrac II, and Douglas bag
collection methods
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Editor’s key points
† Energy requirements are
difficult to measure precisely
in critically ill intensive care
unit patients and are not
monitored routinely.
† This small study compared
two commercially available
metabolic monitors
(Medgraphics Ultima and
Deltatrac II) with a Douglas
bag technique.
† There was poor agreement
between readings from the
three devices.
† More accurate devices are
needed to monitor gas
exchange in mechanically
ventilated patients.
Background. The accuracy of oxygen consumption measurement by indirect calorimeters
is poorly validated in mechanically ventilated intensive care patients where multiple
confounders exist. This study sought to compare the Medgraphics Ultima (MGU) and
Deltatrac II (DTII) devices, and the Douglas bag (DB) technique in mechanically
ventilated patients at rest.
Methods. Prospective comparison of oxygen consumption measurement using three
indirect calorimetry techniques in stable, resting mechanically ventilated patients at rest.
Oxygen consumption (VO2), carbon dioxide production (VCO2), resting energy
expenditure (REE), and respiratory quotient (RQ) were recorded breath-by-breath by the
MGU over a 30–75 min period. During this time, simultaneous measurements were taken
using the DTII, the DB, or both.
Results.While there was no systematic error (bias) between measurements made by the
three techniques (VO2: MGU vs DTII 3.6%, MGU vs DB 3.3%), the limits of agreement were
wide (VO2: MGU vs DTII 33%, MGU vs DB 54%).
Conclusions. Resting oxygen consumption values in stable mechanically ventilated
patients measured by the three techniques showed acceptable bias but poor precision.
There is an important clinical and research need to develop new indirect calorimeters
specifically tailored to measure oxygen consumption during mechanical ventilation.
Keywords: indirect calorimetry; mechanical; oxygen consumption; validation studies;
ventilators
Accepted for publication: 1 August 2014
Metabolicmonitoring isnot routinelyperformedinthe intensive
care unit (ICU) setting. However, recent studies and reviews
havehighlightedthe likely importanceofadequateassessment
of energy requirements inmechanically ventilatedpatients.1–4
Hypocaloric feedingwill potentially exacerbate poor functional
outcomes through significant long-term calorie deficits, while
overfeeding is associated with higher mortality rates5 and an
increased length of ICU stay.6 7 Furthermore, a more precise
estimation ofmetabolic activity to prevent over- or underfeed-
ing may improve patient outcomes.8–10
An important challenge arises from the difficulty in achiev-
ing reliablemeasurements. Predictive equations used to calcu-
late energy requirements in mechanically ventilated ICU
patients showpoor agreement against valuesmeasured by in-
direct calorimetry.11 12 Whole-body oxygen consumption can
be measured directly with the pulmonary artery catheter.
However, theuseof this invasivedevicehasdwindledmarkedly
over the last fewyears13andhas inherenterrors, including lung
oxygen consumption and mathematical coupling.14 Even if
used, the catheter is unlikely to remain in situ long after the
resolution of shock or during the recovery phase of critical
illness to avoid infectious and other complications. Thus, the
non-invasive technique of indirect calorimetry, using data
obtained from inspired and expired gas analysis, is the most
readily available means of measuring oxygen consumption
and carbon dioxide production.
TheDeltatrac II (DTII, DatexOhmeda, Finland) has been the
mostwidely used and validated device in the ICU,15 16 but is no
longer manufactured nor supported. Newer devices are cur-
rently targeted towards exercise testing in spontaneously
& The Author 2014. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved.
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breathing patients and little validation data are available in
mechanically ventilated patients. While in vitro validation of
such devices using lung simulatormodels is straightforward,17
in vivovalidation techniquesare farmorechallengingasmech-
anical ventilation introduces significant inconsistencies in
temperature, humidity, peak airway pressure, expiratory flow
rates, and bias flow. We thus decided to compare readings
obtained from a currently available device, the Ultima (MGU)
manufactured by Medgraphics (St Paul, Minneapolis, MN,
USA), with traditional ‘reference standards’ the DTII, and
the Douglas bag (DB) technique, in mechanically ventilated
patients at rest.
Methods
Ethical approval was granted for the study (REC reference
number: 09/H1307/107) and informed consent or surrogate
approval obtained from all patients or their next-of-kin.
Patients undergoing mechanical lung ventilation with
stable settings were recruited from the ICU at University
College Hospital, London, UK. Patients were excluded if they
had burns, endotracheal or tracheal leaks .10%, open chest
drainage, an inspired oxygen (FIO2 ) ≥0.6, were pregnant,
,18 yr of age, or had cardiorespiratory instability requiring
frequent changes in ventilator settings, FIO2 , inotropic, or seda-
tive drug dosages. The measurements were taken simultan-
eously; therefore, factors such as room temperature and
nutritional statuswerenot controlled. Themechanical ventila-
tor used in all studieswas theServo-i (Maquet, Solna, Sweden).
Before each test, theDTII andMGUmachineswerewarmedup
for 30 min and calibrated in line with the manufacturers’
instructions. Patients were clinically stable for 30 min preced-
ing measurement (,20% variation in heart rate, arterial
pressure, or oxygen saturation). Mechanical ventilation set-
tings were kept stable over the hour preceding and during
the test period.
Oxygen consumption (VO2), carbon dioxide production
(VCO2), resting energy expenditure (REE), and respiratory quo-
tient (RQ) were recorded breath-by-breath by the MGU over a
30–75 min period. During this time, simultaneous measure-
ments were taken using the DTII, the DB, or both. The tests
were repeated, where possible, at different time points over
the subsequent month to collect up to three paired measure-
ments per patient using both MGU and DTII, and MGU and DB
collection techniques (Fig. 1A and B).
DB collection
Thismethod, first described in 1911 by theOxford physiologist,
GordonDouglas,18 has latterly been used to validatemeasure-
ments made by various metabolic monitors.19–22 For the
current study, gas was collected over three 5 min periods
fromtheexpiratoryexhaustof theventilator, intoseparatepre-
labelled 100 litre PVC gas collection bags (Harvard Apparatus
Ltd, Edenbridge, UK). Pre-labelled 50 ml syringes and three-
way taps were purged with 100 ml of expired gas from the re-
spective gas collection bags, before aspiration of 50 ml of gas
for analysis from each bag. Twenty millilitres of this gas were
thenanalysedusingabloodgasanalyser (ABL735or825, Radi-
ometer, Brønshøj, Denmark). Two precision gases; 5% CO2/
55% O2 (General Electric, Amersham, UK) and 1.5% CO2/21%
O2 balanced with N2 (BOC, Windlesham, UK) were used to
I E
MGU
Ventilator
Deltatrac II
Expired gas
F I
sampling line
I
MGU
Ventilator
Expired gas
Douglas bag
A
Douglas bag
C
Douglas bag
B
A B
2O
E
Fig 1 Schematic for (A) MGU and DTII set-up and (B) MGU and DB set-up.
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create reference equations for the gas analysers before the
study began.
Thegas collectionbagswereemptiedusingawall-mounted
suction unit set at low flow, through a Harvard dry gas meter
(Harvard Apparatus, Holliston, MA, USA) calibrated at the be-
ginning of the study. VO2, VCO2, and REE of the DBs were then
calculated (Supplementary material SA).
Deltatrac II
First described by Merila¨inen,23 this open-circuit calorimeter
has two chambers. The first chamber collects and mixes the
gas expired by the patient. Gas is then sampled from this
chamber and the fraction of expired O2 and CO2 analysed
using paramagnetic and infrared analysers, respectively. The
expired gas is then drawn through an air dilution chamber at
a constant flow rate of 40 litre min21. The flow rate and RQ
were calibrated using an ethanol burn test before commence-
ment of the study.24 Gas is sampled from the air dilution
chamberand the fractionofCO2analysed, allowingcalculation
of the volume of CO2 expired by the patient, that is,
VCO2 = FECO2 × 40 (flow constant). The RQ is derived from a
transformation of the Haldane equation with the assumption
that nitrogen is neither produced nor retained by the body,
and thatnogasesarepresent other thanO2, CO2, andnitrogen.
As theDTIImeasures neither flownor volume, it is not affected
by flow-by.
Data were collected over 1 min intervals. The mean of the
values obtained over the first 5 min period where the
within-test coefficients of variation of both VCO2 and VO2
were ≤5% was used in the analysis.25–27
Medgraphics Ultima
The MGUmeasures inspiratory and expiratory flows through a
bi-directional flow sensor and therefore does not require the
Haldane equation used by most indirect calorimeter devices
to calculate inspiratory volumes from expiratory volumes.
The oxygen analyser is a fuel cell with a response time ,80 ms,
while the carbon dioxide analyser is a non-dispersive infrared
sensor with a response time ,150 ms. The system samples
gas continuously and phase aligns O2 and CO2 signals with
the flow signal to calculate inspired and expired values. In
vitro validation of the device was carried out jointly by the
study group and Medical Graphics UK (Gloucester, Glos, UK)
using a lung simulator.17 The flow sensor was calibrated
using a 3 litre syringe and the gas analysers were calibrated
with precision gas before each individual test.
Data points within the MGU tests were excluded if the RQ
was ,0.6 or .1.2, the VT was ,150 ml, or the VO2 or VCO2
were ,50 ml min21. Collected data were then averaged as
the middle five of seven breaths.
Analysis
Simultaneous MGU recordings were used for comparison
against both DTII and DB measurements. Measurements
were discarded if the mean RQ value obtained from either
the 5 min DTII or the three DB collections were ,0.6 or
.1.2. Data were to be excluded if the coefficient of vari-
ation (COV) was .10% for individual DB collections, in the
event, none needed to be excluded or .5% for the DTII
tests. All coefficients of variation for the MGU tests were
,14%. The Bland–Altman plots (mean measurements
made by the two devices vs the difference in measure-
ments between the devices) were used to calculate preci-
sion and bias. We decided a priori that a 30% error was
acceptable, as recommended by Critchley and Critchley.28
This would give +600 kcal day21 error for a patient con-
suming 2000 kcal day21.
Results
Sixteen patients were recruited and tested on 39 occasions.
Patient characteristics and ventilator settings for each test
are given in Table 1. Comparisons between techniques,
number of tests performed, and proportion of excluded tests
are shown in Table 2, while the reliability of the individual tech-
niques is shown in Table 3.
TheBland–Altmanplots of VO2, VCO2, REE, and scatter plots
for RQ are presented in Figure 2, with bias and precision (95%
limits of agreement) shown in Table 4.
Medgraphics Ultima vs Douglas bag
Nineteenvalid testswere carriedout inninepatients. Although
biaswas good for VO2, VCO2, and REE, precisionwasweakwith
wide levelsofagreementandamaximumrandomerrorof54%
forVO2, 51%forVCO2, and43%for REE. If proportionalityof the
measurements is taken into account and the percentage error
foreach individualdataset calculated, then the randomerror is
42% (227% to 15%) for VO2, 57% (217% to 40%) for VCO2,
and 32% (29% to 23%) for REE (Supplementary material SB).
Medgraphics Ultima vs Deltatrac II
Nineteenvalid testswerecarriedout in10patients.Overall bias
was good for VO2, VCO2, and REE; however, yet again, there
werewide limitsofagreement forall threemeasures. Itwassu-
perior to the comparison betweenMGUand the DB techniques
with random errors of 33%, 27%, and 31% for VO2, VCO2, and
REE, respectively. If proportionality of measurements is taken
into account, and the percentage error for each data set calcu-
lated, then the randomerrorwidens to41% (213%to28%) for
VO2, 31% (2%to29%) for VCO2, and37%(228%to9%) for REE
(Supplementary material SB).
Discussion
This studydescribestheuniquecomparisonofacurrentlyavail-
able device the Ultima (MGU) with traditional reference stan-
dards, the DTII and the DB techniques, in mechanically
ventilated patients at rest.
While the systematic error (bias) between the MGU mea-
surements of VO2, VCO2, and REE, and both those of the DTII
and the DB, was acceptable, the limits of agreement were
wide. Comparisonbetween theMGUand theDTIIwasmoreac-
ceptable but at the margins of acceptability for the measure-
ment of metabolic activity, either for research or clinical
A comparison of three metabolic monitoring methods in ICU BJA
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purposes, albeit assuming the DTII represents an accurate ref-
erence standard. There is a remarkable lack of consistency in
the criteria deciding comparability between a reference tech-
nique and new devices. Using cardiac output measurement
techniques as an example, Critchley and Critchley28 proposed
that the accuracy of both devices should be taken into
account. Thus, if the reference device, in this case, the DTII,
was considered to have an accuracy of +20% and the test
method, in this case, the MGU, a similar accuracy, then the
shared limits of agreement would be+28%.
The MGU is predominantly used in exercise testing in
spontaneously breathing patients.29 Validation for this
device is relatively scanty, even in spontaneously breathing
subjects. Cooper and colleagues30 compared the MGU and
four other devices against the DTII in resting subjects and
found all were inferior in terms of within-patient COV for
resting metabolic rate, ranging from 4.8% to 10.9% com-
pared with 3% for the DTII. Other studies in healthy self-
ventilating individuals using the Medgraphics CCM Express,
a device similar to the MGU, have shown acceptable agree-
ment, although lower absolute values compared with the
reference technique.31 32 VO2 in mechanically ventilated
patients at rest is relatively low (400 ml min21), in com-
parison with the 2–5 litre min21 values seen at peak exer-
cise in ambulant healthy individuals.33 Therefore, the
signal-to-noise ratio is far greater in resting mechanically
ventilated patients than that recommended by the exercise
testing literature.34
Data directly validating indirect calorimetry devices inmech-
anically ventilated patients are also scarce, despite their promo-
tionasatool totitratenutritional input.Arecentstudy35 in24ICU
patients reported the mean REE values as 64% higher for the
Table 1 Patient characteristics. FIO2 , fraction of inspired oxygen
Patient Test Reason for admission Age BMI Gender Pressure support PEEP FIO2
1 1 AAA repair 82 29 M 12 5 0.35
2 12 5 0.40
2 1 Pneumonia 45 14 F 9 2 0.35
3 1 Gastric resection 79 25.7 F 5 5 0.40
2 12 5 0.45
3 12 5 0.45
4 1 Pneumonia 70 30 M NAVA 5 0.30
2 NAVA 5 0.30
3 NAVA 5 0.30
5 1 Pneumonia 71 20 M 13 5 0.25
2 13 5 0.25
6 1 Coronary artery bypass graft 78 — M 12 10 0.50
2 12 10 0.55
3 6 10 0.45
7 1 Whipple’s procedure 66 — M 10 5 0.30
8 1 Hemi-colectomy 75 21.7 F 13 5 0.35
2 12 5 0.25
3 10 5 0.30
9 1 Pancreatitis 79 27.7 M 10 5 0.25
2 15 5 0.25
3 0 0 0.28
10 1 Small bowel resection 79 19.7 F 5 5 0.28
2 5 5 0.28
3 5 5 0.30
11 1 Thrombotic thrombocyto-penic purpura 58 35 F 10 5 0.30
2 10 5 0.35
3 0 5 0.35
12 1 Pleurodesis 76 34 M 8 5 0.30
13 1 Small bowel ischaemia 69 — F 14 5 0.35
2 5 5 0.30
3 0 5 0.30
14 1 Urosepsis and heart failure 74 — F 20 5 0.40
2 20 8 0.30
3 15 5 0.30
15 1 Femoral artery aneurysm 69 — M 0 5 0.25
2 0 5 0.30
16 1 Pneumonia and heart failure 61 47.3 M 0 5 0.30
2 0 5 0.30
3 5 5 0.30
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CCM Express compared against the Deltratrac. Repeated read-
ings from the same instrument gave a COV of 4.1% and 7.9%
for Deltatrac and CCM Express, respectively. In the present
study,wedidnotfindasystematicbias, although limitsofagree-
mentwerewide. The coefficients of variation for VO2were,5%
between each minute of the 5 min test for the DTII, ,10%
between each bag in a single DB collection test, and ,14% for
breath-to-breath measurements with the MGU. However,
despite our measurements being taken at rest, the pattern of
breathing ofmost patients was irregular. Thismay have contrib-
uted to the intra-device differences, in particular the MGU that
measures breath-by-breath, the DT that measures over 1 min,
while the DB measure is averaged over a 5 min collection. This
is consistent with the lack of bias but poor precision seen
between techniques.
Given the high likelihood of a marked day-to-day variability
in VO2 in ICU patients, we felt that repeatability of tests taken
over different days could not be reliably assessed. Our pilot
data did however demonstrate that COV between repeated
tests taken within the same hour in resting patients was
between 1% and 9%.
The accuracy of the reference standard must be taken into
account. Tissot and colleagues22 directly compared the DTII
with either DB gas collections ormass spectroscopy in 35mech-
anically ventilated patients, and found both excellent bias and
precision. On the other hand, Takala and colleagues16 found
VO2 values obtained from the Deltatrac were consistently
higher than pulmonary artery catheter-obtained indirect Fick
measurements in ICU patients after cardiac surgery. These
ranged from 16 (9)% during controlled ventilation, 21 (8)%
during synchronized intermittent mandatory ventilation, to 25
(8)% during spontaneous breathing. Levinson and colleagues36
also found that VO2 measured by indirect calorimetry (using a
DBandmass spectrometry)was15%higher than thatmeasured
by thermodilution in29mechanically ventilatedpatients. Inpart,
this discrepancy may be related to lung oxygen consumption
which is not measured by thermodilution and estimated to be
14 (3)%ofwhole body VO2.
37 Other studies also report inconsist-
ent findings regarding the accuracy of newer devices compared
against the DTII, for example, the M-COVX device.38–40
Many of these studies were performed using mechanical
ventilatorsthatdidnotusebiasflow(flow-by). This isacontinu-
ous flow of gas, usually in the order of 2 litre min21 of the
pre-set level of inspired O2 that is incorporated into most, if
not all, modern ventilators. It is delivered through the ventila-
tion circuit and reduces the work of breathing and the sensa-
tion of air hunger experienced by the patient during the
breath trigger phase of the breathing cycle. Depending on
thedevice beingutilized foroxygen consumption,mishandling
of this extravolumeofoxygenadded to theexpiredvolumecan
significantly impact on the values obtained. Both theMGU and
DTII are unaffected by bias flow; the MGU utilizes a flowmeter
sited at the tracheal tubewithin the ventilator circuit, while the
DTIImeasuresneitherflownor volumeaspartof its calculation
technique.However, this is apotential sourceof error for theDB
collectionoranyotherdevice that reliesonexpiratory volumes.
On theother hand, thedead space created by ventilator tubing
and heat–moisture exchange systems must be adequately
accounted for, so that the MGU correctly phase aligns the
flow, oxygen, and carbon dioxide signals.
For reliable measurements, scrupulous attention needs to
be paid to the performance of the different techniques, and
awareness of the many potential pitfalls. For example, both
the DB technique and the indirect calorimetry have multiple
potential sources of error (Tables 5 and 6). While every
attempt was made to control these errors during this study,
the Bland–Altman plots illustrate considerable random
rather than systematic error. A 16% measurement error for
VO2 is recognized for the DB technique.
36
We reduced the potential physiological variability of the tests
by performing measurements simultaneously. The possibility
that the sampling techniques bias each other was small. The
DTII samples inspiratory gas continuously at 150 ml min21
against a meanminute ventilation (MV) of 12 litre min21 giving,
at worst, a reduction of 1.25% of minute volume. The MGU
samplesgascontinuously,bothduring inspirationandexpiration,
at amaximumof 130mlmin21, potentially creating a 0.36% in-
spiratory volume error and a 0.72% expiratory volume error.
The MGU consistently reported greater MV than the Servo-i
ventilator. This error can be accounted for in the different
ways the gases are described by the respective device; MGU
as body temperature and pressure-saturated and Servo-i as
Table 2 Distribution of tests across patient samples. MGU,
Medgraphics Ultima; DB, Douglas bag; DTII, Deltatrac II; RQ,
respiratory quotient; COV, coefficient of variation
Comparison No. of
patients
tested
No. of
tests
No. of
tests
used
Reason for
not using
tests
MGU vs DB 9 25 19 (1) MGU COV
and RQ DB
(2) MGU COV
and RQ DB
(3) MGU COV
and DTII
RQ
(4) DTII COV
and RQ DB
MGU vs DTII 10 24 19
Total 16 39 35 4
Table 3 Reliability of the individual techniques. MGU, Medgraphics
Ultima;DB, Douglas bag; DTII, Deltatrac II; RQ, respiratoryquotient;
COV, coefficient of variation
Technique Unusable data Reason why unusable
MGU 3 of 39 (7%) Unstable VO2
DB 26 of 75 bags collected
(34%)
19 RQ unacceptable
Six volume loss from DBs
One expiratory gas analysis
error
DTII 3 of 24 (12%) Two RQ unacceptable,
1COV error
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Fig 2 Bland–Altman plots for VO2 and VCO2, and scatter plots for RQ for comparisons between the MGU, DTII, and DB techniques. Each colour
represents an individual patient. All plots are MGU-the reference device.
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atmospheric temperature and pressure-saturated at 218C. Of
interest, the Servo-i delivers a 10–20% larger breath than
most clinicians would expect (Supplementary material SC).
As a clinical tool, changes in VO2may bemore relevant and
reliable than absolute values, for example, in response to a
physiological challenge (e.g. sitting on the edge of bed,
change of ventilator settings).
Our study enrolled relatively low numbers of patients with a
limited range of VO2, but it serves to highlight some of the
issues and pitfalls that must be addressed to develop a meta-
bolic monitoring device that is fit for purpose. Such a device
needstobe integrated intoamechanical ventilator, accommo-
date thechallengesof temperature, humidity, dead space,and
tidal volume entropy and specifically have precision at low
levels of VO2.
Conclusion
Although showing lowbiaswhen comparedwith the reference
methodsof theDB techniqueand theDTII indirect calorimeter,
the MGU lacks precision. This may be due in part to limitations
of the reference methods. For this field to move forwards, in-
dustry must collaborate with clinicians and researchers to
improve the accuracy of devices that monitor gas exchange
in mechanically ventilated patients.
Supplementary material
Supplementarymaterial is availableatBritish Journal ofAnaes-
thesia online.
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